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STELLINGEN 
behorende bij het proefschrift 
"Permeability and modulation of the intestinal epithelial barrier in vitro" 
van Erwin Duizer, 
te verdedigen op woensdag 16 juni 1999, om 16.00 uur te Wageningen. 
1 Voor het modeleren van de paracellulaire permeabiliteit van de dunne darm voor 
hydrofiele macromoleculen voldoet het twee-compartimenten systeem beter als het 
wordt uitgerust met dunne darm cellen (IEC-18) dan met, van oorsprong, dikke darm 
cellen (Caco-2) (dit proefschrift). 
2 Veranderingen in de transepitheliale elektrische weerstand (TER) zijn geen goede 
kwantitatieve indicatie voor veranderingen in de transepitheliale permeabiliteit voor 
macromoleculen (dit proefschrift). 
3 Het voorspellen van de orale bio-beschikbaarheid van een stof, ongeacht de absorptie 
route, aan de hand van een enkel in vitro model is nu nog niet mogelijk (dit 
proefschrift). 
4 Cadmium heeft enkele eigenschappen gemeen met de ideale "drug absorption enhancer" 
(dit proefschrift). 
5 Het gebruik van "permeation enhancers" kan gemakkelijk leiden tot een verhoging van 
het aantal mensen met voedselallergie. 
(Pena and Crusius. Food allergy, coeliac disease and chronic inflammatory bowel disease in man. Vet. Q. 
1998;20Suppl3:S49-52. 
Ahmed and Fuchs. Gastrointestinal allergy to food: a review. J. Diarrhoeal Dis. Res. 1997;15:211-23). 
6 Dat verminderde gluthation peroxidase activiteit door Selenium-deficientie kan leiden 
tot enterovirale myocarditis, is eerder toe te schrijven aan een verhoging van de 
virulentie van de enterovirussen dan aan een verminderd functioneren van het 
immuunsysteem. 
(Beck et al. Increased virulence of a human enterovirus (Coxsackievirus B3) in selenium-deficient mice. J. 
Inf. Dis. 1994;170:351-357. 
Beck et al. Glutathione peroxidase protects mice from viral-induced myocaritis. FASEB J. 1998;12:1143-
1149). 
7 In een celkweek laboratorium is er een positieve correlatie tussen de reproduceerbaarheid 
van de experimenten en het alcohol gebruik. 
(Ojeh et al. Evaluation of the effects of disinfectants on rotavirus RNA and infectivity by the polymerase 
chain reaction and cell-culture methods. Mol. Cell Probes 1995;9:341-346). 
8 De angst dat chimpansees een reservoir zullen vormen voor levend poliovirus en 
daarmee de eradicatie van polio in gevaar brengen is ongegrond, het is waarschijnlijker 
dat de chimpansees eerder zijn ge-eradiceerd dan het poliovirus. 
(Dowdle and Birmingham. The biological principles of poliovirus eradication. J. Infect. Dis. 
1997;175:S286-S292). 
9 Een turner staat het liefst niet met beide benen op de grond. 
10 Voor zowel cabaret programma's als wetenschappelijke artikelen geldt 
"gebruik altijd de teksten van een ander tenzij die van jezelf beter zijn" en 
"schrijven is schrappen". 
(Herman Finkers en dit proefschrift). 
In dankbare herinnering, 
voor mijn vader 
A good place to begin is at the beginning, 
because otherwise things can get confuzzled. 
Winnie-the-Pooh 
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Introduction and Methodology 
Chapter 1 Introduction 
Chapter 1 
General Introduction 
Manuscript based on the chapters 1, 2 and 8 in preparation; to be submitted to ATLA. 
In a challenging effort to gain a better insight in oral bioavailability of food components, 
toxicants, and drugs, we studied the absorption and barrier characteristics of two intestinal cell 
lines, Caco-2 and IEC-18, cultured in a two-compartment system. We wondered whether the rat 
small intestinal cell line IEC-18 could provide a better model than the Caco-2 cell line, in 
obtaining in vitro permeation rates to predict oral bioavailability in vivo, for non-nutrient 
hydrophilic molecules. 
Secondly, in order to gain insight in the mechanisms by which the integrity of the epithelial 
barrier may be compromised, the filter-grown cells are exposed to a drug absorption enhancer 
(palmitoyl carnitine) and to a possible food contaminant (cadmium). In these experiments the 
relation between increased permeability for hydrophilic macromolecules, an altered paracellular 
barrier structure, and the viability of the epithelial cells was assessed. 
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§ 1.1 Introduction 
The bioavailability of all ingested compounds is to a great extend determined by the ability 
of these compounds to pass the intestinal epithelium. A high bioavailability is guaranteed for most 
nutrients and electrolytes since they are actively absorbed by the epithelium. The same epithelium, 
however, presents an almost impermeable barrier to non-nutrient (potentially harmful) hydrophilic 
(macro-) molecules, viruses and bacteria, rendering their entrance into the systemic circulation 
very low. To perform its function as a selective absorber (or a selective barrier) on the interface 
between the intestinal lumen and the internal host milieu, the intestinal epithelium has evolved 
into a highly specialized structure. The single cell layer forming the intestinal epithelium consists 
of several cell types, each with a specific morphology and function. For example, the intestinal 
epithelial absorptive cells, the enterocytes, are polarized to allow vectorial transport, they posses 
microvilli to enlarge the absorptive area, and the cells are sealed together by a junctional complex 
to maintain a barrier in order to avoid absorption of potentially harmful compounds and to prevent 
back-flow of the actively absorbed nutrients. 
The complexity of the gastrointestinal tract, and the complications caused by pre-and post-
absorptive kinetics when studying the absorption and barrier functions of the intestinal epithelium 
in vivo, were great stimuli to develop in vitro models for the intestinal epithelium. One of the 
established in vitro models consists of epithelial cells grown on a permeable support in a two-
compartment system. The development, characterization and application of this model was 
recently boosted by the need for a high-throughput screen to select drugs with oral bioavailability, 
and by the recognition that the filter-grown intestinal epithelial Caco-2 cells allowed the 
determination of in vitro permeation rates, that were predictive for in vivo oral bioavailability, for 
a wide variety of compounds (Artursson and Karlsson, 1991). 
However, for hydrophilic molecules, which were not transported across the epithelium by 
transporters or carriers, the permeation rates obtained with these colonic carcinoma derived Caco-
2 cells, were very low and did not allow for an accurate determination of the expected 
bioavailability. The absorption of these hydrophilic compounds must occur by the paracellular 
pathway, i.e. the route along the cells. However, the rate limiting barriers in the paracellular 
pathway, the tight junctions, are much more restrictive (colon-like) in the Caco-2 cell layers than 
in the small intestinal epithelium in vivo. Since permeation will occur at sites posing the lowest 
resistance, permeation of hydrophilic compounds will occur in the small intestine. At the moment 
there is no established model available which mimics the permeability of the small intestinal 
epithelium for non-nutrient hydrophilic molecules. The IEC-18 cells might pose such a model 
because these cells are derived from the small intestine and they were found to be able to grow 
on filters. We, therefore, chose to study the paracellular permeability of the small intestinal cell 
line IEC-18 and compare this to the permeability of the colonic carcinoma cell line Caco-2. 
The permeability of the intestinal epithelium is not a fixed measure, but it is subjected to 
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various modulations. The absorptive and barrier functions are regulated physiologicaly, for 
example, by serosal peptide hormones (Hochman and Artursson, 1994) or luminal D-glucose 
(Madara and Pappenheimer, 1987), but it can also be hampered in patho-physiological conditions 
(Hollander, 1988; Schulzke et al., 1998). It has also been recognized that nutritional and 
xenobiotic compounds can modulate the epithelial integrity by causing lytic mucosal damage, or 
by opening the paracellular pathway (Hochman and Artursson, 1994). The opening of the 
paracellular pathway depends on changes in the structure and function of tight junctions, and it 
is now understood that a great variety of cellular signaling pathways is involved in controlling the 
barrier function of the tight junctions (see § 1.6). Especially the interest of pharmaceutical 
companies in making drugs with a low intestinal absorption rate, available as oral dosing, has 
triggered the development of an in vitro system to screen drug absorption enhancers for effects 
on the intestinal barrier function, i.e. to establish the relation between efficacy and (mucosal) 
toxicity. However, perturbation of the intestinal epithelial barrier function is not a feature of drug 
absorption enhancers alone, but it can also be caused by food additives or food contaminants. In 
the studies described in this thesis the filter-grown Caco-2 and IEC-18 cells have been evaluated 
as in vitro models to determine the effects of drug absorption enhancers and food components on 
the intestinal epithelial barrier. Furthermore, a method allowing the assessment of effects which 
occurred concomitantly with a reduced barrier function, when the epithelial-like cell sheets were 
exposed to barrier disruptors (e.g. drug absorption enhancers or food contaminants), would help 
to gain insight in the mechanism of barrier disruption, i.e. to determine whether permeation 
enhancement was due to increased paracellular or transcellular permeation. 
§ 1.2 Transepithelial permeation routes in the intestine 
The anatomy of the gastrointestinal tract with the presence of structures that greatly 
increase the total surface area of the intestinal epithelium (i.e. plicae circularis, mucosal crypts 
and villi, and the microvilli at the apex of the absorptive cells), indicates that the intestinal tract 
is structured to perform its absorptive function. For most nutrients, the villus tips of the small 
intestine suffice to absorb most of the ingested load. The epithelium at the villus tips consists of 
a single cell layer of highly differentiated columnar absorptive enterocytes and several (5-10%) 
mucus secreting goblet cells (Madara and Trier, 1994; Kato and Owen, 1994). Absorption across 
this cell layer can occur by two different routes: one through the cells, the transcellular pathway 
and one along the cells, the paracellular pathway. In the intestinal epithelium the transcellular 
pathway occupies more than 99.9% of the total surface area, leaving less than 0.1 % of the total 
surface area for the paracellular pathway. 
Lipophilic molecules (0 < log D < 4, where D is the octanol/water partition coefficient) 
can be absorbed by energy-independent (passive) diffusion (route A in Figure 1.1) due to their 
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solubility in the lipid bilayers (Wils et al., 1994b and references therein). Hydrophilic (log D <0 
) molecules can not readily pass the lipid bilayers but their transcellular absorption can be 
facilitated by substrate specific active transporters (route E in Figure 1.1), carriers (i.e. energy-
independent carrier proteins, route C in Figure 1.1) or by passive membrane passage through 
channel proteins (i.e. ion channels) in the apical and/or basolateral membrane. The absorption of 
nutrients such as mono-saccharides, amino acids and di/tripeptides, and of electrolytes such as 
sodium, chloride and potassium is mostly energy-dependent (active) transport, and is performed 
by substrate specific and saturable transporters (reviewed in Alberts et al, 1989; and Sadee et al, 
1995). It is important to note that passive and facilitated diffusion is driven by a concentration 
gradient and that it can take place in both directions, while active transport is energy-dependent, 
vectorized and can take place against a concentration gradient. The pathways and mechanisms by 
which the various compounds may cross the intestinal epithelium are shown in Figure 1.1. 
B D E F 
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Figure 1.1: Transepithelial permeation routes in the intestine:A; passive transcellular diffusion, B; passive 
paracellular diffusion, C; facilitated transcellular diffusion, D; solvent drag, E; active transcellular transport, F; 
transcytosis, LIS; Lateral Intercellular Space. 
The combination of a large surface area and the activity of apical and basolateral carriers 
and transporters brings about an absorptive capacity for small molecules which generally exceeds 
the intake. Whereas the epithelial permeability for lipophilic and small hydrophilic molecules 
(nutrients) is generally high, the epithelial permeability for macromolecules is low and the 
nutritional significance of the absorption of intact peptides (>3 amino acids), proteins or other 
macromolecules (> 400 Da) is considered to be negligible (i.e. < 1 % bioavailability; Lennernas, 
1998; He et al, 1998). However, even low transepithelial passage of these molecules can be of 
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great importance due to the possibly high intrinsic biological, immunological, toxicological or 
therapeutical activity of those molecules. Furthermore, many data are based on the low 
bioavailabilities found in animal or human volunteer experiments. These data may underestimate 
the actual transepithelial passage of the compounds due to, for example, the inappropriate 
extrapolation of incomplete urinary recovery profiles (Nasrallah and Iber, 1969) or instability of 
the compounds in the gastrointestinal tract or in the body. 
The transepithelial permeation of macromolecules can occur by the transcellular or 
paracellular route. The transcellular route for macromolecules comprises the passive trans-
membrane route for lipid-soluble compounds and (active) receptor mediated transcytosis (route 
F in Figure 1.1) for proteins and viruses (Okamoto, 1998). Transcellular passage of bio-active 
macromolecules is, however, greatly diminished by cytoplasmatic or lysosomal digestive activities 
in the enterocytes (Gardner, 1994). Increased transepithelial permeation of macromolecules is 
found to occur in neonates and in the M cells in the small intestine of adults. In neonates of many 
mammal species, considerable amounts of intact orally ingested proteins can be absorbed due to 
the incompleteness of the intestinal closure at the time of birth. The higher permeability to 
macromolecules of the intestinal epithelia of neonates most likely has a transcellular (transcytotic) 
and a paracellular component, and is important for acquiring passive and active immunity 
(Henning et al, 1994). In the adults' small intestine, the M cells overlay the Peyers patches and 
seem to be specialized in transporting luminal antigens over the epithelium to the underlying 
immunocompetent cells. They differ from the absorptive villus enterocytes not primarily by a 
higher transcytotic capacity, but by a lower degradative activity (Madara and Trier, 1994). 
Transepithelial passage of macromolecules by the paracellular route (Route B in Figure 
1.1) would get round the intracellular degradative processes. The significance of the paracellular 
pathway to the absorptive capacity of the intestinal epithelium is still uncertain. This pathway, 
through an "aqueous pore", is available to hydrophilic molecules. Transepithelial passage by this 
extracellular route depends on passive diffusion, but might be enhanced by the induction of 
solvent drag. The tight junctional permeability is size- and charge- (cation-)selective, but the 
influence of the size of the molecules is dominant over that of the charge in the intestinal epithelia 
(Pauletti et al,. 1997). The permeability and size selectivity of the paracellular route varies along 
both, the longitudinal and the crypt-villus, axis of the gastrointestinal tract. The diameter of the 
junctional pore decreases from an estimated 30-40A in the most leaky part of the small intestine, 
the jejunal crypts, to 3-6 A in the human colon (Chadwick et al, 1977; Powell, 1987; Cerejido, 
1992; Ma et al, 1995; Thillainayagam, 1998). In the small intestine the paracellular permeability 
decreases from crypt to villus (Madara and Trier, 1994; Schulzke et al, 1998). Marcial et al. 
(1984) calculated that in the ileum, 73% of paracellular conductance was attributable to the crypts. 
The contribution of the highly permeable crypts to the total intestinal paracellular absorption is, 
however, questionable due to the low availability of the crypt surface area and the secretory nature 
of the crypts (Bjarnason et al, 1995; Madara and Trier, 1994; Barrett, 1997). Even though larger 
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pores are suspected to be present within the gastrointestinal epithelium as a whole, paracellular 
passage in vivo is generally found to be restricted to molecules < 11 A (Madara, 1989; Hochman 
and Artursson, 1994; Fasano, 1998). 
Although paracellular passage is essentially passive, the combined activity of digestive 
enzymes, apical and basolateral carriers and transporters may cause an additional absorptive 
paracellular process called "solvent drag" (route D in Figure 1.1). Solvent drag is the presumed 
result of a high osmotic load of electrolytes and nutrients in the lateral intercellular space (LIS), 
caused by the activity of Na-coupled nutrient transporters. The high osmotic load in the LIS leads 
to an osmotic gradient between the lumen and the LIS and to morphological alterations in the 
junctional complex, which in turn allow a flow of luminal fluid through the tight junctions into 
the hyper-osmotic LIS. It has been suggested (Pappenheimer and Reiss, 1987; Atisook and 
Madara, 1991; Pappenheimer, 1993) that this route contributes considerably to the absorption of 
nutrients (up to 60 to 80% for monosaccharides and amino acids) in the small intestine. However, 
the significance of the by solvent drag increased intestinal permeability is questioned by others 
(Fine etal, 1993; Uhing, 1998). 
§ 1.3 The transcellular barriers of the intestinal epithelium 
Being the first contact site of all orally ingested compounds, the epithelium of the 
gastrointestinal tract has an important absorptive function for nutrients but it also needs to present 
a barrier to absorption of potentially harmful compounds. It is this barrier that also limits the 
bioavailability of many orally administered drugs. The barrier related features of small intestinal 
villus epithelial enterocytes are shown in Figure 1.2 and will be discussed in more detail in this 
paragraph. In the barrier presented by the intestinal epithelium, as in the epithelial absorptive 
function, it is possible to discriminate a transcellular and a paracellular component. Other, non-
enterocytal, barriers such as the luminal degradation, the aqueous boundary layer, the mucus layer 
(Karlsson, 1995) and the immunological barriers (e.g. IgA secretion) are beyond the scope of this 
thesis. 
Some of the barrier features mentioned could also be presented in the absorptive function. 
Brush border enzymes (C in Figure 1.2) such as peptidases and oligo- and disaccharidases, for 
intact absorbtion. example, enhance the absorption of di/tripeptides, amino acids and 
monosaccharide, but they do so by breaking down proteins and carbohydrates. Furthermore, the 
cell membranes are essentially permeable for lipophilic compounds but present an impermeable 
barrier for hydrophilic compounds.Not only in the brush-borders, but also in the cytoplasm and 
lysosomes, the cells contain all kinds of digestive enzymes which can degrade macromolecular 
compounds to prevent intact absorbtion. 
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Figure 1.2: Epithelial permeation barriers of the intestine: Epithelial permeation barriers of the intestine: A; apical 
cell membrane, B; basolateral cell membrane, C; degradative brush border enzymes, D; intracellular degradative 
enzymes, E; tight junctions, F; apical efflux systems, G; phase I metabolizing enzymes, H; phase II metabolizing 
enzymes, I; intracellular sequestration of toxic compounds and extrusion of dead cells. 
Besides the general structural barriers (membranes) and the digestive enzymes, mature enterocytes 
also posses several features more specifically involved in limiting oral bioavailability of 
potentially harmful compounds. This barrier activity depends on cellular metabolizing enzymes 
(G and H in Figure 1.2) such as glutathione S-transferases and cytochrome P450, and on efflux 
proteins in the apical membrane (F in Figure 1.2). Recently there has been much attention for the 
expression and functions of efflux systems, and several were found to be expressed in the 
intestine. Examples are, the permeability-glycoprotein (P-gp) which was found to be expressed 
in the apical cell membrane of intestinal epithelial cells (Terao et al., 1996), the multidrug 
resistance associated protein 1 (MRP1) and MRP2/cMOAT (canicular multispecific organic anion 
transporter, Makhey et al., 1998). The activity of the metabolizing enzymes might even be 
orchestrated with the activity of the efflux systems in the intestinal apical cell membrane. For 
example, the significant overlap in substrate specificities and the co-localization of CYP3A4 and 
P-gp in the villus tip enterocytes, suggest a combined action in limiting oral bioavailability of their 
substrates (Watkins, 1997; Wacher et al., 1998). A similar combined action is suggested for 
glutathione S-transferases and MRP in MCF7 cells (Morrow et al., 1998), and this enzymatic 
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barrier function might also prevail in the intestine. 
An additional, intestinal epithelium specific, transcellular barrier function results from the 
high turnover rate of the intestinal cells. Potentially toxic compounds, which have entered the cells 
but cannot be detoxified or effluxed to a sufficient extent, can be sequestered in the cells by 
specific proteins, or bound covalently to cellular macromolecules (I in Figure 1.2). In such cases 
the bound toxic compounds can be drained into the intestinal lumen by the extrusion of the dead 
cells. 
§ 1.4 The paracellular barrier of the intestinal epithelium 
The intercellular transepithelial permeation route is called the paracellular pathway. This 
pathway has long been thought to be completely sealed for permeation of all compounds by the 
junctional complex. Only in the nineteen-sixties came the recognition that there were tight and 
leaky epithelia and that the existence of an aqueous extracellular permeation route was likely in 
the leaky epithelia such as that of the intestinal mucosa. By now, it has become clear that 
paracellular solute permeation does occur (see §1.2), that it is regulated physiologically (Bentzel 
et al., 1992; Madara, 1998), and that it can be modulated by lumenal contents (see §1.6; Ballard 
et al, 1995). The paracellular pathway can be seen as a two-component system (Figure 1.3): one 
of the components is the junctional complex and the other is the lateral intercellular space (LIS 
or ICS, Inter-cellular space). In epithelial cells the junctional complex consists of tight junctions, 
adherens (intermediate) junctions and desmosomes (Figure 1.3). Desmosomes (macula adherens) 
provide the epithelial cell layer with tensile strength by anchoring the intermediate filaments of 
the cytoskeleton, and attaching neighboring cells to each other. The cadherin based adherens 
junctions form a continuous belt (zonula adherens) around the apex of the epithelial cell. The 
adherens junctions link the cytoskeleton to the cell membrane and provide structural integrity to 
the epithelia. Junctional localization of E-cadherin (uvomorulin) is believed to be an early trigger 
in the cascade which leads to epithelial cell differentiation, polarization and assembly of tight 
junctions (Gumbiner, 1992; Balda, 1992; Nybom, 1996). The most apical (luminal) structure in 
the junctional complex is the tight junction. Just as adherens junctions, tight junctions form a 
continuous belt (zonula occludens) which encircles the cells. At the site of the tight junctions the 
lateral cell membranes of adjacent cells are in very close apposition and electron microscopy 
revealed the presence of extracellular material at these sites (Madara, 1992). Therefore, it was 
suggested that the tight junctions are the sealing elements between the epithelial cells and the rate 
limiting barrier in the paracellular pathway. By restricting paracellular diffusion along the cells 
("gate" function) and by restricting free diffusion of membrane components from the apical to the 
basolateral membrane ("fence" function), these structures are essential for the barrier and for the 
absorptive functions of the intestinal epithelium (Balda and Matter, 1998). 
10 
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Figure 1.3: The seperate junctions and some of their building proteins in the junctional complex of epithelial cells. 
§ 1.5 Tight Junctions: The gate-keepers of the paracellular barrier 
Due to the leading role of the tight junctions in the maintenance of the epithelial barrier, 
a separate paragraph will be dedicated to this intriguing cell-structure. Study of the molecular 
composition of tight junctions and regulation of the paracellular permeability barrier is now 
proceeding at a rapid pace. This paragraph will deal only with those aspects of tight junction 
composition, and permeability regulation with direct relation to the thesis. For detailed 
information and the state of the art on this subject refer to: Stevenson and Keon, 1998; Madara, 
1998; Mitic and Anderson, 1998; Cereijido etai, 1998; Furuse etal., 1998 and references therein. 
At low magnification, the tight junctions appear as kissing lateral membranes of adjacent 
cells, and at higher magnification (approximately 50.000x) the membranes appear to fuse. In 
freeze fracture replicas the tight junctions can be seen as strands in the cytoplasmic leaflet of the 
plasma-membrane (P-face) and correlating grooves in the exoplasmic leaflet (E-face; Madara, 
1992). Ultrastructural studies showed that the P-face strands formed a cell-circumscribing network 
with varying features which correlated to paracellular barrier function of the epithelium. The 
morphological factors which are now considered to contribute to the permeability of this 
junctional pathway are (Figure 1.4): the junctional density (junctional length per cm2, i.e. relative 
surface area of the paracellular pathway; A and B in Figure 1.4), the number of junctional strands 
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(or fibrils) per lateral membrane (C in Figure 1.4), the junctional complexity (density of 
anastomoses between strands, i.e. number of crosses per um junctional strand), depth of the 
junctional area in the lateral membrane (in um; E in Figure 1.4), and the width and length of the 
lateral intercellular space. A popular model for junctional permeability assumes pores (in the 
junctional strands) with various, but fixed, sizes and a regulated "open probability" (Reuss, 1992; 
Gonzalez-Mariscal, 1992). Along the small intestinal crypt-villus axis it has been shown that the 
junctional density decreases from 91 to 34 m/cm2 in rats, due to the increase in cell size in the villi 
(Collettt et al., 1997). However, the junctional strand number increases from 4.7 to 5.5 strands (in 
human jejunum; Schulzke etal, 1998), the junctional complexity increases, and junctional pores 
size and number decrease, altogether resulting in a more tight paracellular barrier in the 
differentiated villus epithelium (Madara and Trier, 1994; Bjamason et al, 1995, Schulzke et ah, 
1998). 
En-face image 
Cell Cell border 
Figure 1.4: Morphological factors determining the permeability of the tight junctions. A; a small apical surface area 
of the cells results in a relative high junctional density, B; a large apical surface area of the cells results in a relative 
low junctional density, C; junctional strand number in the lateral membrane (n=6), D; anastosome, E; junctional 
depth. 
Biochemical studies into the constitution of the tight junctions have revealed that the 
strands (fibrils) are proteinaceous in nature (Anderson and Stevenson, 1992), but the lipid 
composition of the proximate bilayers is also of importance. By now, using immunocytochemical 
and biochemical techniques, 12 proteins have been localized to the tight junctional region in 
epithelial cells. The best-studied is ZO-1, a 210-225 KDa protein which localizes in the 
cytoplasmic plaque of tight junctions. Two isoforms of ZO-1, ZO-loc+ and ZO-1 a-, are described 
and these isoforms differ in the absence or presence of the a domain and the expression in 
different epithelia and endothelia. In intestinal epithelia the ZO-1 oc+ form is expressed which is 
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indicative for a structurally less dynamic tight junction (Balda and Anderson, 1993). In epithelia 
ZO-1 forms a complex with ZO-2 and ZO-3 (formerly known as pi30/130k), and all three are 
phosphoproteins and members of the Membrane-Associated GUanylate Kinase (MAGUK) protein 
family. Members of this protein family are all involved in (the regulation of) protein-protein 
interactions and/or signal transduction, and they are all localized at the cytoplasmic surface of the 
plasma membrane. ZO-1 is now known as (one of) the bridging protein between occludin and 
cytoskeletal actin (Fanning et al., 1998). Occludin was the first known tight junctional 
transmembrane protein, it contains 4 transmembrane domains, 2 extracellular loops and a C-
terminus which interacts at the intercellular side with the ZO-1/ZO-2/ZO-3 complex (Mitic and 
Anderson, 1998; Stevenson and Keon, 1998). But very recently 2 novel integral membrane 
proteins were discovered and designated claudin-1 and claudin-2 (Furuse et al., 1998a). These 
small (22 kD) proteins also contain 4 transmembrane domains but do not show sequence similarity 
with occludin. It is now suggested that the claudin-1 and claudin-2 proteins are responsible for 
tight junction strand formation and that occludin is an accesorry protein (Furuse et al., 1998b). 
Other tight junction associated proteins are cingulin, 7H6 (only in polarized epithelia), Rab3B, 
Symplekin (only in polarized epithelia), AF-6 and 19B1. Another cellular component which is 
associated with the tight junctional complex is actin. Actin is not an exclusively junctional protein, 
but a major component of the cytoskeleton. Actin prevails in two states, globular actin (G-actin) 
and its cellular polymer, filamentous actin (F-actin). In differentiated epithelial cells the F-actin 
at the apical cell side is organized in the terminal web and a circumferential ring of actin and 
myosin II, named the perijunctional actin-myosin ring. This ring is an important factor in 
regulation of paracellular permeability (Madara, 1992; Mitic and Anderson, 1998). Actually, the 
relationship between the tight junctions and the cytoskeleton was among the first discovered 
interactions involved in the regulation of tight junction function. It is now clear that junctional 
permeability can be regulated physiologically and that it can be increased by nutritional, 
pharmaceutical or toxicological compounds (see § 1.6). Furthermore, a decreased intestinal 
paracellular barrier function is found to play a role in the etiology and pathogenesis of Celiac 
disease (gluten sensitive enteropathy or non-tropical sprue, Schulzke et al, 1998) and 
inflammatory bowel diseases (e.g. Crohn's disease and ulcerative colitis, Hollander, 1988; Wild 
etal., 1997). 
§ 1.6 Modulation of the intestinal epithelial barrier: 
The relationship between increased permeability and toxicity 
Oral dosing is the most convenient and preferred way to administer drugs. However, many 
hydrophilic drugs (e.g. peptides and proteins, peptidomimics) have a very low bioavailability and 
therefore, several ways to improve bioavailability have been explored. One way to increase oral 
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bioavailability of drugs is to enhance the transepithelial passage (permeation) of the intact drug 
(reviewed by Hoogdalem et al., 1989; Swenson and Curatolo, 1992; and Fix, 1996). Other 
mechanisms and methods to improve oral bioavailability are beyond the scope of this thesis and 
will not be discussed here. In the remaining part of this paragraph the terms "permeability" or 
"permeation enhancement", will be used instead of "absorption enhancement", this to refer more 
precisely to the mechanism of absorption enhancement (thus excluding other mechanisms as for 
example inhibition of efflux systems present in the apical cell membrane, inhibition of degradative 
enzymes in the cytoplasm, or the use of prodrugs). 
In order to accomplish a higher transepithelial permeation of a drug, the barrier function 
of the epithelium must be reduced. Irrespective of the mechanism by which the barrier is 
disrupted, the effect is clearly a toxic one since one of the main functions, the barrier function, of 
the epithelium is compromised. In order to minimize adverse systemic effects, it was stated that 
a permeation enhancer should act rapidly and site specifically (preferably in the small intestine), 
it should not be cytotoxic (or at least allow a rapid recovery of epithelial integrity), and the 
permeation enhancement should be size specific, allowing the drugs to pass the epithelium but 
still abolishing the permeation of viruses and bacteria (Fix, 1996; Fasano, 1998). Since the barrier 
consists of a transcellular and a paracellular component, the permeation enhancers can be divided 
in two groups. The first group acts on the transcellular pathway, and decreases the barrier 
presented by the cell membranes, whereas the second group of permeation enhancers can act on 
the paracellular pathway by decreasing the barrier presented by the tight junctions, or by increasing 
the fluid flow through the paracellular pathway (solvent drag, e.g. oral rehydratation solutions). 
The transcellular permeation enhancers are in general surfactant-like compounds such as 
surfactants (e.g. SDS, Triton X-100), bile salts, phospholipids, medium chain glycerides, fatty 
acids and their derivatives (Swenson and Curatolo, 1992; LeCluyse and Sutton, 1997). Since the 
very mechanism of surfactant-like absorption enhancers is the disruption of the transcellular 
barrier by membrane solubilization and cell lysis, efficacy of these compounds is likely to be 
directly related to epithelial damage (Swenson and Curatolo, 1992; Uchyama et al, 1996; 
Lindmark et al, 1997). Moreover, absorption enhancement obtained by lytic activity can not be 
specific for the (size of the) drug of interest, and thus the intestinal barrier to entry of toxins, 
viruses and bacteria is also compromised. It was therefore suggested (Hochman and Artursson, 
1994; LeCluyse and Sutton, 1997) that the preferable route to be enhanced was the paracellular 
route. This preference was stimulated by the observation that paracellular permeability could be 
increased by nutritional components such as glucose (Madara and Pappenheimer, 1987) and by 
the recognition that intestinal tight junctions could be loosened in a non-cytolytic and size 
selective manner by compounds such as sodium caprate or tumor necrosis factor (Lindmark et al, 
1997; Mullin etal, 1997). 
Until recently the only compounds known to selectively enhance paracellular permeation 
were Ca-chelators (EGTA, EDTA), but, by now, many common cellular effectors, including intra-
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and extracellular Ca2+, tyrosine- and serine/threonine phosphokinases and phosphatases, protein 
kinase C and cAMP, are found to be involved in the physiological regulation of tight junction 
permeability (reviewed in: Lutz and Siahaan, 1997; Mitic and Anderson, 1998; Madara, 1998). 
Additionally, all these cellular regulatory pathways of tight junctions can be activated or inhibited 
by nutritional or xenobiotic compounds (reviewed in: Hochman and Artursson, 1994; Ballard et 
al, 1995; Anderson and Itallie, 1995; LeCluyse and Sutton, 1997). Some interesting examples are 
the paracellular permeability-increasing effects of natural toxins such as okadaic acid (diarrhetic 
shellfish poisoning, Tripuraneni et al, 1997), presumably by increasing junctional protein 
phosphorylation, or the zonula occludens toxin (ZOT) of vibrio cholerae (Fasano et al. 1997). 
ZOT interacts with a specific surface receptor in the small intestine, but not in the colon, and 
induces a PKC dependent polymerization of actin filaments in the junctional region. Due to the 
specific non-cytotoxic effects of ZOT, this toxin is studied as absorption enhancer for insulin 
(Fasano, 1998). A similar mechanism involving PKC activation and actin polymerization was 
suggested for capsianoside, a component of sweet peppers (Hashimoto et al., 1997). 
Even though many compounds are found to decrease the intestinal epithelial barrier 
function, and much research effort has been put in elucidating their mode of action, often the exact 
mechanism of barrier disruption is unknown. The introduction of appropriate in vitro models, 
most of all the Caco-2 cell culture model, has made it possible to study the relation between 
permeation increasing en (cyto-) toxic effects in more detail (Anderberg et al., 1992; Schasteen 
et al, 1992; Lindmark et al, 1997; Quan et al, 1998). Without doubt these studies have 
contributed greatly to the knowledge on the transepithelial permeation enhancing mechanisms of 
drug absorption enhancers. However, it has still proven difficult to differentiate between 
paracellular and transcellular permeation enhancement (LeCluyse and Sutton, 1997). 
§ 1.7 Intestinal epithelial cell lines as model for the intestinal epithelium: 
Paracellular permeation prognosis beyond Caco-2. 
To date, several in vitro methods have been developed to study the intestinal absorptive 
and barrier functions. Some models such as everted sacs, intestinal rings and intestinal mucosa 
preparations in Ussing chambers, are discussed by Stewart et al (1995) and Grass (1997), but due 
to difficulties in obtaining viable human tissues, most studies are now being performed with cells 
cultured on permeable supports. This so-called two-compartment cell culture system (see § 2.1) 
is by now a widely used model to study permeability and metabolism of drugs and nutrients, to 
study mechanisms of drug absorption enhancement, or to study effects of toxins on barrier or 
absorptive functions (reviewed by Quaroni and Hochman, 1996). Especially, the human carcinoma 
derived Caco-2 cells are, due to their enterocyte-like differentiation, among the most widely used 
cells, as model for the intestinal epithelium. Transepithelial transport rates for various compounds, 
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obtained in the two-compartment system with Caco-2 cells, are successfully correlated to human 
absorption data (Artursson and Karlsson, 1991; Artursson et al., 1996). This suggested that during 
the enterocyte-like differentiation, the Caco-2 cells obtain many absorptive functions which are 
also operative in the intestinal epithelium in vivo. However, the cell line is derived from a colonic 
adenocarcinoma and some features may be fetal colonic, instead of enterocytal (Pinto etal., 1983; 
Quaroni and Hochman, 1996). Moreover, the barrier presented by the junctional complex which 
limits the passive diffusion of hydrophilic macromolecules across the cells is un-physiologically 
tight, or at best, resembling colonic epithelium (Hidalgo et al., 1989; Tanaka et al, 1995; 
Artursson et al, 1996). However, paracellular permeation of hydrophilic molecules occurs 
predominantly in the small intestine, due to the fact that ingested compounds first reach the small 
intestine, prior to the colon, and the epithelium of the small intestine has a higher paracellular 
permeability. Therefore, permeability rates obtained with the Caco-2 model could lead to an 
underestimation of intestinal absorption of hydrophilic drugs and toxins. Thus, there is a clear 
need for an in vitro model with a small intestinal paracellular permeability. For that purpose, we 
chose to study the absorption and barrier characteristics of the small intestinal cell line IEC-18. 
It was found that the TER of the ileal IEC-18 cells more closely resembles the TER of the small 
intestine (Ma et al., 1992; Tanaka et al., 1995), and that the transport of various paracellular 
markers, such as the hydrophilic molecules inulin and mannitol and the macromolecule albumin, 
was limited by filter-grown IEC-18 cells, albeit to a lesser extent than by Caco-2 cells. This sug-
gests a more permeable paracellular pathway in filter-grown IEC-18 cells than in the Caco-2 cells. 
To establish whether the IEC-18 cells could be used to model small intestinal permeability, the 
permeability and the barrier functions of the IEC-18 cells were further determined and evaluated 
in this thesis. Furthermore, it was found that IEC-18 cells could be induced to acquire 
(differentiated) villus enterocyte characteristics by matrix components (Benya etal., 1993) or a 
small intestinal extract (Sintani et al., 1989). Therefore, it was also investigated whether the filter-
grown IEC-18 cells could be used as a model to study the development of the intestinal epithelial 
barrier along the crypt-villus axis. 
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§ 1.8 Objectives and Approach 
The two experimental sections in this thesis deal with the in vitro model based on Caco-2 
and IEC-18 cells in a two-compartment system. In Section II the permeability of the filter-grown 
cells is determined. In Section III the cellular effects co-occurring with the modulation of the 
barrier function of the filter-grown cells are assessed. 
The aims of this thesis were 
- To investigate and evaluate the filter-grown small intestinal IEC-18 cells as model for 
small intestinal permeability, with special emphasis on the transepithelial passage of 
hydrophilic (macro-) molecules whose transport is dependent on paracellular permeability. 
- To study the effects of intestinal epithelial cell differentiation on paracellular barrier 
development, i.e. to develop a model to study paracellular permeability along the crypt-
villus axis. 
- To investigate and evaluate filter-grown Caco-2 and IEC-18 cells as models for the 
assessment of effects of ingested compounds on the small intestinal epithelial barrier. 
and, 
- To assess the mechanism of barrier perturbation in a cell culture system with emphasis 
on the relation between permeation enhancement (barrier function), the disruption of the 
tight junctional morphology (paracellular barrier structure), and cytotoxicity. 
In chapter 3 and 4 the cell layer morphology, brush border enzyme activities, active and 
passive absorption properties, and the barrier functions of both cell lines were determined and 
correlated to the differentiation status of the cells. In chapter 5, the effects of an epithelial cell 
differentiation inducer (dexamethasone) on the paracellular barrier of the crypt-like IEC-18 cells 
are assessed, and correlated to changes in the F-actin organization, ZO-1 localization and cell 
(layer) morphology. In chapter 6 and 7 the barrier function of the filter-grown Caco-2 and IEC-18 
cells is compromised by treatment with the drug permeation enhancer palmitoyl carnitine (PCC) 
or the possible food contaminant cadmium. Subsequently, the relation between permeation 
enhancement, transepithelial electrical resistance, tight junction structure and cell viability is 
studied. 
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Chapter 2 
Methodology 
Application of cell culture systems in studies of intestinal 
permeability and permeability modulation 
§ 2.1 The two-compartment cell culture system 
The two-compartment cell culture system consists of a permeable cell culture (filter-
insert which is placed in a well of a normal cell culture plate. The cells are seeded on the 
filter-inserts and cultured to cover the whole surface area. When cells are grown to 
confluence, the total cell number is fixed and the cell layer forms a barrier between the two 
compartments. In the case of polarized intestinal epithelial cells, the two compartments are 
designated the apical or luminal compartment and the basolateral or serosal compartment. 
Several advantages of this system include (Karlsson, 1995): 1/ small amounts of the 
compound suffice to perform a transport or effect experiment, 2/ experiments are relatively 
rapid and reproducible compared to other absorption models, 3/ real intestinal epithelial 
permeation rates can be determined (i.e. no gastrointestinal degradation, hepatic first-pass 
metabolism or complicating whole-body kinetics do not obscure the results), 4/ several 
parameters can be determined almost simultaneously for each filter-insert. 
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Apical/luminal 
compartment 
Transepithelial 
permeation 
Tight Junction 
Epithelial sheet of 
Caco-2orIEC-18cells 
Filter 
Basolateral/serosal 
compartment 
Figure 2.1: The configuration of the two-compartment cell culture system. 
The configuration of the two-compartment cell culture system allows determination of: 
- transport of several classes of compounds in two directions, thus both, absorption and 
secretion can be studied. 
effects on the cell layer after exposure to the apical (luminal), basolateral (serosal) or 
both cell sides 
- cell layer integrity within seconds on the basis of the transepithelial electrical 
resistance (TER) 
- cell viability (cytotoxicity) with several assays (for example: LDH leakage, NR uptake 
and PI uptake) on basis of a fixed number of cells 
- cell morphology by light-, and/or electron microscopy 
cellular localization of proteins using immunocytochemistry and fluorescence 
microscopy. 
Within this thesis combinations of measurements with respect to absorptive 
permeability, integrity and morphology of layers of Caco-2 and IEC-18 cells in the two-
compartment system are explored. 
Without doubt the use of intestinal epithelial cells in the two-compartment system has 
contributed to the knowledge on the differentiation and functions of the intestinal epithelium. 
However, some factors need to be considered in the interpretation of the measured transport 
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rates. One factor is the difference in the absorptive surface area between the flat cell culture 
model in which the absorptive surface area = anatomical surface area, and the in vitro models, 
using intestinal tissue preparations, where the absorptive surface area « anatomical surface 
area due to the crypt-villus configuration (Artursson et ah, 1996). This can be of particular 
interest to the absorption of compounds with a low permeability, such as hydrophilic 
macromolecules. As a result of their low permeation rate across the epithelium of the villi, 
these compounds might be able to penetrate into the direction of the mid-villus or crypt. By 
doing so they not only increase the available absorptive surface area, but they possibly also 
reach regions with a higher intrinsic permeability (Figure 2.2). 
Goblet cell 
Artery 
Vein 
Lympatic vessel 
Differentiated villus enterocytes 
- Highly available for luminal contents 
- High expression of absorption systems 
- High degradative activity 
- High expression of efflux systems 
- Low paracellular permeability 
Undifferentiated crypt cells 
- Low availability for luminal contents 
- Low expression of absorption systems 
- Low degradative activity 
- Low expression of efflux systems 
- High paracellular permeability 
Figure 2.2: Structures and functions along the small intestinal crypt-villus axis. 
Another factor which needs to be considerer in the use of the two compartment system, is that 
after seeding, the cells are cultured for a fixed period of time and it can thus be assumed that 
most cells obtain a similar degree of differentiation, with other words, each filter might 
represent a model for only one region along the crypt-villus axis. This information can in 
principle be used to obtain knowledge on the permeability of the different regions (e.g. crypt, 
mid-villus, villus tips). Within this thesis we would like to develope a model with which the 
21 
Chapter 2 Methodology 
relation between the differentiation of the enterocytes and the development of their 
permeability and barrier functions can be studied. 
§ 2.2 The intestinal epithelial cell lines Caco-2 and IEC-18 
The intestinal cell line most intensively studied and used for its applicability as 
intestinal transport model is the Caco-2. This human colon carcinoma cell line made it to the 
forefront of intestinal research due to its autonomous differentiation (Pinto et al., 1983). When 
seeded on a filter and given time to grow to confluence and to differentiate (2-3 weeks), these 
cells display many structural and functional characteristics of differentiated small intestinal 
enterocytes. The Caco-2 cells form polarized columnar cells with a well developed brush 
border and junctional complex at the cells' apex (Pinto et al., 1983). The brush borders were 
found to exhibit digestive enzymes (e.g. sucrase isomaltase, lactase, dipeptidyldase IV and 
alkaline phosphatase) and many intestinal carrier systems (e.g. carriers for glucose, amino 
acids and di/tripeptides, nucleosides, bile acids and vitamin B12)(Quaroni and Hochman, 
1996; Hidalgo and Li, 1996). Furthermore, Caco-2 cells express efflux systems (e.g. P-
glycoprotein), Phase I metabolic enzymes (cytochrome P450s) and Phase II conjugating 
enzymes (sulfotransferase, UDP-glucuronyltransferase, glutathione S-transferase) and thus 
represent an intestinal-like biochemical barrier (Gan and Thacker, 1997). Some disadvantages 
of the Caco-2 cells are that the cell line is morphologically and functionally very 
heterogeneous (Vachon and Beaulieu, 1992) and that functional and structural features are 
variable with passage number (Briske-Anderson et al, 1997; Yu et al, 1997). 
The rat ileal crypt-derived non-transformed cell line IEC-18, was originally isolated by 
Quaroni and co-workers and used to investigate cytotoxic effects of chemical carcinogens 
(Quaroni and Isselbacher, 1981). They found that IEC-18 cells were able to metabolize 
dimethylbenz[a]anthracen and benzo[a]pyrene and that the cells were very sensitive for the 
cytotoxic effects of these compounds. Since then, the IEC-18 cells were found to express P-
450 reductase, microsomal and cytosolic epoxide hydrolases, glutathione S-transferase and 
UDP-glucuronosyl transferase (Glatt and Gemperlei, 1987). The cells were also used as model 
for the small intestinal epithelium to study mechanisms of carrageenan or reactive oxygen 
species induced injury in the intestine (Ling et al., 1988; Ma et al, 1991). In the early nineties 
Ma et al. (1992) started using filter-grown IEC-18 cells as a model to study small intestinal 
epithelial permeability. It was found that filter-grown IEC-18 cells expressed the junctional 
proteins ZO-1 and desmoplakin, that they developed a TER comparable to that of the small 
intestine (approximately 20 to 45 Q*cm2) and that the cells formed a permeation barrier for 
hydrophilic molecules. 
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§ 2.3 Methods to assess the functionality of the Intestinal epithelium in vitro 
§ 2.3.1 Measurement and meaning of the Transepithelial electrical resistance 
The TER is generally used to determine the integrity of the epithelial barrier. Since the 
resistance of biomembranes, i.e. the apical and basolateral cell membranes, are usually very 
high (>1000 Q.cm2), in fully functional confluent cell layers the TER reflects the paracellular 
barrier towards electrolytes (Reuss, 1992; Madara, 1998). The TER is therefore a very 
sensitive measure to detect changes in the paracellular permeability. However, when the cells 
are exposed to membranolytic compounds such as surfactants, fatty acids and bile salts, the 
resistance of the biomembranes are decreased. Due to the fact that the area of the transcellular 
pathway is more than 1000 times larger than the area of the paracellular pathway, a decreased 
resistance of the membranes (transcellular pathway) may result in a decreased TER. 
Furthermore, extensive opening or activation of ion channels in the cell membranes can 
decrease the TER substantially (Madara, 1998). 
The transepithelial electrical resistance (TER) was measured using the Millicell-ERS 
epithelial voltohmmeter with Ag/AgCl electrodes (Millipore Co., Bedford, USA) in iso-
osmotic (approximately 300 mOsm) media. The TER of the cell layers was calculated 
according to the following equation: 
TER = (Rlolal-Rblank) X A (Q.cm2), 
Rlotal = the resistance measured, 
Rblank = resistance of control filters without cells (approximately 140 Q.cm2) 
A = surface area of the filter (1 cm2). 
The TER can be expressed as absolute value (Q.cm2) to compare different regions of the 
intestine or different cell lines, but within an experiment the TER is preferably expressed as % 
of control (i.e. control is untreated filter or the same filter prior to exposure). The Caco-2 
monolayers obtain a TER between 300 and 600 Q.cm2 after prolonged culture, which is un-
physiologically high for the intestine (Artursson et ah, 1996). The IEC-18 cells develop a TER 
of approximately 50 Q. cm2 which is in good agreement with the TER of the small intestine 
(Ma etal, 1992). 
§ 2.3.2 Assessment of transepithelial permeation rates 
The transepithelial passage of all kinds of compounds in both directions is easily 
studied in the two-compartment system. A detectable tracer is added to the donor 
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compartment (in case of absorption: at the apical/luminal side) and its appearance in the 
acceptor compartment (basolateral/serosal) can be followed in time. The transport experi-
ments were carried out at 37°C in Transwell inserts with 0.5 ml medium with tracers apically 
and 1.8 ml medium basolaterally. With these volumes there is no hydrostatic pressure since 
the media levels apically and basolaterally are even. A reduction of the unstirred water layer 
and homogeneous mixing of the probes was achieved by rotating the two-compartment 
transport system at 30 rpm on a rotating platform device. For the studies in this thesis the 
Polyethyleneglycols PEG-900 (+900 D) and PEG-4000 (± 4000 D) and the fluoresceine-
isothiocyanate-labeled Dextrans FD4 (4400 D), FD20 (19400 D), FD70 (71200 D), and 
FD500 (487 kD) were used as model compounds for hydrophilic macromolecules (i.e. 
proteins; Noach, 1994). As models for smaller hydrophillic compounds, mannitol (182 D) 
and fluoresceine (332 D) were used. These compounds were found to be stable in the systems 
used, and transepithelial passage of these compounds occurred mainly paracellularly under 
physiological conditions (Schasteen et ah, 1992; Bjarnason et al., 1995; Noach, 1995). 
Permeation rates frequently used in the literature are the flux representing the nett 
passage of compound per unit of time (mol.s"'), the clearance (flux/C0 in pl.s"1) and the 
apparent permeability coefficient (Papp in cm.s'1) representing the steady-state flux under sink 
conditions (i.e. before 10% of the total amount of tracer has appeared in the receptor 
compartment), normalized for the start concentration of the tracer, and for the area. Thus the 
Papp is the flux divided by A and C0. 
In formula: 
Papp=P/(A*C0) (cm.s-') 
P = permeability rate or flux (mol.s1) 
C0= Initial apical concentration of test substance (M) 
A = area of filter (cm2) 
In this thesis the Papp will be used to express the permeability rates since it was already shown 
in 1991 (Artursson and Karlsson, 1991) that for a broad range of chemical compounds the Papp 
found in a Caco-2 system correlated well with human absorption data. 
§ 2.3.3 Qualitative Immunofluorescence localization of junctional proteins 
Indirect immunolabeling was performed to establish the organization and localization 
of junctional proteins (ZO-1, occludin and E-cadherin) and filamentous actin (F-actin). The 
tight junctional proteins ZO-1 and occludin were immunolabeled to verify the presence of 
tight junctions at sites of cell-cell contact. Many reports describe the structural expression and 
changes therein of these proteins using immunolabeling and western blotting (reviewed by 
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Mitic and Anderson, 1998). For both proteins it has been shown that disappearance, reduced 
junctional expression or altered phosphorylation status was concomitant with reduced 
paracellular barrier functionality (Balda and Matter, 1998; Anderson and Itallie, 1995). 
However, it was also shown that junctional ZO-1 expression not always correlated to barrier 
function (Itoh et al., 1993) and that a discontinuous occludin ring could suffice to form 
electrically tight MDCK monolayers (Balda et al., 1996). Nonetheless, we hypothesize that if 
non-physiological permeation enhancement is achieved mainly by paracellular permeation 
enhancement, this should be accompanied by structural changes in the tight junctions and 
these structural changes can be visualized by altered immunolocalization of ZO-1 and/or 
occludin. 
For immunocytochemistry the cells were fixed in 1% formaldehyde in HBSS for 5 min 
and permeabilized in 0.2% Triton X-100 in HBSS for 30 min. Subsequently the first 
antibodies (Polyclonal rabbit anti-ZO-1, polyclonal rabbit anti-Occludin, polyclonal Goat anti 
human E-Cadherin) were diluted in 0.1% Triton X-100 in HBSS and incubated for 1-3 h at 
room temperature or at 4°C overnight. After rinsing, the secondary antibodies (anti-rabbit IgG 
conjugated with biotin, anti-goat IgG conjugated with biotin) were diluted in HBSS and 
incubated at RT for 1 h. In the final step the biotin-groups were stained with streptavidin 
conjugated with TRITC or FITC. F-actin was stained with phalloidin conjugated with TRITC 
or FITC in a one step procedure. All immunofluorescence label protocols could be combined 
with the staining of nuclei using Hoechst 33258. 
§ 2.3.4 Quantification of junction-related ZO-1 using confocal scanning laser microscopy 
and image processing 
In addition to the qualitative descriptions of patterns, and changes therein, of labeled 
proteins, we developed a method which allowed for quantification of changes in the junction 
related ZO-1 pattern in CLSM images of filter-grown epithelial cells. Earlier reports 
mentioned the use of CLSM to determine the transport route of fluorescent compounds (Hurni 
et al., 1993) or for the semi-quantitative evaluation of cellular ZO-1 and F-actin content 
(Nybom and Magnusson, 1996). 
Confocal fluorescence microscopy was performed with the Bio-Rad MRC600, using 
the PlanApoChromat 40x objective with variable diaphragm (Zeiss, Oberkochen, Germany). 
All images were recorded at standardized acquisition conditions; per cell line and per 
experiment settings for pinhole, gain and blacklevel were optimized and applied throughout 
that experiment. Images are single plains (a depth of 7 um covers >90% of the total intensity) 
recorded using the Kalman filter mode at n=5 with Bio-Rad software (COMOS version 7.0a). 
After transfer to an image processing workstation, the original grey value images (Figure 
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2.3A) were processed by a custom written program, based on the image processing toolbox 
SCIL-Image (version 1.3, Free University of Amsterdam, Netherlands). The program was 
developed to discriminate between junction-related immunolabeled ZO-1 and non-junction-
related immunolabeled ZO-1 and background and consists of three sequential steps. In the 
first step, two methods are applied to differentiate between immunolabeled ZO-1 and 
background using a threshold value of 1.4. The two resulting binary images are combined to a 
usually honeycomb-like skeleton. This intermediate skeleton represents most of the junction-
related ZO-1 pattern, sometimes with small discontinuities and some not junction-related 
appendixes. In the second part of the program, the skeleton can be improved, first by closing 
the small discontinuities of the borderlines using a maximum cost procedure (adding less than 
0.5% to the total pixel count) and secondly, by interactive and automatic removal of spurious 
line fragments. Finally, from the binary image (Figure 2.3B) of the optimized skeleton the 
total number of pixels is determined and used as measure for junctional density. The final 
binary image is subsequently superimposed on the original grey value image to determine the 
average pixel intensity over the actual cell borderlines throughout the monolayer. This 
measure is an indirect quantification of the amount of junctional protein (comparable to the 
number of junctional strands) in the lateral membranes. 
Figure 2.3: The immunocytochemical localization of ZO-1 in a Caco-2 cell monolayer in an original CLSM 
image (A) and in a binary image after processing by a cutsom written program which selected the honeycomb-
like tight junctional pattern (B). 
§ 2.3.5 Assessment of adverse effects on the intestinal epithelium in vitro 
There are many assays available to detect cytotoxic effects of chemicals on cells in 
culture (LDH leakage, NR or PI uptake, MTT assay etc.) and all these assays can be 
performed on filter-grown cells too. Additionally, in the two-compartment system the 
transepithelial permeation of tracer molecules and the transepithelial electrical resistance can 
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be used to detect adverse effects on the absorptive or barrier function of the epithelial cell 
layers. Furthermore, changes in expression or immunolocalization of structural and functional 
proteins can be interpreted as adverse effects on the cells or cell layers. 
Whereas in most studies these assays are used to assess cytotoxicity, or cell viability, 
in general, in this thesis the LDH leakage, the NR and PI uptake assays are considered with 
respect to the actual effect they are pointing at. The LDH leakage assay is based on the release 
of cytosolic LDH into extracellular medium and thus indicates damage to the cell membrane. 
Damage can be expressed as units, or percentage, of LDH released from the cells into the 
medium, or remaining in the cell. This assay has been shown to be extremely sensitive since 
many LDH units are present in the cell layers and the activity is determined with great 
sensitivety. Since LDH leakage is such a direct measure of increased (apical) membrane 
permeability (or cell lysis), and the surface area of the cell membranes is at least 1000 times 
larger that the paracellular surface area, we assume a correlation between LDH leakage and 
disruption of the transcellular barrier. 
Another membrane damage assay used is the propidium iodide (PI) uptake assay. 
Functional biomembranes do not allow cellular uptake of propidium iodide, however, when 
the permeability of these membranes is increased, this dye can enter the cells. Staining can be 
determined by counting the stained nuclei under a fluorescence microscope, cytotoxicity is 
then expressed as number (%) of nuclei stained (Hochman et al., 1994). It is also possible to 
quantify total fluorescence of a PI exposed cell layer and to express cytotoxicity as increase in 
fluorescence (chapter 6). An advantage of this method is that it can be used together with the 
immunofluorescent localization of junctional proteins, allowing determination of functional 
and structural effects on the transcellular and the paracellular barrier. 
The neutral red uptake assay is based on the passive diffusion through the cell 
membranes, and subsequent intracellular sequestration, of this weakly cationic dye in 
lysosomes (Babich and Bohrenfreund, 1990). The uptake is dependent on the functionality of 
the membrane on the side of NR exposure while the sequestration is dependent on the 
functionality of the lysosomes. Both, uptake and sequestration are dependent on cell number. 
In the two-compartment cell system the cells are cultured to confluence thus a fixed number 
of cells is present at the start of the experiment. Reduced NR uptake readings may indicate a 
reduction in cell number (severe lysis), or more subtle effects as reduced lysosomal 
functionality. NR uptake data are usually presented as % uptake relative to NR uptake by 
control cell layers. 
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Chapter 3 
Comparison of permeability characteristics of the human colonic 
Caco-2 and rat small intestinal IEC-18 cell lines 
Erwin Duizer, Andre H. Penninks, Wilma H. Stenhuis, and John P.Groten. 
Journal of Controlled Release, 1997;49:39-49. 
Abstract 
Several human colonic carcinoma cell lines are used to study the intestinal transport of 
compounds in vitro. However, the major site of absorption of drugs and nutrients is the small 
intestine, which differs greatly from the colon in paracellular permeability. Several 
hydrophilic compounds, of which intestinal uptake in vivo was found, are not transported 
across filter-grown colonic cells in vitro. The aim of this study was to compare transport 
properties of the low resistance rat small intestinal cell line IEC-18 to those of the high 
resistance human colonic cell line Caco-2. 
After prolonged culture of Caco-2 and IEC-18 on Trans well polycarbonate filters 
enzyme activity determinations revealed the presence of sucrase-isomaltase and mature 
enterocyte alkaline phosphatase in Caco-2 and fetal alkaline phosphatase in IEC-18. Both cell 
lines formed a confluent layer as confirmed by transepithelial electrical resistance 
measurements (TERCaco.2= 350+14 Q/cm2, TERIEC.18= 55±4 Q/cm2) and fluorescence 
microscopy on immunolabeled F-actin. The tight junctional protein ZO-1 is organized into 
cell circumscribing strands in both cell lines. 
Transport rates of lipophilic compounds transported transcellularly were almost 
similar in both cell lines but transport rates of hydrophilic compounds transported 
paracellularly were clearly higher in IEC-18 cells. IEC-18 cells also allowed for a better 
discrimination on the basis of molecular size between several compounds which are 
transported paracellularly. 
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Introduction 
The intestine forms the main port of entrance for many nutrients and drugs. Several ex 
vivo and in vitro models have been developed and utilized to study intestinal permeability. 
One frequently used in vitro model is the two-compartment transport system which is based 
on filter-grown intestinal cell lines. The popularity of this system is mainly due to the ability 
of some human colonic tumor cell lines to undergo differentiation into polarized epithelial 
cells in culture. Well known cell lines being used in the two-compartment cell culture model 
are Caco-2 (Hidalgo et al., 1989; Hilgers et al, 1990; Artursson and Karlsson, 1991), T84 
(Dharmsathaphorn and Madara, 1990; Madara et al, 1987) and HT-29 (Karlsson et al, 1993; 
Wis etal., 1994a). 
For drug absorption studies the Caco-2 cell line is most frequently used. This cell line 
is derived from a human colon adenocarcinoma and differentiates spontaneously into 
polarized columnar enterocyte like cells after reaching confluence (Pinto et al., 1983; Wilson 
et al., 1990). The differentiated Caco-2 cells grown on permeable filters, present a mixed set 
of small intestinal and colonic characteristics. With respect to the passive and active 
transcellular transport of electrolytes, sugars, amino acids and lipophilic drugs, the Caco-2 
monolayer displays several features of the small intestinal epithelial barrier (Hillgren et al., 
1995). Also, a good correlation between in vivo human absorption data and transport in Caco-
2 cells was found for several compounds (Artursson and Karlsson, 1991). However, many of 
the newly synthesized drugs or nutrients are neither transported by active transcellular 
processes nor are they absorbed by passive diffusion through the cells due to their size and/or 
hydrophilicity (Hillgren et al, 1995; Artursson and Karlsson, 1991). The only remaining and 
most likely port of entrance of these compounds is the paracellular pathway, i.e. along the 
cells, through the tight junctions and the intercellular spaces. Especially with respect to this 
paracellular pathway the Caco-2 monolayer displays the tightness of colonic epithelium. The 
transepithelial electrical resistance (TER) of the colonic epithelium, a direct measure of 
monolayer resistance to passive electrolyte and ion permeation, is much higher than that of 
small intestinal epithelium. This means the Caco-2 monolayer excludes the passage of several 
hydrophilic molecules, which are probably transported to some extend by the leaky small 
intestinal epithelium in vivo (Artursson and Karlsson, 1991; Blomqvist et al., 1993; Bijlsma et 
al, 1995; Ma et al, 1995). Therefore the suitability of the colonic Caco-2 cells as a model to 
study paracellular permeability of drugs that are absorbed incompletely, is probably limited 
(Artursson and Karlsson, 1991; Nellans, 1991). This indicates there is a clear need for 
additional cell culture models resembling the paracellular transport properties of the small 
intestinal epithelium more closely. 
IEC-18, a small intestinal crypt-derived cell line, was originally isolated by Quaroni 
and co-workers and used to study cytotoxic effects of chemical carcinogens (Quaroni and 
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Isselbacher, 1981), mechanisms of carrageenan or radical injury (Ling et ah, 1988; Ma et al., 
1991) and oxidant-dependent bactericidal activity (Deitch et ah, 1995). Just recently Ma and 
coworkers (1992) started using filter-grown IEC-18 cells as a model to study small intestinal 
epithelial permeability. The TER of these IEC-18 cells more closely resembles the TER of the 
small intestine, which could indicate a comparable leakiness/tightness of the paracellular 
pathways. Transport of various paracellular markers, such as the hydrophilic molecules inulin 
and mannitol and the macromolecule albumin, was limited by filter-grown IEC-18 cells, albeit 
to a lesser extend than by Caco-2 cells. This suggests a more permeable paracellular pathway 
in IEC-18 than in the colonic Caco-2 cells. Whether the differences in TER and paracellular 
permeability between IEC-18 and Caco-2 cells are related to the structure of the junctional 
complexes is unknown. 
In order to confirm the suitability of the IEC-18 cell line as an in vitro model for 
small intestinal transport of lipophilic and hydrophilic compounds we compared transport 
properties of this cell line to those of the Caco-2 cell line. This characterization is not 
restricted to paracellular and transcellular transport alone, but is also based on the 
differentiation stage and the development of the junctional complexes of both cell lines. For 
that purpose brush border enzyme activities, transepithelial electrical resistance and 
morphological features of both cell lines are compared during prolonged culture under similar 
test conditions. 
Materials and methods 
Cell culture 
The Caco-2 cell line originating from a human colorectal carcinoma, and IEC-18 cells 
originating from rat ileum epithelium were obtained from the American Type Culture Collec-
tion. Cells were maintained at 37°C in an atmosphere of 5% C02 and 90% relative humidity. 
Maintenance medium was DMEM with high glucose (4.5 g/1) and 25 mM Hepes, 
supplemented with 1% (v/v) MEM nonessential amino acids, 6 mM L-glutamine, 50 pg/ml 
gentamycin (all from Gibco, Paisley, Scotland), and 10% (v/v) foetal calf serum (FCS, 
Integra, Zaandam, Netherlands) for Caco-2, and 5% (v/v) FCS and 0.1 U/ml insulin (Sigma, 
Beers, Belgium) for IEC-18 cells. 
Cells grown in 75 cm2 flasks (Costar, Badhoevedorp, Netherlands) were passaged 
weekly at a split ratio of 1:10 using 0.05% trypsin in PBS with 0.022% EDTA. For transport 
experiments approximately 2 *105 cells/cm2 (IEC-18) or 1 *105 cells/cm2 (Caco-2) were 
seeded on Trans well polycarbonate cell culture inserts with a mean pore size of 0.4 pm 
(Costar, Badhoevendorp, Netherlands). Cells were cultivated for 18-29 days. Caco-2 cells 
were used at passages 85-97, IEC-18 at passages 18-30. 
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Transepithelial electrical resistance (TER) 
The transepithelial electrical resistance of filter grown cells was measured using the 
Millicell-ERS epithelial voltohmmeter (Millipore Co., Bedford, USA) at different time inter-
vals (n=6). The TER of the cell monolayers was calculated according to the following 
equation: TER = (Rtola]-Rbiank) X A (Q.cm2), Rt01a] is the resistance measured, RWank is resistance 
of control filters without cells (approximately 140 Q.cm2), A = surface area of filter (1 cm2). 
Cell number 
Cell counting of filter grown cells was performed using fluorescence microscopy after 
staining the cell nuclei with Hoechst 33258 (2.5 ug/ml). For each time point at least 8 area's 
(>300 cells) were counted on two different filters. Nucleus staining was combined with a F-
actin label (phalloidin-FITC from Sigma, Beers, Belgium) to check for monolayer confluency. 
Cell numbers of plastic grown cells (25 or 75 cm2 flasks, Costar, Badhoevedorp, Netherlands) 
were determined after trypsinization using a heamatocytometer. 
Light microscopy 
Filter grown cells were fixed in 4% formaldehyde in PBS. Cells were dehydrated using 
an ascending series of ethanol with the final step in 100%. Filters with cells were embedded in 
Technovit 7100 (Heraeus Kulzer GmbH, Wehrheim, Germany) with 1% polyethyleneglycol-
4000. Cross sections (thickness is 2-4 um) of filter grown cells were stained with trypan blue. 
Immunocytochemistry 
For immunocytochemistry the filters with cells were fixed in 1% formaldehyde in 
HBSS and permeabilized in 0.2% triton X100 in HBSS. F-actin was stained with phalloidin 
conjugated with TRITC or FITC (Sigma, St.Louis, USA). Polyclonal rabbit anti-ZO-1, anti-
rabbit IgG-biotin and streptavidin-FITC (Zymed, San Francisco, USA) were used to visualize 
ZO-1 in both cell lines. Monoclonal antibody to desmoplakin I and II was obtained from 
Boehringer Mannheim Biochimica (Mannheim, Germany) and rhodamine-conjugated rabbit-
anti-mouse IgG from Dako (Glostrup, Denmark). 
Confocal Scanning Laser Microscopy 
Confocal fluorescence microscopy was performed with the Biorad MRC600, using 
Plan-neofluar objective 63/1.25 and PlanApoChromat 40/1.0 (Zeiss, Germany). Images were 
recorded with Biorad software and processed using the image processing toolbox SCIL-Image 
(VU Amsterdam, Netherlands). 
Enzyme activity 
Activities of alkaline phosphatase were determined according to Tietz (1983), on the 
BM/Hitachi 911 using p-nitrophenylphosphate as a substrate. Cell homogenates were diluted 
to 30 mU ALP/mL and incubated with levamisol (10 min, 0-10 mM) at room temperature to 
discriminate between the differentiated enterocyte isotype of ALP and the fetal or 
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liver/kidney/bone isotype (Hoffman et al., 1994). A modification of the method of Dahlqvist 
(1984) was used to determine sucrase-isomaltase activity. In short, the cell homogenate was 
incubated 30 min at 37°C with 100 mg/ml sucrose as substrate, the reaction was stopped by 
boiling for two minutes. The glucose formed was measured with the BM/Hitachi 911 using 
the hexokinase/G6P-DH assay (Boehringer, Mannheim, Germany). Total protein contents 
were determined according to Lowry with bovine serum albumin as standard. 
Transepithelial transport 
14C-polyethyleneglycol-4000, 14C-salicylic acid, 14C-acetyl salicylic acid, 14C-testos-
terone, 3H-mannitol, and 3H-propranolol (NEN products, Boston, USA), were mixed with 
unlabelled compounds to yield final concentrations of 1 to 100 uM with specific activities of 
30 Ci/mol to 300 Ci/mol. Specific activities of the probes shown in fig 5 were: 270 Ci/mol for 
14C-polyethyleneglycol-4000 and 3H-mannitol, and 180 Ci/mol for 14C-testosterone. 3H- and 
14C-labelled probes were analyzed using a Wallac 1409 Liquid Scintillation Counter. 
Fluorescein and the fluorescein isothiocyanate dextrans (FD) with average mol weights of 
4,400 (FD-4), 19,400 (FD-20), 71,200 (FD-70) and 487,000 (FD-500) Da were from Sigma, 
St.Louis, USA. Fluorescein and the FD samples were analyzed using HPLC and fluorescence 
detection (seize exclusion columns 500G and sec30XL in series in this order, a mobile phase 
of 25 raM NaH2P04 buffer pH 9, flow rate 0.5 ml/min, and detected with excitation at 495 nm 
and emmission at 519 nm with a Jasco FP920 Fluorescence detector). All dextrans showed 
one peak in the HPLC profiles. Retention times of the transport solution and the basolateral 
samples were the same in all cases. 
Transport experiments were carried out at 37°C in Transwell inserts with 0.5 ml 
medium apically and 1.8 ml medium without test compound basolaterally. The medium used 
in transport experiments was DMEM with non-essential amino acids, gentamycin, and 0.1% 
BSA. A slight reduction of the aqueous boundary layer and homogeneously mixing of the 
probes was achieved by rotating the two-compartment transport system at 30 rpm on a 
rotating platform device. Apparent Permeability coefficients (Papps) were determined on basis 
of appearance of the probe in the basolateral receiver compartment before 10% of the probe 
was transported (i.e. under sink conditions) according to the following equation (Artursson 
and Karlsson, 1991): Papp= P/A*C0 (cm/s), P = permeability rate (mol/s), C0= Initial apical 
concentration of test substance (mol/ml), A = area of filter (cm2). The effect of metabolism on 
Papps w a s neglected for compounds of which cellular uptake was known to be very low 
(mannitol, fluorescein, FD4, PEG-4000, FD20, FD70 en FD500). The Papps of salycilic acid, 
acetyl salycilic acid, testosterone and propranolol were determined under conditions where 
effects of drug metabolism were minimized i.e. under sink conditions and at different 
concentrations. 
Results 
Cell growth and development of transepithelial electrical resistance 
The cell number and transepithelial electrical resistance were determined of both cell 
lines grown on Transwell permeable cell culture inserts at several timepoints after seeding. 
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Data of a typical experiment are presented in Figure 3.1. Cells were seeded at 1 to 1.5-105 
cells/cm2. The cell number of Caco-2 cells increased up to day 15 and remained relatively 
constant from day 15 to day 29 at approximately 8-105 cells/cm2. The TER of the Caco-2 
monolayer showed a clear increase during the whole culture period of 29 days. Even from day 
15 onwards, when cell numbers were constant, the TER increased steadily. IEC-18 cells 
proliferate quickly up to a density of 5-105 cells/cm2 on day 4, after which a slow gradual 
increase to ±7-105 cells/cm2 on day 29 was observed. However, the TER of filter grown IEC-
18 cells reached a maximum value of approximately 50 Q-cm2 within 4 days after seeding and 
stayed relatively constant up to day 29. 
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Figure 3.1: Time-dependent growth pattern and Transepithelial electrical resistance (TER) development of 
Caco-2 and IEC-18 cells grown on 12mm-Transwell polycarbonate filters. Cell numbers (Caco-2 -A- and IEC-18 
-»-) are expressed as means±SD for 10 areas (5 areas/filter). The TER (Caco-2 open columns and IEC-18 black 
columns) is shown as means±SD for 6 filters.. 
In Figure 3.2 the total protein contents and activities of alkaline phosphatase and 
sucrase-isomaltase of whole-cell homogenates are presented. Both cell lines showed a gradual 
increase in alkaline phosphatase activity in time. Lack of inhibition with levamisole revealed 
that the alkaline phosphatase of Caco-2 cells was the intestinal isoenzyme (data not 
shown).The alkaline phosphatase activity of IEC-18 was dose-dependently inhibited by 
levamisole, indicating that this was not the mature enterocyte intestinal alkaline phosphatase. 
Sucrase-isomaltase activity showed a gradual increase in time in Caco-2 cells whereas no 
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sucrase-isomaltase activity could be detected in the IEC-18 cells so far (detection limit of 
method used is 1 mU/cm2). 
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Figure 3.2: Total protein contents (-»-) and enzyme activities (sucrase-isomaltase (-•-), alkaline phosphatase 
(-•-)) of Caco-2 (A) and IEC-18 (B) cells grown on 12mm-Transwells for 29 days. Data are expressed as 
means±SD (n=3). 
Light microscopy and confocal scanning laser microscopy 
Plastic imbedded filters with 22 days old Caco-2 cells (Figure 3.3) showed a well 
polarized monolayer of ±58 um high cells with well developed brush borders. The filter 
grown IEC-18 cells showed a less organized pattern and seemed to be pseudo-stratified or 
even double layered. The single cell height was approximately 14 um but the height of the 
whole cell layer came close to 25 um. Confocal images of immunofluorescent labelled cells as 
shown in Figure 3.4, indicate that the tight junctional protein ZO-1 was present at all stages of 
differentiation in both cell lines. However, the organization of ZO-1 is changing in time. The 
images of Caco-2 cells 1 day after seeding show strand-like tight junctions at locations of cell-
cell contacts. At sites lacking cell-cell contacts the ZO-1 protein is localized in a vesicle-like 
manner in the proximity of the lateral cell membrane (Figure 3.4A). The typical pattern of cell 
circumscribing tight junctional strands was complete from day 8 onwards (Figure 3.4B and 
3.4C), which coincides with the observed starting increase in TER. The overall intensity of 
ZO-1 label does not seem to increase from day 8 to day 22, while the TER almost triplicates. 
At all stages of growth the Caco-2 cells presented a peripheral actin belt (data not shown) 
which is characteristic for epithelial cells. In contrast with ZO-1 there is also an actin belt 
present in cells lacking cell-cell contacts. During differentiation there is a decrease in cell-
stretching fibrils of F-actin and an increase of sharpness and intensity of the peripheral belt. 
No remarkable changes were seen in the F-actin morphology from day 14 onwards. 
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s 
Figure 3.3: Light micrographs of cross sections through 22 days old filter grown Caco-2 (A) or IEC-18 cells 
(B). Magnification 200X, bar is 25 um. 
The tight junction development in IEC-18 cells seems to start with small ZO-1 strand-
fragments at day 1 (Figure 3.4D) at sites of cell-cell contact but without any detectable ZO-1 
at sites lacking these contacts. Tight junctions appear to be formed by connecting the small 
fragments to a cell circumscribing network at day 8 (Figure 3.4E), followed by an increase in 
total ZO-1 protein in the junctional strands as indicated by a more intense fluorescence signal 
at day 22 (Figure 3.4F). However, in IEC-18 cells the changes in ZO-1 organization do not 
coincide with a change in TER, which remains relatively constant from day 4 onwards. One 
day after seeding there is a belt-like organization of F-actin at the periphery of many cells. 
During growth the total amount of F-actin in IEC-18 seems to increase but this does not lead 
to a clear actin belt. The presence of desmosomes in the lateral cell membrane was also 
confirmed in this study at day 15 and 22 by the patchy staining with desmoplakin antibodies 
in both cell lines (data not shown). 
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Figure 3.4: En face (x-y) confocal images showing immunolocalization of ZO-1 in filter grown Caco-2 (A-C) 
and IEC-18 (D-F) cells. Cells were seeded on day 0 and fixed and immunostained for ZO-1 on day 1 (A D) 8 
(B,E) and 22 (C,F). Magnification 200X. 
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Transepithelial transport 
Transport of various compounds across filter grown cells was studied in apical to 
basolateral direction (Table 3.1). For all compounds tested at concentrations ranging from 1 to 
100 uM, the apparent permeability coefficients were not found to be concentration dependent, 
and no cytotoxicity was indicated as measured by LDH leakage. The transport pathway for the 
hydrophilic compounds fluorescein, mannitol, PEG-4000 and the FDs is thought to be the 
paracellular route. Testosterone and the drugs salicylic acid, acetyl salicylic acid and 
propranolol are mainly transported by a (passive) transcellular pathway, although there might 
be a variable contribution of the paracellular pathway. In Caco-2 monolayers there are clear 
differences between P for hydrophilic (Papp < 7.6-10"7 cm/s) and lipophilic compounds 
(6-10'6 cm/s< Papp < 4-10'5cm/s). The Papps found for lipophilic compounds across IEC-18 cells 
are in the same order of magnitude as those found for the Caco-2 cells. In contrast, the Papps for 
the hydrophilic compounds are at least 4 times higher in IEC-18 cells than in Caco-2 cells. 
The time course of transport of the hydrophilic markers mannitol and PEG-4000 and the 
lipophylic marker testosterone is shown in Figure 3.5. 
Table 3.1: Permeability coefficients (Papps) of various test compounds as calculated from transport studies across 
filter grown IEC-18 (TER ± 55 Q.cm2) and Caco-2 (TER ± 350 Q.cm2) cells. 
P^Ccm.s'xlO-6)" 
compound Mw(D) Mr(A) IEC-18 Caco-2 
Mannitol 
Fluorescein 
FD4 
PEG-4000 
FD20 
FD70 
FD500 
Salicyilic Acid 
Acetyl salicylic acid 
Propranolol 
Testosterone 
182 
332 
4,400 
4,000 
19,400 
71,200 
487,000 
138 
180 
259 
288 
3.6 
5.5 
14 
? 
31 
60 
135 
5.7 
6.9 
9.0 
8.0 
8.3 
4.1 
1.77 
2.3 
0.12 
0.05 
<0.01 
9.6 
14.1 
36.6 
24.9 
0.76 
0.21 
0.03 
0.58 
<0.01 
<0.01 
<0.01 
6.0 
6.0 
30.6 
18.0 
Mw (D) Molecular weight in Daltons 
Mr (A) Molecular radius of the molecules in A. Stokes radius was used for mannitol, fluorescein, FD4, FD20, 
FD70 and FD500, vanderWaals radius was used for for salycilic acid, acetyl salycilic acid, propranolol and 
testosterone 
"Values are means of at least three experiments performed in triplicate, standard deviations were less than 10%. 
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Figure 3.5: Apical to basal transport of Mannitol (-+-), PEG-4000 (-A-) and testosterone (-0-) across filter 
grown Caco-2 (a) and IEC-18 cells (b) in time. For each sampling time individual datapoints are shown. Lines 
represent calculated best fits for n=3 per time point. 
Figure 3.6 shows a plot presenting the relation between the molecular radius (Mr) and the P 
for the hydrophilic markers. PEG-4000 is not depicted in the figure because it is impossible to 
calculate the exact molecular radius. There is a gradual decrease in Papp with increasing Mr for 
both cell lines. However, the curve for IEC-18 cells is shifted towards higher Papp values and 
the slope of the curve for IEC-18 cells is less steep than that for Caco-2 cells. This indicates 
that the number and size of the junctional pores is higher in IEC-18 than in Caco-2 cell layers. 
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Figure 3.6: Relation between 
molecular radius (Mr) and apparent 
permeability coefficient (P>pp, see 
Table 3.1) for hydrophilic probes 
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18 cells. 
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Discussion 
The aim of the present study was to compare filter grown IEC-18 and Caco-2 cells, 
with emphasis on differentiation, development of the tight junctional complex and transport 
properties. Histomorphological examination of cross sections of filter grown cells revealed 
that the Caco-2 monolayer consisted of well polarized, columnar epithelial cells with 
microvilli on the apical side. On the other hand, IEC-18 cultures seemed to be pseudo-layered 
or consisted of multilayers of less differentiated epithelial cells. Previous studies using 
electron microscopy have shown that these IEC-18 cells had a patchy appearance of microvilli 
(Quaroni and Isselbacher, 1981; Groten etal., 1992). 
Determinations of enzyme activities indicated that both cell lines express alkaline 
phosphatase, albeit the fetal isotype in IEC-18 and the mature enterocyte isotype in Caco-2. 
Levels of sucrase-isomaltase activities were found in Caco-2 cells in the same order of 
magnitude as in the literature (Pinto et al., 1983; Chantret et al., 1994), but we were unable to 
detect sucrase-isomaltase activity in IEC-18 cells. This is supported by Quaroni et al. (1979) 
who described that also with immunocytotochemical methods no sucrase-isomaltase 
complexes could be detected in IEC cells. 
The differentiation stage of the two cells was not only reflected by the activity and 
isotype of the brush border enzymes, but also by the TER development, ZO-1 expression and 
actin-belt formation. The F-actin in Caco-2 cells is organized into a peripheral actin-belt at the 
apical cell side, a characteristic for mature epithelial cells. In IEC-18 cells F-actin is not 
organized into an actin belt but expressed as cell crossing fibres. Both cell lines do form a cell 
circumscribing network of ZO-1 strands. The intensity of the ZO-1 signal in IEC-18 seems to 
increase in time without a concomitant increase in TER while no clear change in ZO-1 pattern 
or intensity was seen in Caco-2 during a time-period in which the TER almost triplicates. If 
the intensity of the fluorescence signal of ZO-1 might be considered a good measure for the 
quantity of junctional proteins, these findings do not support the structure-function hypothesis 
for tight junctions which states that the TER is directly related to the number of tight 
junctional strands (Claude, 1987). Our results indicate that neither the pattern nor the intensity 
of the immunofluorecence signal of this tight junctional protein can be used as indicators of 
relative junctional tightness when comparing different cell lines. This was also shown by 
Stevenson et al. (1988) who found that the ZO-1 contents of two MDCK strains was identical 
while the TER of these strains differed remarkably. 
In the present study it was shown that the differences in TER between IEC-18 and 
Caco-2 clearly correspond to differences in paracellular permeability. In IEC-18 the 
paracellular permeability is not only higher than in Caco-2 cells, but it even offers the 
possibility of a more clear discrimination between hydrophilic compounds which are poorly 
absorbed in vivo. For example, in Caco-2 monolayers the Papp for PEG-4000 (not absorbed in 
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humans) differed only slightly from that for mannitol (more than 60% absorption in humans; 
Nasralla and Iber, 1969), whereas in IEC-18 cells the Papp for mannitol is much higher than for 
PEG-4000. The relation between the molecular radius of the hydrophilic markers and the Papps, 
would thus allow for a more accurate prediction of transport rate on basis of molecular 
dimensions in IEC-18 than in Caco-2. 
The paracellular permeability in IEC-18 cells may be more comparable to that of the 
small intestine than the permeability in the Caco-2 cells. The IEC-18 cells appear to have a 
tight junctional network resembling that of the ileum, the area of the gastro-intestinal tract 
where permeation of hydrophilic molecules is most likely. The TER of Transwell grown IEC-
18 cells (±50 Q.cm2) is slightly lower than the TER for the rat ileum (88 Q.cm2) as reported by 
Powell (1981). The low TER might be the result of the crypt origin and the low 
differentiation stage of the IEC-18 cells. Within the ileum the TER in the crypts is lower than 
at the villus tips (Heresbach et al., 1994), therefore one might assume that the paracellular 
pathway through the ileal crypt epithelium is a favourable route for hydrophillic 
macromolecules. However the accessibility of the crypt epithelium is generally very low thus 
making the physiological importance of this route questionable. Nevertheless, based on our 
present knowledge, absorption of macromolecular hydrophilic drugs through the small 
intestinal crypts can not be excluded. 
The transport of lipophilic compounds is quite similar in both cell lines. Considering 
that passive diffusion of these compounds will occur transcellularly, no relation between 
transport and TER was expected. The slightly lower transport rates of the lipophilic 
compounds in Caco-2 cells might be due to a thicker aqueous boundary layer, which is known 
to be a barrier for lipophilic compounds (Karlsson and Artursson, 1991). We did not try to 
reduce the aqueous boundary layer by stronger agitation since the layer is part of the system, 
both in vivo and in vitro. It was also shown that a rather slow agitation rate of approximately 
30 rpm was sufficient to allow for diffussion of highly lipophylic PCB congeners through the 
aqueos boundary layer (Dulfer et al, 1996). 
Not much is known so far about active transport properties of IEC-18 cells but 
considering the low state of differentiation one might assume that these cells lack the 
expression of many of the active transport systems known to be present in human intestinal 
epithelium and in Caco-2 cells (Griffith et al, 1994; Hillgren et al, 1995). Among our future 
interests with implications to the paracellular pathway are the relevance and possible 
mechanisms of IEC-18 and Caco-2 cells to induce solvent drag (Pappenheimer and Reiss, 
1987). 
In summary, although the Caco-2 system has proven to be a powerful tool in 
absorption studies concerning transcellular transport processes (Artursson and Karlsson, 1991; 
Wilson et al, 1990; Stewart et al, 1995), its use as model in predicting uptake of poorly 
absorbed compounds which are transported paracellularly is probably limited. This is due to 
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the poor discrimination in Papps between various compounds with clearly different values of 
absorption rates in in vivo experiments (Artursson and Karlsson, 1991; Griffith et al, 1994). 
In contrast, IEC-18 cells seem to be more useful as a model to obtain information on transport 
rates of paracellularly transported compounds. Discrimination between several hydrophilic 
macromolecules on basis of transport rate is possible using filter-grown IEC-18 cells whereas 
this was not possible using Caco-2 cells. 
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Chapter 4 
Carrier-mediated transport in rat small intestinal IEC-18 cells: 
Comparison with the human colon carcinoma Caco-2 cell line. 
Carolien H.M. Versantvoort, Erwin Duizer, Andries J. Gilde and John P. Groten. 
Submitted. 
Abstract 
Previous studies have shown that the rat small intestinal cell line IEC-18 provides a 
size-selective barrier for paracellular permeation of hydrophilic macromolecules. In order to 
determine the utility of IEC-18 cells as a model to study intestinal carrier mediated transport, 
we have now examined the transport of GlySar (H+-coupled di/tripeptide carrier), 0-methyl-
D-glucose (glucose carrier), vincristine and rhodamine 123 (P-glycoprotein), and calcein and 
DNPSG (MRP/cMOAT). The transepithelial permeation of these compounds in IEC-18 cells 
was compared with the permeation across the human colon carcinoma Caco-2 cells. In IEC-
18 cells, the permeation of GlySar and methylglucose was as fast as that of mannitol, which 
permeates passively via the paracellular route. The transepithelial passage of mannitol was 
much lower than that of GlySar and methylglucose in Caco-2 cells. In contrast to Caco-2 cells, 
no H+-coupled transport of GlySar could be measured in IEC-18 cells. 
P-glycoprotein mediated transport was characterized in Caco-2 cells by an enhanced 
transport of vincristine and rhodamine 123 in the basolateral to apical direction and by 
inhibition of this transport by verapamil. In IEC-18 cells, permeability of vincristine and 
rhodamine 123 was similar in both directions and verapamil had no effect on the 
transepithelial permeation of these compounds. IEC-18 and Caco-2 cells showed transport of 
the organic anions calcein and DNPSG, which could be inhibited by probenecid. 
In conclusion, no carrier mediated transport of GlySar, methylglucose, vincristine and 
rhodamine 123 could be determined in IEC-18 cells in contrast to Caco-2 cells. However, 
both IEC-18 and Caco-2 cells showed MRP/cMOAT mediated efflux system(s) in the apical 
and basolateral membrane. 
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Introduction 
The small intestinal epithelium forms a permeability barrier influencing oral drug 
absorption. The predominant absorption route for compounds is the transcellular route. This 
includes compounds that are sufficiently lipophilic to pass the cell membranes by passive 
diffusion and hydrophilic compounds including many nutrients such as glucose, amino-acids 
and dipeptides, which are transported by carrier-mediated processes. Another possible way for 
hydrophilic compounds to pass the intestinal epithelium is the passive paracellular route along 
the epithelial cells. In addition to selective transport systems for the absorption of nutrients, 
the intestinal epithelium presents a first line of defense against the absorption of xenobiotics. 
This defense consists of the detoxification of the xenobiotics by metabolizing enzymes and/or 
extrusion of the (metabolized) xenobiotics from the mucosa cells into the intestinal lumen by 
transport proteins such as P-glycoprotein and MRP/cMOAT (Hunter et al, 1997). The 
substrate specificity of P-glycoprotein is very broad but a general feature is that the 
compounds are hydrophobic (cations). Like P-glycoprotein, the multidrug resistance-
associated protein (MRP) is a membrane glycoprotein which transports various hydrophobic 
anti-cancer agents out of tumor cells (Versantvoort et al, 1992; Zaman et al, 1993). In 
contrast to P-glycoprotein, MRP/cMOAT is able to transport not only hydrophobic 
compounds but also compounds conjugated with glutathione, other organic anions, and bile 
salts such as taurocholate (Jedlitschky et al., 1994; Miiller et al, 1994; Versantvoort et al., 
1995; Biichler et al, 1996; and Paulusma et al, 1996). RNA analysis showed that 
MRP/cMOAT is expressed in small intestine but the precise localization in the small intestine 
is not known at this moment (Paulusma et al, 1996; Kool et al, 1997). 
To anticipate the intestinal absorption of compounds and to investigate their 
mechanism of transport, monolayers of intestinal cell lines grown on permeable filter supports 
are increasingly used (Hillgren et al, 1995). One of the most commonly used cell lines is the 
differentiated human colon adenocarcinoma Caco-2. In several studies the permeability of 
compounds in Caco-2 monolayers correlated with the human oral absorption in vivo. Caco-2 
cells are an useful model for studying the functionality of carrier mediated transport in the 
small intestine, although these carriers are often expressed to a lesser extent in Caco-2 cells 
than in normal enterocytes (Hillgren et al, 1995; Artursson et al, 1996; Hunter et al, 1997). 
However, due to the tightness of the Caco-2 monolayer, the paracellular barrier presented by 
Caco-2 cells is much higher than that of the small intestinal epithelium. For that reason we 
have used the rat small intestinal crypt cell line IEC-18, to study the transport of poorly 
absorbed hydrophilic compounds. The transepithelial electrical resistance of filter grown IEC-
18 cells resembles the resistance for rat ileum and these cells seem to be a useful model to 
obtain information on the small intestinal permeability barrier for paracellularly transported 
hydrophilic macromolecules (Ma et al, 1992; Duizer et al, 1997). The IEC-18 cells are less 
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well differentiated than the Caco-2 cells, but not much is known about the expression of 
carrier mediated transport systems in this cell line. 
In the present study, we have investigated the utility of IEC-18 cells as a model to 
study intestinal carrier mediated transport. Thereto, the transport of GlySar (H+-coupled 
di/tripeptide carrier), methylglucose (glucose carriers), vincristine and rhodamine 123 (P-
glycoprotein), and calcein and DNPSG (MRP/cMOAT) is characterized in IEC-18 cells. The 
transport of these compounds is compared with the transport in Caco-2 cells. 
Methods 
Chemicals 
Radiolabeled chemicals used were obtained from the following suppliers 3H-
vincristine sulphate (Amersham, 0.3 GBq/mmol), 3H-0-methyl-D-glucose (Amersham, 185 
GBq/mmol), 3H-mannitol (ICN, 1 GBq/mmol), l4C-Gly-Sar (Zeneca Cambridge Research 
Biochemicals, 2.1 GBq/mmol). Calcein acetoxymethyl ester was obtained from Molecular 
Probes. Rhodamine 123, verapamil hydrochloride, probenecid and chlorodinitrobenzene were 
from Sigma, phloridzin dihydrate was from Aldrich. 
Cells 
The human colon carcinoma cell line Caco-2 and the rat epithelial cell line IEC-18 
were obtained from the American Type Culture Collection. Caco-2 cells were used at 
passages 26-38, IEC-18 at passages 25-33. Cells were maintained at 37°C in an atmosphere of 
5% C02 in Hepes buffered DMEM (4.5 g/1 glucose), supplemented with 1% (v/v) MEM 
nonessential amino acids, 6 mM L-glutamine, 50 ug/ml gentamycin (all from Gibco), and 
10% (v/v) FCS (Integra) for Caco-2, and 5%(v/v) FCS and 0.1 U/ml insulin (Sigma) for IEC-
18 cells. For transport experiments, cells (1-2 x 105 cells/insert) were seeded on Transwell 
polycarbonate cell culture inserts (12 well format) with a mean pore size of 0.4 um (Costar). 
Cells were then cultured for 17-24 days. 
Drug transport and cellular accumulation 
Transepithelial drug transport in IEC-18 and Caco-2 cells was measured as described 
before (Duizer et ah, 1997). Transport of 10 uM compound (unlabeled compound plus tracers 
of radiolabel) was determined in Transwell inserts with apical 0.5 ml transport medium 
(Hepes buffered DMEM supplemented with 1% (v/v) MEM nonessential amino acids, 6 mM 
L-glutamine, 50 ug/ml gentamycin (all from Gibco), and 0.1% bovine serum albumin (Sigma) 
and basolateral 1.8 ml transport medium on a rotating platform (30 rpm) at 37°C. In case of 
transport studies using a medium pH of 6.0, DMEM was replaced by Hanks Balanced Salt 
Solution (Gibco). Apparent permeability coefficients (Papp values) were determined on basis of 
the appearance of the probe in the receiver compartment (Duizer et al., 1997). 3H- and Re-
labeled compounds were analyzed by using a Wallac 1409 liquid scintillation counter. 
Transport of rhodamine 123 was measured by fluorescence detection using Cytofluor 2300 
(Millipore) with excitation filter at 485 nm and emission filter at 530 nm. 
For cellular accumulation studies, the medium was removed at the end of the 
incubation period, and the monolayers were washed rapidly with 1 and 2 ml of ice-cold PBS 
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in the apical and basolateral compartment, respectively. The filters with cells were detached 
from the inserts, and immerged in scintillation liquid. 
Calcein efflux 
Calcein transport was studied after loading the cell layer by incubation with 2 uM 
calcein acetoxymethyl ester (calcein-AM) (apical and basolateral exposure) for 30 min at 
37°C. Cells exposed to calcein-AM become fluorescent following cleavage of the calcein-
AM by cellular esterases to produce the fluorescent derivative calcein. In order to maximally 
load the cells with calcein, 2 mM probenecid and 20 uM verapamil were added to the calcein-
AM solution in order to inhibit the transport of calcein and calcein-AM, respectively, during 
the loading period (Versantvoort et al., 1995). Subsequently, the apical and basolateral 
calcein-AM solutions were removed, the filters were rinsed with ice-cold PBS and the inserts 
were transferred to new wells containing fresh pre-warmed medium with or without 20 uM 
verapamil or 2 mM probenecid. Efflux of calcein from the cells into the medium was 
measured by sampling from the apical and basolateral compartments at indicated time points. 
Samples were analyzed by fluorescence detection using a Cytofluor 2300 (Millipore) with 
excitation filter at 485 nm and emission filter at 530 nm. 
Cellular accumulation and efflux ofDNPSG 
Transport of DNPSG out of the cells into the medium was studied after the 
monolayers were incubated with 25 uM CDNB in Hanks at 37°C in a C02 incubator. At the 
indicated time points, 400 pi samples were taken from both the apical and basolateral 
compartment and were subsequently precipitated with 100 ul 20% (w/v) TCA. The remaining 
medium was then removed, and the cells were washed with ice-cold PBS. DNPSG (and other 
CDNB metabolites) were extracted from the cells by addition of 400 ul 5% (w/v) TCA in 
Hanks. DNPSG was analyzed by HPLC (Pharmacia LKB HPLC system) on a Zorbax ODS 
column (4.6*250 mm, Alltech Applied Science Group, Emmen, The Netherlands), eluted at a 
flow rate of 1 ml/min with 0.1% (v/v) trifluoro acetic acid (solvent A) and 0.1% (v/v) trifluoro 
acetic acid in methanol (solvent B) isocratically at 30% B for 5 min, followed by a linear 
gradient of 30-90% B in 22.5 min (retention time 14 min for DNPSG and 21 min for CDNB). 
Quantification of DNPSG was performed by peak area integration at 340 nm, using 
concentration/absorbance curves of a DNPSG standard. To prevent hydrolysis of DNPSG by 
y-glutamyl transferase, 2 mM acividin was added to incubation medium (Oude Elferink et al, 
1993). 
Results 
H*-coupled GlySar and O-methyl-D-glucose transport 
Transport characteristics of the small hydrophilic compounds GlySar (MW 146), O-
methylglucose (MW 194) and mannitol (MW 182) were compared in IEC-18 and Caco-2 
cells. These compounds can not permeate the cell membrane easily because of their 
hydrophilicity and are transported exclusively via the paracellular route unless a carrier system 
is present to facilitate transcellular permeability. Time course of the drug transport was 
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examined when the drug was added to either the apical or basolateral side of the monolayers. 
Figure 4.1 A shows that in IEC-18 cells the transepithelial transport of GlySar, methylglucose 
and mannitol was similar. We also found that transport of all three compounds was as fast in 
the apical to basolateral direction as the other way around. In Caco-2 cells, transport of 
methylglucose was faster than that of mannitol and GlySar (Figure 4.IB). Furthermore, 
phloridzin (100 uM) inhibited the transport of methylglucose to 77+ 8 % of control (P<0.01 
Students paired f-test (n=3)) in Caco-2 cells, without affecting the methylglucose transport in 
IEC-18 cells (105±13%). In Caco-2 cells, no difference was found in transport of 
methylglucose and mannitol in apical to basolateral or basolateral to apical direction, whereas 
GlySar transport was significantly faster from the apical to basolateral direction than that from 
the basolateral to apical side (Table 4.1). 
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Figure 4.1: Transepithelial permeability of GlySar, methylglucose and mannitol in IEC-18 and Caco-2 cells. 
Apical to basal transport of 10 pM GlySar, methylglucose (Meth-Gluc) and mannitol was determined from 0 to 
240 min in IEC-18 (A) and Caco-2 cells (B). Each point is the mean ±sd of at least two experiments each 
performed in triplicate. 
It has been shown that an H+ gradient is the driving force for the transport of 
dipeptides in the intestine and Caco-2 cells (Thwaites et al, 1993; Matsumoto et al., 1994). 
The effect of FT gradient on the transepithelial transport and cellular accumulation of GlySar 
is summarized in Table 4.1. The transport of GlySar in either direction was 2-fold increased in 
Caco-2 cells by introduction of a H+ gradient (pH 6 and pH 7.4 in donor and receiver 
compartment, respectively). Moreover, the transport of GlySar was decreased when transport 
was measured against a H+ gradient (Pbasoiaterai-to-apicaiwas 2-8 vs 2.1 xlO6 cm/s in case pH7.4-to-
pH7.4 vs pH7.4-to-pH6.0, respectively). The accumulation of GlySar after 4 hours of 
incubation was 2.5 to 3-fold lower when GlySar was administered at the basolateral 
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compartment and could be increased only 1.2- to 1.4-fold, by introduction of a H+ gradient. 
Acidifying the donor incubation medium to a pH 6 had no effect on the permeability and 
accumulation of GlySar in IEC-18 cells. Furthermore, the accumulation of GlySar in IEC-18 
cells (5-6 pmol / filter) is much lower compared to the accumulation in Caco-2 cells (224-278 
pmol / filter). These results suggest that GlySar transport in Caco-2 cells is mediated by the 
H+-coupled di/tripeptide carrier, while it is not in IEC-18 cells. 
Table 4.1. pH-dependent GlySar transport and accumulation in IEC-18 and Caco-2 cells. 
Monolayers were incubated for 4 hours with 10 uM GlySar added to the apical or basolateral compartment with 
pH 6 or pH 7.4. The appearance of GlySar in the receiver compartment (pH7.4) was measured in time and the 
cellular accumulation was determined at the end of the experiment. Data are mean ± sd, number of independent 
experiments in parentheses, in each experiment at least two monolayers were used. 
apical to 
basolateral 
pH7.4->pH7.4 
pH6.0->pH7.4 
basolateral to 
apical 
pH7.4->pH7.4 
pH6.0->pH7.4 
IEC-18 
Pab 
(lO6 cm/s) 
12.1 ±2.7 (4) 
11.3 ±2.5 (3) 
Pba 
(10-6cm/s) 
11.9 ±2.7 (4) 
12.5 ± 3.6 (2) 
accumulation 
(pmol/filter) 
6.0 ±0.7 (4) 
5.1 ±1.9 (3) 
accumulation 
(pmol/filter) 
7.2 ± 2.5 (4) 
8.9 ±1.5 (2) 
Caco-2 
Pab 
(10* cm/s) 
4.6 ±1.1 (4) 
8.7 ± 2.0 (4)* 
Pba 
(106 cm/s) 
2.8 ± 0.8 (4)* 
5.5 ±1.0 (2)* 
accumulation 
(pmol/filter) 
224 ±33 (4) 
278 ± 32 (4)* 
accumulation 
(pmol/filter) 
78 ± 15 (4)* 
109 ± 5 (2) 
* Transepithelial permeability and cellular accumulation along the H+ gradient are significantly different 
compared to pH 7.4 in donor compartment; P<0.05, Student's Mest. 
#
 Transport and cellular accumulation of GlySar is significantly different when applied at the basolateral side of 
the cell layer than when applied at the apical side; /><0.01, Student's paired Mest. 
F'-glycoprotein mediated transport 
Transport of the P-glycoprotein substrates vincristine and rhodamine 123 were 
compared in IEC-18 and Caco-2 cells. P-glycoprotein is expressed in Caco-2 cells at the 
apical cell membrane, which is consistent with the in vivo functionality of P-glycoprotein 
mediating the transport of compounds into the intestinal lumen (Hunter et al., 1993, Meyers et 
al., 1991). The present study shows that transport of vincristine and rhodamine 123 in Caco-2 
cells was much faster in the basolateral to apical direction than vice versa, whereas it was 
similar in both directions in IEC-18 cells (Figure 4.2). Verapamil, an inhibitor of P-
glycoprotein mediated transport, decreased the difference in bidirectional transport of 
50 
Chapter 4 Carrier mediated transport in Caco-2 and IEC-18 
rhodamine 123 and vincristine in Caco-2 cells whilst having no effect in IEC-18 cells (Figure 
4.2). 
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Figure 4.2: Bidirectional apparent permeability coefficients of vincristine and rhodamine 123 across IEC-18 and 
Caco-2 cells. The cells were incubated for 4 h in the presence or absence of 20 uM verapamil with the substrate 
added to the apical or basolateral compartment. Data are mean ± sd, n=2 to 6 experiments, with 3 filters per 
experiment. 
Caco-2 cells undergo differentiation and polarization during culture of the cells on 
permeable filter supports (Hillgren et al., 1995; Hunter et al. 1997; Duizer et al., 1997). In 
order to determine whether the expression of P-glycoprotein was related to the differentiation 
and polarization status of Caco-2 monolayers, the transport of rhodamine 123 was determined 
at 6, 13 and 20 days after seeding. The ratio Pba/Pab increased from 10.8 at day 6 to 29.2 at 
day 20 after seeding of the cells, indicating that the P-glycoprotein expression was indeed 
correlated to differentiation. 
MRPIcMOAT mediated transport 
The organic anion calcein and the glutathione 5-conjugate DNPSG were used as 
substrates to study the function of MRP/cMOAT in the two intestinal cell lines. Figure 4.3 
shows the calcein efflux out of the IEC-18 and Caco-2 cells in presence or absence of 
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probenecid, an inhibitor of organic anion transport. Calcein efflux out of IEC-18 cells was as 
fast to the apical as to the basolateral compartment. Incubation with probenecid resulted in a 
reduced efflux to either side (Figure 4.3A). In Figure 4.3B is shown that the efflux of calcein 
from Caco-2 cells was approximately 4-fold higher to the apical than to the basolateral 
compartment and that the apical efflux was more susceptible for inhibition with probenecid. 
Verapamil (20 uM) had no effect on the efflux of calcein in either cell line (data not shown). 
In contrast to the increased P-glycoprotein mediated rhodamine 123 transport, the efflux of 
calcein was not affected by the differentiation and polarization status of Caco-2 monolayers. 
At day 6 and day 20, the apical over basolateral efflux of calcein was 3.8. 
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Figure 4.3: Calcein efflux from IEC-18 and Caco-2 cells. IEC-18 (A) and Caco-2 (B) cells were loaded for 30 
min with 2 pM calcein-AM in presence of 20 pM verapamil and 2 mM probenecid. Release of calcein to the 
apical (Ap) and basal (Bl) compartment was measured in absence or presence (+Prob) of 2 mM probenecid after 
transfer of the filter-grown cells into prewarmed calcein-free medium. Each point is mean ± sd of three 
independent experiments. 
Because of its hydrophilicity, DNPSG can not pass the cell membranes easily by 
passive diffusion and, therefore, transmembrane transport systems are essential for the 
elimination of cellular DNPSG. Cells were exposed apically to 25 uM CDNB. In the cells 
CDNB is rapidly conjugated to glutathione by GST and the transport of the glutathione 5-
conjugate, DNPSG, was followed in time. DNPSG was preferentially effluxed to the apical 
compartment in both cell lines (Figures 4.4A and 4.4B). Probenecid blocked the efflux of 
DNPSG to both directions, and thus retaining DNPSG in the cells. Incubation of Caco-2 cells 
with 2 mM probenecid resulted in a large decrease (>60%) in DNPSG efflux to the basolateral 
compartment, whilst having only a small effect (5-25% inhibition) on the transport to the 
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apical side. The DNPSG transport to the apical (and basolateral) compartment could be 
inhibited more efficiently by increasing the concentration of probenecid (Figure 4.4B). 
Control 2 mM Probenecid 5 mM Probenecid 
Apical Basolateral Cells 
Time (min) 
15 30 60 15 30 60 15 30 60 
Time (min) 
Figure 4.4: DNPSG transport and cellular accumulation in IEC-18 and Caco-2 cells. IEC-18 (A) and Caco-2 (B) 
cells were apically exposed to 25 pM CDNB. Cellular accumulation and transport of DNPSG to the apical and 
basal compartment was measured during 60 min in the absence or presence of probenecid. Data are mean ± sd of 
at least three experiments. 
In Table 4.2 is shown that the preferential efflux of DNPSG to the apical compartment 
was dependent on the side of exposure of the cells to CDNB. When CDNB was applied at the 
basolateral side of the monolayers, DNPSG was effluxed to the same extent to both 
compartments in both cell lines. This was due to combination of a reduced DNPSG efflux to 
the apical compartment and an increased DNPSG efflux to the basolateral compartment 
compared to the DNPSG efflux when CDNB was applied at the apical side. The relative 
effects of probenecid on DNPSG transport, however, were independent of the side of CDNB 
exposure (Table 4.2). 
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Table 4.2: DNPSG efflux after apical or basolateral exposure of the cells to CDNB. Cells were incubated for 30 
min with 25 pM CDNB applied at the apical or basolateral compartment in the absence or presence 2 mM 
probenecid. After 30 min, the DNPSG content was measured in the apical, basolateral and cellular compartment. 
Data are mean ± sd of 3-6 independent experiments. 
CDNB exposure 
ratio DNPSG efflux 
apical/basolateral 
IEC-18 
apical 
2.34 ± 0.67 
basolateral 
1.16 ±0.41* 
Caco-2 
apical 
2.55 ±0.68 
basolateral 
1.17 ±0.38* 
ratio probenecid/control 
apical 
basolateral 
cells 
0.39 ±0.15 
0.23 ±0.11 
5.00 ±1.50 
0.40 ± 0.06 
0.45 ±0.14 
4.32 ± 0.96 
0.82 ± 0.07 
0.20 ± 0.07 
1.60 ±0.12 
0.77 ±0.26 
0.15 ±0.02 
1.51 ±0.02 
* Ratio of DNPSG efflux is significantly different when CDNB was applied at the apical resp. basolateral side 
of the monolayer; P<0.05, Student's r-test. 
Discussion 
Intestinal absorption of drugs and nutrients occurs predominantly in the small 
intestine. Previously, we have studied passive transcellular and paracellular transport 
characteristics in rat small intestinal IEC-18 cells (Duizer et al., 1997). Grown on permeable 
filters, IEC-18 cells are less differentiated than the Caco-2 cells as was determined by 
histomorphology (not very well polarized) and brush border enzyme activities (no expression 
of sucrase-isomaltase or intestinal isotype of alkaline phosphatase (Duizer et al., 1997). 
However, the IEC-18 cells, originating from rat ileum epithelium, appear to more closely 
resemble the permeability for paracellularly permeating compounds (Ma et al., 1992; Duizer 
et al, 1997). In this paper, we have investigated the usefulness of IEC-18 cells as a model to 
study carrier mediated transport processes. 
First, the transepithelial permeability characteristics of the small hydrophilic 
compounds GlySar (substrate for H+-coupled di/tripeptide carrier), methylglucose (glucose 
carriers) and mannitol (paracellular route) were examined in IEC-18 and Caco-2 cells. These 
three compounds, which differ in molecular weight only from 146 to 194, passed equally fast 
across the IEC-18 cells (Papp -12 x 10"6 cm/s), and there was no difference between the 
transport rates from apical to basal and basal to apical direction. Moreover, an H+ gradient did 
not affect GlySar permeation (Table 4.1) and phloridzin did not inhibit the transepithelial 
passage of methylglucose. This suggests that the paracellular route is the predominant route 
for the absorption of GlySar and methylglucose in IEC-18 cells. In contrast to IEC-18 cells, 
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the transepithelial passage of mannitol in Caco-2 cells was much lower than that of GlySar 
and methylglucose (Papp is 0.4, 4.6, and 20.2 x 10"6 crn/s, respectively). Indeed, Caco-2 cells 
are known to express carrier-mediated systems for the transport of GlySar and methylglucose 
(Thwaites et al, 1993; Hillgren et al, 1995). Note that although the transport of GlySar and 
methylglucose in Caco-2 cells is facilitated by carriers, the apparent permeability of GlySar 
and methylglucose was almost as high in IEC-18 cells as in Caco-2 cells (Figure 4.1 and Table 
4.1). The high transport in IEC-18 cells might be explained by the fact that the transepithelial 
electrical resistance of the IEC-18 cells (small intestine) is much lower than that of the Caco-2 
cells (large intestine), 50 versus 500 Q.cm2, respectively (Duizer et al., 1997). These "loose" 
tight junctions in the small intestine allow small hydrophilic compounds (MW<350) to be 
absorbed via the paracellular route (He et al, 1998). Thus, the results from the transport 
experiments with GlySar, methylglucose and mannitol indicate that these compounds can be 
absorbed by the passive paracellular route (IEC-18 cells) and by the carrier-mediated 
transcellular route (Caco-2 cells). 
The H+-di/tripeptide co-transporter plays an essential role in the absorption of several 
important pharmaceuticals such as the cephalosporin 6-lactam antibiotics (reviewed by 
Dantzig, 1997). Studies with the B-lactam antibiotics loracarbef, ceftibuten and cephadrine 
suggested that the transcellular absorption depends on at least two distinct oligopeptide 
transporters, an apical H+-dependent co-transporter and a basolateral ^-independent carrier, 
and that the basolateral carrier forms the rate-limiting step for transcellular transport in Caco-2 
cells (Hu et al., 1994; Matsumoto et al., 1994). In these studies, however, the transport of the 
cephalosporins in basolateral-to-apical direction was measured against a H+-gradient 
(basolateral pH 7.4 and apical pH 6.0), whereas the transport in apical-to-basolateral direction 
was determined along a H+-gradient. Our data showed that when transport was determined 
along a H+-gradient in both directions in Caco-2 cells, the transport in either direction was 
equally proton dependent (Table 4.1). These data are in agreement with the results reported by 
Thwaites et al. (1993), showing that the transport of GlySar in Caco-2 cells was mediated by 
expression of an H+-coupled carrier at both apical and basolateral membranes. Cellular 
accumulation of GlySar in Caco-2 cells was higher when GlySar was applied at the apical 
compared to the basolateral side of the cells (Table 4.1). A similar side-specific cellular 
accumulation in Caco-2 cells has been measured for several cephalosporins (Inui et al., 1992; 
Matsumoto et al., 1994). The lower cellular accumulation and lower transepithelial 
permeability of GlySar when GlySar was applied at the basolateral side indicate indeed that 
the transport across the basolateral membrane forms the rate-limiting step for transcellular 
transport in Caco-2 cells. 
Besides the function of the intestinal epithelium in the absorption of nutrients, the 
intestinal epithelium plays an important role in protecting the body from against the 
absorption of ingested xenobiotics. Transport proteins such as P-glycoprotein and 
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MRP/cMOAT may contribute to such line of defense by expelling xenobiotics into the 
intestinal lumen (Hunter and Hirst, 1997). In the intestine P-glycoprotein is localized in the 
secretory domain of the enterocytes (van der Valk et al, 1990), and its expression is very low 
in the crypt but increases along the crypt-villus axis (Meyers et al, 1991). Thus, the lack (or 
low) P-glycoprotein activity in IEC-18 cells correlates with the low differentiation status and 
the origin of these cells from crypt ileum epithelium (Quaroni et al, 1981; Duizer et al., 
1997). Moreover, the increased P-glycoprotein activity during ongoing differentiation of the 
Caco-2 cells (from day 6 to day 20 after seeding) correlated with the in vivo expression of P-
glycoprotein in the small intestine. 
MRP1 expression, like P-glycoprotein expression, has been associated with the efflux 
of lipophilic agents out of tumor cells (Versantvoort et al, 1992; Zaman et al, 1993). 
Recently, a number of homologues of MRP1 (MRP2-MRP5) have been identified (Kool et 
al., 1997). The precise localization and function of for example MRP1 and MRP2/cMOAT in 
the intestine is not known at this moment. MRP1 is expressed in most tissues (Zaman et al., 
1993; Flens et al, 1996) and the substrate specificity of MRP1 is very broad. Not only 
hydrophobic compounds can be transported by this protein but also organic anions and 
compounds conjugated with glutathione (Jedlitscky et al, 1994; Miiller et al., 1994; 
Versantvoort et al., 1995). MRP2 (cq. cMOAT) is highly expressed in the canalicular 
membrane of hepatocytes and has been shown to be responsible for the transport of 
taurocholate out of the cells into the bile (Biichler et al., 1996; and Paulusma et al., 1996). In 
the small intestine only low RNA expression has been found so far (Kool et al, 1997). 
In this study we have characterized intestinal MRP/cMOAT-mediated transport by 
studying the transport of the model substrates calcein and DNPSG. Calcein efflux from IEC-
18 cells was similar in both directions whereas calcein was preferentially effluxed into the 
apical compartment by the Caco-2 cells (Figure 4.3). A similar preferential, apical efflux of 
calcein was found in rat jejunum (Fujita et al, 1997), suggesting that enterocytes express a 
MRP-like transport system at the apical membrane. However, the transport of DNPSG and the 
inhibition by probenecid (Figure 4.4 and Table 4.2) indicates that IEC-18 and Caco-2 cells 
express MRP-like transport systems at not only the apical but also the basolateral membrane. 
Since the DNPSG and calcein efflux from Caco-2 cells to the apical and basolateral 
compartment was not equally susceptible for inhibition by probenecid, it is suggested that 
different transport systems are expressed in the apical and basolateral membrane of the cells. 
Transfection experiments with MRP1 and MRP2/cMOAT in polarized kidney tumor 
cells showed that MRP1 was localized at the basolateral membrane whereas MRP2/cMOAT 
was localized at the apical membrane (Evers et al, 1996 and 1998). When the routings found 
by the transfection experiments are representative for the localization of MRP1 and cMOAT 
in the intestine, these findings suggest that MRP1 is expressed at the basolateral membrane 
and MRP2/cMOAT at the apical membrane of Caco-2 cells. However, the identity and 
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localization of the MRP/cMOAT like transport systems in intestinal Caco-2 and IEC-18 cells 
will have to be determined by immunocytochemical techniques. Our results further indicate 
that MRP/cMOAT mediated transport in the intestine is not confined to the differentiated 
enterocytes, but that MRP/cMOAT transport systems are likely to be present along the whole 
crypt-villus axis. 
In conclusion, the bidirectional permeation rates of GlySar, methylglucose, vincristine 
and rhodamine 123 in IEC-18 cells gave no indication for the expression of, respectively, the 
H+-coupled di/tripeptide carrier, glucose carriers or P-glycoprotein in these small intestinal 
crypt cells. However, a probenecid-sensitive efflux of calcein and DNPSG to both cell sides 
did suggest the presence of MRP/cMOAT mediated efflux system(s) in the apical and 
basolateral membrane of the crypt and villus-like intestinal epithelial cells. For Caco-2 cells, 
the presence of H+-coupled di/tripeptide carrier, glucose carriers and P-glycoprotein were 
confirmed, and our data suggested a differential expression of MRP homologues over the 
apical and basolateral membranes in these differentiated intestinal epithelial cells. 
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Chapter 5 
Dexamethasone inhibits cell proliferation and enhances the 
paracellular barrier function of rat ileal IEC-18 cells. 
Erwin Duizer, Carolien H. M. Versantvoort, Andries J. Gilde, and John P. Groten. 
Submitted 
Abstract 
The paracellular pathway in the small intestine has been recognized to contribute 
significantly to the oral bio-availability of hydrophilic (macro-)molecules. The paracellular barrier 
was found to increase with the ongoing differentiation along the crypt-villus axis. Our aim was 
to develop a cell culture model allowing the study of small intestinal paracellular permeability 
and to correlate cell proliferation and differentiation to paracellular barrier development. 
IEC-18 cells were seeded on polycarbonate filter inserts and treated with 0.1-10 /zM 
dexamethasone for 4-19 days. Measures of cell differentiation (morphology and brush border 
enzyme activities) and proliferation (cell number) were correlated to paracellular barrier 
development. Dexamethasone induced growth arrest in filter-grown IEC-18 cells. This was 
concomitant with a reduction of non-intestinal alkaline phosphatase expression, an increased 
organization of F-actin and the tight junctional protein ZO-1, and a decrease in the paracellular 
permeability of electrolytes and macromolecules. Furthermore, TPA and EGTA completely 
abolished the dexamethasone induced increase in paracellular barrier function without causing 
cytotoxic effects. 
Dexamethasone reduced cell proliferation, induced an epithelial-like cell morphology and 
increased the paracellular barrier function of filter-grown IEC-18 cells. The dexamethasone-
induced changes suggest a maturation of the junctional complex in these ileal crypt cells. 
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Introduction 
The epithelium in intestinal crypts is one of the most rapidly proliferating tissues. As cells 
move away from the lower part of the crypts towards the villi, they stop proliferating and start to 
differentiate into several cell types of which the enterocyte is the most abundant. This 
differentiation process is regulated by matrix factors, cell-cell interactions, growth factors and 
hormones (Koldovsky, 1994; Quaroni and Hochman, 1996) and it is characterized by an 
irreversible loss of the proliferative potential, by an increase in the expression and polarization 
of many enzymes and transporter systems, and by the development of the epithelial barrier 
function (Henning et al, 1994). The epithelial barrier is composed of a transcellular and a 
paracellular component. The cell membranes and cellular contents form the transcellular 
component, while the apical junctional complex and the lateral intercellular space form the 
paracellular component (Reuss, 1992). Along the small intestinal crypt-villus axis the increase 
in paracellular barrier function is concomitant with an increase in cell-circumscribing tight 
junctional strand number at the apical cell side (Madara and Trier, 1994). 
One of the most widely used in vitro models to study enterocytic differentiation is the 
Caco-2 cell line (Pinto etal, 1983; Peterson and Mooseker, 1993). But, even though use of these 
cells have greatly advanced insight in intestinal brush-border development and intestinal transport 
and permeability properties (Hidalgo et al, 1989; Artursson et al., 1996), this cell line is not a 
very valuable tool for studying the (development of the) small intestinal paracellular barrier 
function. One important reason is that the tight junctional barrier formed by this colonic 
carcinoma cell line restricts the passage of hydrophilic macromolecules known to pass to some 
extent the small intestinal epithelium in vivo. The rat ileum derived cell line IEC-18 was found 
to be a more appropriate model for small intestinal permeability of hydrophilic macromolecules 
(Ma et al., 1992; Duizer et al., 1997). These epithelial cells have a normal rat karyotype and 
express intestinal epithelial specific cell surface antigens (Quaroni and Isselbacher, 1981) and 
junctional proteins such as ZO-1 and desmoplakin (Ma et al, 1992; Duizer et al, 1997). 
Furthermore, it was found that IEC-18 cells could be induced to acquire villus enterocytic 
characteristics by extracellular matrix components (Benya et al., 1993) or a small intestinal 
extract (Shintani et al., 1989). On the other hand, IEC-18 cells cultured on un-coated filters under 
standard conditions grew in multilayers and showed a low expression of brush-border enzymes 
and a low organization of F-actin (Duizer et al., 1997). 
Additionally, while small intestinal paracellular permeability can be regulated in vivo to 
increase the uptake of nutrients (Madara and Pappenheimer, 1987; Madara, 1987; Ballard et al, 
1995) or to improve bioavailability of orally administered drugs (Hochman and Artursson, 1994; 
Lutz et al., 1997), specific modulation of paracellular permeability in IEC-18 cell layers was not 
readily achieved (Duizer et al, 1998; Duizer et al, 1999). In mature enterocytes, the regulation 
of paracellular permeability is, at least partly, dependent on the peri-junctional actin belt. This 
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peripheral ring of actin microfilaments is part of the cytoskeleton and it is connected to junctional 
membrane components in polarized epithelial cells (Madara and Trier, 1987; Mitic and Anderson, 
1989). The very low transepithelial electrical resistance (TER) and the lack of a recognizable 
perijunctional actin belt in filter-grown IEC-18 cells, suggests that the paracellular barrier has not 
yet developed to the full extent in these undifferentiated cells. In order to be able to study 
modulation of small intestinal paracellular permeability in more detail, a further maturation of 
the paracellular barrier of these cells is required. 
The synthetic glucocorticoid dexamethasone was found to cause an increase in TER and 
a concomitant decrease in mannitol and inulin permeability in the mouse mammary epithelial 
31EG4 cells. These dexamethasone-induced effects could not be correlated to changes in F-actin, 
E-cadherin or ZO-1 production or location using indirect immunofluorescence (Zettl et al., 1992). 
However, under comparable conditions, a 2.3 fold increase in levels of ZO-1 protein was found 
using quantitative Western blotting (Singer et al., 1994). Thus the mechanism by which the 
paracellular barrier function was increased in these mammary epithelial 31EG4 cells has not been 
resolved, but it was suggested that glucocorticoids provide a signal for rearrangement of 
regulatory or structural junctional components (Zettl et al., 1992). Moreover, dexamethasone is 
reported to have maturing effects on brush-border enzyme expression in the developing 
mammalian gastrointestinal tract in vivo (Beaulieu and Calvert, 1985; Koldovsky, 1994), and on 
differentiating human fetal intestinal crypt cells in vitro (Quaroni and Beaulieu, 1997). 
The aim of the present study was therefore to differentiate filter-grown IEC-18 cells to 
obtain a better model for the small intestinal paracellular barrier. Using dexamethasone as a 
culture medium supplement, we want to prevent growth into multilayers and to induce a more 
mature paracellular barrier in this undifferentiated crypt cell line. The functionality of the barrier 
formed in the presence or absence of dexamethasone was determined by measuring the 
permeability of the cell layers for electrolytes (TER) and hydrophilic macromolecules. 
Immunofluorescence microscopy was used to assess the localization of the tight junctional protein 
ZO-1 and the organization of filamentous actin (F-actin). Additionally we studied the effects of 
the paracellular barrier perturbants EGTA (Cassidy and Tidball, 1967; Gorodeski et al., 1997) and 
TPA (Ojakian, 1981; Anderson and Itallie, 1995) on the permeability of hydrophilic 
macromolecules, to determine whether tight junction-specific effects could be evoked in 
dexamethasone treated IEC-18 cells. 
Materials and Methods 
Cell Culture 
IEC-18 cells originating from rat ileum epithelium were obtained from the American Type 
Culture Collection. Cells were maintained at 37°C in an atmosphere of 5% C02 and >90% 
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relative humidity. Standard medium was DMEM with high glucose (4.5 g/L) and 25 mM Hepes, 
supplemented with 1% (v/v) MEM nonessential amino acids, 6 mM L-glutamine, 50 fxg/m\ 
gentamycin (all from Gibco, Paisley, Scotland) and 5% (v/v) heat-inactivated fetal calf serum 
(batch: 5-41101 Integra b.v., Zaandam, Netherlands), and 0.1 U/mL insulin (Sigma, Beers, 
Belgium). Cells grown in 75 cm2 flasks were passaged weekly at a split ratio of 1:10 using 0.05% 
trypsin in PBS with 0.022% EDTA. Cells were used at passages 18-28. For experiments the cells 
were resuspended in culture medium at a concentration of 3 x 105 cells/ml. The IEC-18 cells were 
subcultured onto Transwell cell culture inserts (growth area of 1 cm2 per filter, 0.5 ml cell 
suspension apical and 2 ml medium basolateral) and allowed to settle for 12-16 h under standard 
culture conditions. Subsequently, the medium was replaced by standard culture medium without 
(basolateral) or with (apical) dexamethasone (0.1-10 /JM) every 2 or 3 days. The mouse fibroblast 
L929 cells and human colonic carcinoma Caco-2 cell line were cultured as described previously 
for Caco-2 (Duizer et al., 1997). 
Light microscopy 
Filter-grown cells were fixed in 4% phosphate-buffered formaldehyde. The cells were 
dehydrated in an ascending series of 70 to 100% ethanol and subsequently embedded in 
Technovit 7100 (Heraeus Kulzer GmbH, Wehrein, Germany). The 2-4 //m thick cross-section 
were stained with toluidine blue. 
Enzyme Activity 
Cell homogenates were obtained by sonicating filter-grown cells in ice-cold PBS. 
Activities of alkaline phosphatase were determined spectrophotometrically on the BM/Hitachi 
911 using p-nitrophenylphosphate as a substrate. Cell homogenates were diluted to 20 mU 
ALP/mL and incubated with levamisol (0-10 mM, 10 min, room temperature) to discriminate 
between the (levamisol resistant) adult intestinal isotype of ALP and the (levamisol sensitive) 
fetal or liver/kidney/bone isotype (Hoffman et al., 1994). LDH was measured at the BM/Hitachi 
911 using pyruvate as substrate. A modification of the method of Dahlqvist (1984) was used to 
determine sucrase-isomaltase activity. In short, the cell homogenate was incubated 30 min at 
37°C with 100 mg/ml sucrose as substrate. The reaction was stopped by boiling for two minutes 
and the glucose formed was measured with the BM/Hitachi 911 using the hexokinase/G6P-DH 
assay (Boehringer, Mannheim, Germany). Total protein contents were determined according to 
Lowry with bovine serum albumin as standard. 
Transepithelial Paracellular Transport and Transepithelial Electrical Resistance 
The radioactive tracers ,4C-polyethyleneglycol-4000,3H-polyethyleneglycol-900 (NEN 
products), 3H-mannitol (ICN), were mixed with unlabeled compounds to yield final concentra-
tions of 10 fiM with specific activities of 10-30 Ci/mol. 3H- and 14C-labeled probes were 
analyzed using a Wallac 1409 Liquid Scintillation Counter. Fluorescein and the fluorescein 
isothiocyanate dextrans (FDs) with average molecular weights of 4,400 (FD-4), 19,400 (FD-20), 
71,200 (FD-70) and 487,000 (FD-500) Da were from Sigma (St.Louis, USA). Fluorescein and 
the FD samples were analyzed using fluorescence detection on a Cytofluor 2300 (Millipore, 
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Bredford, MA) with excitation at 485 nm and emission at 530 nm. The percentage of free 
fluorescein isothiocyanate (FITC) in the FDs was determined on a HPLC system, using a 500G 
size exclusion column as stationary phase. The mobile phase consisted of a linear acetonitril 
gradient (2.5-25% in 20 min) in a 0.01 mM phosphate buffer. Fluorescence was detected by 
excitation at 519 nm and emission at 495 nm on a Jasco FP-929 Intelligent Fluorescence detector. 
Corrections were made for the free FITC impurity in the FDs. 
The transport experiments were carried out in Transwell inserts on a rotating platform 
device (30 rpm, 37 C, and >90% relative humidity) with 0.5 ml DMEM-BSA (standard medium 
without insulin and FCS but with 0.1% bovine serum albumin) with marker apically and 1.8 ml 
DM-BSA without marker basolaterally. Initial transport rates, expressed as apparent permeability 
coefficients, were determined on basis of appearance of the tracer in the basolateral compartment. 
The transepithelial electrical resistance of filter grown cells was measured using the Millicell-
ERS epithelial voltohmmeter (Millipore Co., Bedford, USA) in standard culture medium at room 
temperature. 
Immunocytochemistry 
For immunocytochemistry the cells were fixed for 5 min in 1 % formaldehyde in HBSS 
and permeabilized for 20 min in 0.2% Triton X-100 in HBSS. F-actin was stained with FITC- or 
TRITC-conjugated phalloidin (Sigma, St.Louis, USA). Polyclonal rabbit anti-ZO-1 and 
polyclonal anti-Occludin, anti-rabbit IgG-biotin and streptavidin-FITC (Zymed, San Francisco, 
USA) were used to visualize ZO-1 and occludin, respectively. E-Cadherin expression was 
analyzed with a polyclonal Goat anti-E-cadherin (RDI, Flanders, USA) stained with biotin-
conjugated rabbit anti-goat IgG and streptavidin-FITC. Cross-reactivity with rat was confirmed 
for all primary antibodies using cryostat cross-sections of rat ileum. The nuclei of filter grown 
cells were stained with Hoechst 33258 to perform cell counting. The filters were analyzed with 
a standard fluorescence microscope from Zeiss equipped with a PlanApoChromat 40/1.0 (Zeiss, 
Oberkochen, Germany) objective and a COHU monochrome CCD camera. The nuclei were 
counted manually from the display screen. Confocal laser fluorescence microscopy was 
performed with the Bio-Rad MRC600, using a Plan-Neofluar 63/1,25 objective (Zeiss, 
Oberkochen, Germany). 
Exposure to EGTA and TPA 
The filter-grown cells were treated with 5 mM EGTA in DMEM-BSA at both cell sides 
for 45 min. During the transport experiment 5 mM EGTA was maintained basolaterally only. The 
effects of 0.1-10 ^ M TPA were studied after 90 min preincubation with TPA in 0.5 ml DMEM-
BSA at the apical cell side and 1.8 ml DMEM-BSA basolateral. After the preincubation the LDH 
leakage was measured and after the transport experiment a neutral red uptake assay was 
performed to measure cytotoxic effects of the treatment. 
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Results 
Cell proliferation and enzyme activities 
Cells seeded at a density of 1.5xl05 cell/cm2 on polycarbonate filters and cultured in 
standard culture medium grew in several layers of cells (Figure 5.1 A). When dexamethasone was 
added to the culture medium at a concentration of 0.1 to 10 fjM, cell number did not increase and 
a monolayer of cells was formed (Figure 5.1B). Since we did not find a concentration dependency 
in the range from 0.1 to 10 fjM dexamethasone, only 1 fM dexamethasone was used throughout 
all further experiments. 
B 
Figure 5.1: Light photomicrographs of cross-sections of filter-grown IEC-18 cells. Cells were cultured in the 
absence (A) or presence (B) of 1 uM dexamethasone for 19 days (bar = 25 um). 
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The observation that dexamethasone treated cells did not grow into multi-layers was also reflected 
by the cell number per cm2 which was approximately 2.5 times as high in control cell layers than 
in dexamethasone treated cells after 20 days of culture (Figure 5.2A). The activity of ALP was 
found to increase in control cell layers from day 5 to day 8 but no further increase was detected 
to day 20 (Figure 5.2B). The addition of dexamethasone led to a significant decrease in ALP 
activity, both in time and in comparison with control cell layers. The ALP activity in homogenates 
of control and dexamethasone treated cells was inhibited almost completely by 10 mM levamisol 
(data not shown). This indicates that the ALP iso-enzyme found in control IEC-18 and 
dexamethasone treated IEC-18 is not the adult intestinal iso-enzyme (Hoffman et ah, 1994). The 
activity of sucrase-isomaltase was below the detection limit of 1 mU/cm2 in all samples of control 
and dexamethasone treated cells. 
c 1 
O 
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Figure 5.2: Cell number (A) and activities of ALP (B) of filter-grown IEC-18 cells. Cells were seeded at day 0 at 
a density of l ^ l O 5 cells/cm2 and cultured in the absence ( • ) or presence (O) of 1 pM dexamethasone. Data are 
presented as means±SD (n=6). 
Paracellular Barrier 
The TER in control cell layers was constant between day 5 and 20 at 48±7 Q.cm2 (n=48). 
The apparent permeability coefficients (Papps) of a series of hydrophilic macromolecules showed 
a clear dependency on molecular weight (Figure 5.3). The TER and transport rates found at day 
8 and day 20 did not significantly alter from those found at day 5 (data not shown). Culture in the 
presence of dexamethasone resulted in monolayers with a TER of 57±6 Q.cm2 (p<0.05, students 
t-test, n=48). As in control cell layers, the Papps were dependent on molecular weight and were 
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independent of culture time. Dexamethasone decreased permeabilities for the whole series of 
compounds tested (p<0.05, students t-test). 
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Figure 5.3: Apparent permeability coefficients (Papps) of hydrophilic macromolecules across filter-grown IEC-18 
cells at 5 days of age. Cells were cultured in the absence ( • ) or presence ( • ) of 1 uM dexamethasone. Data are 
presented as means±SD (n=6). 
Additional transport experiments to study size-selectivity of the paracellular barrier in the 
IEC-18 cells were performed with all markers using empty filter inserts and filter-grown 
fibroblastic cells (L929). For that purpose the L929 cells were grown for 1 week to obtain a 
confluent cell layer. Even in the confluent state the TER was not significantly increased compared 
to empty filters and no junctional ZO-1 could be detected in these fibroblastic cells, indicating 
the absence of tight junctions. Figure 5.4 presents the Papps for mannitol divided by the Papps 
for the other hydrophilic macromolecules tested (the markers) in IEC-18 (control and 
dexamethasone treated), L929 and empty filters. In this way a permeability ratio is obtained which 
represents the size-selectivity of the paracellular barrier relative to mannitol. This parameter is 
in essence comparable to the lactulose-mannitol ratio which is used in vivo (Ma, 1997). The 
figure shows that the barrier function was almost independent of molecular weight of the marker 
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in the empty filter or filter-grown L929 system. In control IEC-18 cells, the barrier function 
increased with the molecular weight (and radius) of the marker. In the dexamethasone treated 
monolayers the barrier increased more pronounced with molecular weight (Figure 5.4). This 
indicates that IEC-18 cells developed a size-selective paracellular barrier and that the size-
selectivity was increased by dexamethasone treatment. 
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Figure 5.4: Relative barrier function of filter-grown cells. The Papps of hydrophilic macromolecules (see Figure 
5.3) were divided by the Papps for mannitol. IEC-18 cells were cultured for 5 days in the absence (-•-) or presence 
(-o-) of 1 yM dexamethasone, L929 cells (-A-) were cultured for 7 days, empty filters (-+-)were maintained in 
culture medium under standard culture conditions for at least 1 day. 
Localization ofZO-1 and F-actin 
In control cell layers at day 5, the tight junction protein ZO-1 was distributed as small 
fragments with numerous interruptions at regions of cell-cell contacts (Figure 5.5A). After 
prolonged culture the number of fragments had increased and, using low magnification, appeared 
to have formed a cell-circumscribing belt at day 20. However, at higher magnification the "belt" 
had the appearance of a string of fragments (Figure 5.5B). F-actin could be found throughout the 
cells and displayed a low degree of organization at day 5 and day 20 (Figures 5C and 5D). 
In dexamethasone treated IEC-18 cultures at day 5, ZO-1 was localized mainly at sites of 
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cell-cell contact (junctions) but with fragments of non-junction related ZO-1. The peripheral 
pattern of ZO-1 was thin, but belt-like and virtually cell-circumscribing (Figure 5.6A). During 
prolonged culture the staining of ZO-1 intensified but the pattern was not subject to substantial 
changes until day 20 (Figure 5.6B). In dexamethasone treated cells the F-actin was concentrated 
at the periphery and it appeared organized in a peripheral actin-belt. The degree of organization 
reached at day 5 (Figure 5.6C) did not seem to alter significantly until day 20 (Figure 5.6D). 
We did not detect junctional E-cadherin or occludin at regions of cell-cell contact in 
control and dexamethasone treated IEC-18 cells. This indicated that the junctional expression of 
both proteins was very low or absent, even in the presence of dexamethasone. 
70jiM 
Figure 5.5. Immunocytochemical staining of ZO-1 (A and B) and filamentous actin (C and D) in filter-grown IEC-
18 cells. Cells were cultured in control medium for 5 days (A and C) or 20 days (B and D) (original magnification 
630X:bar=70um). 
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Figure 5.6: Immunocytochemical staining of ZO-1 (A and B) and filamentous actin (C and D) in filter-grown IEC-
18 cells. Cells were cultured in the presence of 1 uM dexamethasone for 5 days (A and C) or 20 days (B and D) 
(original magnification 630X: bar =70 um). 
Modulation of the paracellular barrier by TPA and EGTA 
In order to determine whether the barrier of dexamethasone treated monolayers was 
subject to junction-specific modulation by paracellular barrier perturbants, the effects of TPA and 
EGTA on transport rates of mannitol, PEG-4000 and FD-20 were assessed. Preincubation with 
TPA resulted in increased Papps for mannitol, PEG-4000 and FD-20 in control and 
dexamethasone treated filter-grown IEC-18 cells (Figure 5.7). The increased permeability was 
dose-dependent for controls but dose-independent for dexamethasone treated cells in the range 
from 0.1 to 10 (M TPA. In control and dexamethasone treated cells the transport enhancement 
factor of TPA (Papp of tracer in the presence of TPA divided by the Papp for the control) was 
more pronounced with increasing molecular weight of the marker. Nonetheless, the permeability 
was still dependent of the molecular weight of the markers, indicating preservation of some size-
selectivity. In cells cultured in the presence of dexamethasone, the Papps for mannitol, PEG-4000 
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and FD-20 were increased by TP A to the level of control filter-grown IEC-18 cells. None of the 
TPA concentrations caused LDH leakage or a reduced neutral red uptake (data not shown) 
indicating that cell viability was maintained throughout the experiment. 
Similar to TPA, EGTA exposure caused increased Papps for all three markers in control 
and dexamethasone treated IEC-18 cells, with increased transport enhancement factors for 
increased molecular weight of the markers. In control cell layers the Papps for PEG-4000 and FD-
20 were almost equal after EGTA exposure, indicating that the size-selectivity for the larger 
molecules was diminished. In IEC-18 monolayers cultured in the presence of dexamethasone the 
effects of EGTA were similar to those of TPA, i.e. the Papps for mannitol, PEG-4000 and FD-20 
were increased to the level of control IEC-18 cell layers. EGTA caused a slight reduction in 
neutral red uptake by control cell layers while this parameter was unaffected in the 
dexamethasone treated cells. No LDH leakage was detected as a result of EGTA exposure (data 
not shown). 
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Figure 5.7: Apparent permeability coefficients of mannitol, PEG-4000 and FD-20 across filter-grown IEC-18 cells 
preincubated with several concentrations TPA or 5 mM EGTA. Cells were cultured in the absence ( • ) or presence 
( • ) of 1 uM dexamethasone for 5 days. Data are presented as means±SD (n=6). 
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Discussion 
Among the most striking effects of dexamethasone on rodent intestinal organ cultures 
(Beaulieu and Calvert, 1985; Beaulieu and Calvert, 1987; Albert et al., 1994) and on 
immortalized human intestinal epithelial cells (Quaroni and Beaulieu, 1997) are the reduction of 
cell proliferation rate and induction, or increase in expression, of brush-border enzymes. IEC-18 
cells seeded at high density in the presence of 5% FCS and insulin on uncoated polycarbonate 
permeable inserts grow in multilayers of cells. Addition of dexamethasone to the standard culture 
medium resulted in the formation of a monolayer and a complete stop of cell proliferation at a cell 
density of 1.4 xlO5 cells/cm2. This cell density is close to the density originally reported by 
Quaroni (1981) for IEC-18 cells grown on plastic for several days. Thus, dexamethasone 
stimulated the formation of a confluent monolayer of filter-grown IEC-18 cells. The results of this 
study indicate that medium components can induce growth arrest in this primitive ileal crypt cell 
line. This growth arrest might be the result of a direct inhibition of DNA synthesis by 
dexamethasone as was reported by Beaulieu and Calvert (1987) to occur in fetal mouse intestinal 
crypt epithelium after dexamethasone exposure. 
Earlier studies reported that the loss of proliferative activity of small intestinal crypt cells 
occurs concomitant with the onset of, or increase in, brush-border enzyme expression (Beaulieu 
and Calvert, 1985; Beaulieu and Calvert, 1987; Albert et al, 1994; Quaroni and Beaulieu, 1997). 
In this study we found a reduced activity of non-intestinal alkaline phosphatase as a result of 
dexamethasone exposure. We consider the reduction in expression of this presumably fetal 
isoenzyme an intermediate step in the process of intestinal cell differentiation. The brush-border 
enzyme sucrase-isomaltase, which is absent in small intestinal crypt cells in rat in vivo 
(Chandrasena, 1992) and in IEC-18 cells (Quaroni and Isselbacher, 1981; Duizer et al, 1997) 
could not be induced to detectable levels by dexamethasone. It was, however, shown that activity 
of this enzyme was induced in the IEC-18 cells by an acid extract of small intestine (Shintani et 
al, 1989), indicating that this enzyme is inducible in these cells. Thus, even though one of the 
most striking reported effects of dexamethasone was the induction or increased expression of 
brush-border enzymes (Beaulieu and Calvert, 1985; Albert, 1994; Quaroni and Beaulieu, 1997), 
we did not find this to be a clear effect on IEC-18 cells. 
Besides the effects on cell proliferation and brush-border enzyme expression, 
dexamethasone was found to modulate tight junction assembly and paracellular barrier 
development in cultured hepatoma cells (Porvaznic etal, 1979) and mammary epithelial cells 
(Zettl et al, 1992; Singer et al, 1994). In the present study, the development of a barrier in the 
IEC-18 cells was followed during prolonged culture in the absence or presence of dexamethasone. 
The paracellular barrier for hydrophilic macromolecules formed by filter-grown IEC-18 cells was 
found to be size-selective, even though the tight junctional ZO-1 strands appeared discontinuous. 
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Moreover, the ZO-1 pattern did change during prolonged culture but this was not accompanied 
by a change in transport rates. This implies that even incomplete junctional strands are able to 
maintain a size-selective paracellular barrier, probably by bringing lateral membranes of 
neighboring cells in very close apposition (i.e. forming "kisses"). Further biochemical and 
ultrastructural studies will be necessary to verify this hypothesis. The paracellular barrier formed 
in IEC-18 cells after culture in the presence of dexamethasone is more tight and has a higher size-
selectivity than untreated cell layers. Structural features accompanying the increased barrier 
functionality in IEC-18 cells are: decreased cell densities, increased continuity of the junctional 
ZO-1 strands and increased organization of F-actin. Thus in contrast to findings for the mouse 
mammary epithelial 31EG4 cells where no clear effects of dexamethasone treatment on ZO-1 and 
F-actin localization were found (Zettl etal., 1992), we found structural changes in both proteins 
in this small intestinal cell line. Inhibition of cell proliferation, formation of a peri-junctional actin 
belt and increased tight junctional sealing as induced by dexamethasone in IEC-18 cells, are all 
natural events reported to occur in the absorptive cells in the small intestine along the crypt-villus 
axis (Madara and Trier, 1987; Quaroni and Hochman, 1996). From our observations we speculate 
that the junctional fragments as found in the en-face images of ZO-1 labeled control IEC-18 cell 
layers are isolated free-strands and fasciae occludentes, which are common in lateral membranes 
of crypt cells (Madara and Trier, 1987). These fasciae occludentes are then fused to form 
continuous tight junction strands under the influence of dexamethasone. Thus dexamethasone 
induced a more mature paracellular barrier by inducing a continuation of tight junctional strands 
and formation of a peri-junctional actin-belt. 
IEC-18 cells cultured in the absence or presence of dexamethasone were exposed to TPA 
and EGTA in order to explore the possibilities to selectively regulate paracellular permeability. 
The exact mechanism by which the phorbol ester TPA increases the paracellular permeability of 
epitheliums is unknown, but PKC activation, junctional(-related) protein phosphorylation and/or 
contraction of the perijunctional actin-belt ultimately lead to a diminished paracellular barrier 
(Ojakian, 1981; Anderson and Itallie, 1995; Mullin et al, 1997; Mullin et al., 1998). In the 
present study, TPA indeed increased the permeability of control IEC-18 layers to levels which 
are comparable to those of the confluent fibroblastic L929 cells. The same TPA treatment 
increased the permeability of dexamethasone treated cells to the level of that of control IEC-18 
cell layers. Similar findings were found after Ca2+ depletion by EGTA treatment. Ca2+ depletion 
has a direct effect on junctional elements (Gorodeski et al, 1997) and causes microfilaments in 
the peri-junctional actin belt to contract. Both actions can lead to a separation of the tight 
junctional strands of neighboring cells and thus increased junctional permeability (Contreras et 
al, 1992). Thus, the paracellular permeability of IEC-18 cells cultured in the presence of 
dexamethasone is increased by TPA and EGTA treatment, but an epithelial-like barrier (i.e. that 
of control IEC-18 cell layers) seemed to be maintained. These paracellular barrier modulation 
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studies with TPA and EGTA, and the increased organization of ZO-1 and F-actin suggest that the 
tight junctional barrier in dexamethasone treated cells is more mature than the barrier in control 
IEC-18 cells. 
The development of a tighter paracellular barrier as a result of glucocorticoid exposure 
as we found for IEC-18 cells, was also suggested to occur in intestinal epithelium of rats during 
the suckling-weanling transition. During the suckling period, just after a rise in plasma levels of 
glucocorticoids, the small intestinal epithelium is subject to major changes (Henning et al., 1994). 
Prior to weaning the epithelium is highly permeable and allows intact uptake of macromolecules 
such as insulin (6 kD) epidermal growth factor (6 kD) or IgGs (150 kD) from the mother's milk 
(Jarett and Hall, 1979; Henning et al, 1994). However, with weaning starts the intake of non-
sterile food and arises the need to make the epithelium less permeable for macromolecules such 
as bacterial toxins and antigens. It is particularly the barrier for these very large molecules which 
is mostly increased by dexamethasone exposure in IEC-18 cells, cells obtained from rats in the 
suckling-weaning transition. Additionally, a decrease in alkaline phosphatase activity was found 
in the ileum of rats at the time of weaning and in IEC-18 cells after dexamethasone exposure. 
Thus it might be that the changes induced by dexamethasone exposure in IEC-18 cells resemble 
the first steps along the crypt-villus axis in the development of the rodent gastrointestinal tract 
during the suckling-weaning transition phase. This is a phase of which knowledge on barrier 
function is very limited, in contrast to the vast amount of knowledge on the maturation of 
digestive and absorptive functions (Henning et al, 1994). 
In conclusion, dexamethasone inhibited cell proliferation and allowed long-term culture 
of confluent monolayers of IEC-18 cells. Moreover, dexamethasone induced formation of a 
circumferential continuous tight junctional network and an organized cytoskeleton with a 
perijunctional actin-belt. However, no clear induction of the brush-border enzymes sucrase-
isomaltase or intestinal-ALP could be found. Although the physiological significance of the 
reported findings remains to be elucidated, we believe that the results obtained with the IEC-18 
cell line are of considerable interest and will advance studies of the relationship between 
paracellular permeability and intestinal epithelial cell differentiation. 
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Chapter 6 
Absorption Enhancement, Structural Changes in Tight Junctions 
and Cytotoxicity Caused by Palmitoyl Carnitine in Caco-2 and 
IEC-18 Cells. 
Erwin Duizer, Cees van der Wulp, Carolien H. M. Versantvoort, and John P. Groten. 
The Journal of Pharmacology and Experimental Therapeutics 1998;287:395-402. 
Abstract 
Palmitoyl carnitine (PCC) has been shown to be an effective enhancer of intestinal 
transport of hydrophilic molecules. The exact mechanism by which the epithelial barrier 
function is decreased is not clear. In an attempt to elucidate the mechanism of action of PCC, 
we studied the relationship between absorption enhancement, cell viability, and tight junction 
protein localization in the human colonic Caco-2 cell line and the rat small intestinal cell line 
IEC-18. 
Filter grown cells were exposed to 0 - 1 mM PCC for 30 minutes and the efficacy of 
PCC treatment was determined by assessing the transepithelial electrical resistance (TER) and 
the apparent permeability (Papp) for mannitol and PEG-4000. Membrane lysis and 
cytotoxicity were assessed by measurements of lactate dehydrogenase (LDH) leakage and 
uptake of propidium iodide (PI) and neutral red (NR). The immunolocalization of the tight 
junctional protein ZO-1 was quantified using a CSLM and image processing software. 
In both cell lines PCC caused a dose-dependent decrease in TER and a concomitant 
increase in the permeability for mannitol and PEG-4000. The transport enhancement was 
accompanied by an increase in apical membrane permeability and reduction in cell viability. 
At higher PCC concentrations (>0.4 mM) the distribution of the tight junctional protein ZO-1 
was changed and cells were unable to recover viability. PCC is effective as absorption 
enhancer for hydrophilic macromolecules, however, lytic effects on the cell membrane and 
reduced cell viability were concomitant with transport enhancement. 
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Introduction 
Transport across the intestinal epithelium is often the rate limiting step in the total 
process of absorption for orally administered hydrophilic macromolecular compounds. 
Passage of these compounds is most likely to occur extracelluarly by passive diffusion 
through the paracellular pathway. However, tight junctions abolish passage of large molecules 
almost completely. Co-administration of an absorption enhancer is a potential way to increase 
bioavailability of these compounds and considerable effort has been directed towards 
identifying agents able to loosen tight junctions, thus increasing paracellular permeability. 
Although exact mechanisms of action are not fully identified, in general two classes of 
absorption enhancers are distinguished: surfactants and calcium chelators (Hochman and 
Artursson, 1994). Surfactants (bile acids and salts, derivatives of fatty acids, Triton X-100 
etc.) act by increasing the solubility of hydrophobic macromolecules in the aqueous boundary 
layer or by increasing the fluidity of the apical (and the basolateral) membrane. Calcium 
chelators (EGTA, EDTA) reduce the extra-cellular calcium concentration which leads to 
disruption of cell-cell contacts. In general, the surfactants increase transcellular permeability 
while the chelators increase paracellular permeability. Acylcarnitines seem to be an exception, 
since they are suggested to enhance paracellular permeability in a calcium independent way. 
The absorption enhancing properties of these fatty acid derivatives of L-carnitine have 
been studied extensively (Fix et al., 1986; LeCluyse et al., 1993; Sutton et al., 1993a+b). The 
C16 conjugate palmitoyl carnitine (PCC) was found to be very effective in increasing 
transepithelial transport of poorly absorbed drugs in vivo in rats and dogs (Fix et al. 1986; 
Sutton et al., 1993b) and in vitro in intestinal segments (Sutton et al., 1993a; LeCluyse et al., 
1993) and Caco-2 cells (Raeissi and Borchardt, 1993; Hochman et al., 1994). Histological and 
ultra-structural examination of PCC exposed sections of rat jejunum and colon showed slight 
alterations in the microvillus border but an intact cytoplasmic integrity and un-compromised 
junctional complexes (Fix et al., 1986; Sutton et al., 1993). To elucidate the mechanism by 
which PCC exerts its action, in vitro studies were performed using Caco-2 cells (Raeissi and 
Borchardt 1993; Hochman et al, 1994). These studies have shown an immediate drop in 
transepithelial electrical resistance (TER) and increase in mannitol transport after apical 
exposure to sub-millimolar concentrations of PCC. The drop in TER proved to be transient 
and returned to approximately control values in 10-12 hours. No visible damage to the 
epithelium or alterations in the filamentous actin were seen, however, the appearance of tight 
junctions in freeze fracture replicas seemed to be altered; i.e. junctional strands showed a 
beaded appearance, several discontinuities and diminished cross-bridging. These results might 
indicate that PCC is able to reversibly increase permeability without causing major 
morphological alterations in the intestinal epithelium. On the other hand, other studies have 
shown that PCC induces damage to erythrocytes (Cho and Proulx, 1971) and the vaginal 
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epithelium (Richardson et al, 1992) at concentrations likely to be used to achieve absorption 
enhancing effects. In addition, LeCluyse et a/.(1993) reported that after PCC treatment lucifer 
yellow transport could be enhanced without observed exfoliation of cells, however, an 
enhancement factor of 18 for lucifer yellow transport was accompanied by extensive cell 
exfoliation from rat colonic mucosa. 
The exact mechanism of action by which PCC exerts its permeability enhancing action 
has still not been elucidated. Moreover, the sequence of events (i.e. transport enhancement, 
membrane damage and tight junction disruption) is unknown. Therefore, we studied the 
relationship between absorption enhancement, cell viability, and tight junction protein (ZO-1) 
distribution in the human colonic Caco-2 cell line (Hidalgo et al., 1989; Baily et al., 1996; 
Artursson et al., 1996) and the rat small intestinal cell line IEC-18 (Ma et al, 1992; Duizer et 
al., 1997). These two intestinal epithelial cell lines differ greatly in state of differentiation, 
transepithelial electrical resistance and paracellular permeability. Both cells express ZO-1 and 
discriminate paracellular transport rates on basis of molecular radius (Duizer et al., 1997). 
Filter grown cells were exposed to 0 - 1 mM PCC for 30 minutes, TER and transport of 
mannitol and PEG-4000 were used as parameters for epithelial permeability to hydrophilic 
(macro-)molecules. Lactate dehydrogenase (LDH) leakage into the apical medium, propidium 
iodide (PI) and neutral red (NR) uptake were used to detect reduced integrity of the apical cell 
membrane and cell viability. For Caco-2 cells, permeability enhancement, TER reduction and 
LDH leakage resulting from PCC exposure were compared to the effects of the surfactant 
Triton X-100 and the chelator EGTA. Additionally, the immunolocalization of the tight 
junctional protein ZO-1 was correlated with PCC exposure and a method was developed to 
quantify ZO-1 staining using confocal laser scanning microcopy (CSLM) images. 
Methods 
Cell culture 
The Caco-2 cell line originating from a human colorectal carcinoma, and IEC-18 cells 
originating from rat ileum epithelium were obtained from the American Type Culture 
Collection. Cells were maintained at 37°C in an atmosphere of 5% C02 and 90% relative 
humidity. Maintenance medium was DMEM with high glucose (4.5 g/1) and 25 mM HEPES, 
supplemented with 1% (v/v) MEM nonessential amino acids, 6 mM L-glutamine, 50 ug/ml 
gentamycin (all from Gibco, Paisley, Scotland), and 10% (v/v) foetal calf serum (FCS, 
Integra, Zaandam, Netherlands) for Caco-2, and 5% (v/v) FCS and 0.1 U/ml insulin (Sigma, 
Beers, Belgium) for IEC-18 cells. 
Cells grown in 75 cm2 flasks (Costar, Badhoevendorp, Netherlands) were passaged 
weekly at a split ratio of 1:10 (IEC-18) or 1:5 (Caco-2) using 0.05% trypsin in PBS with 
0.022% EDTA. For transport experiments both cell types were seeded on Transwell 
polycarbonate cell culture inserts with a mean pore size of 0.4 um (Costar, Badhoevendorp, 
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Netherlands) at 2-3 *105 cells/cm2 and cultivated for 17-24 days. Caco-2 cells were used at 
passages 30-40, IEC-18 at passages 25-32. 
TER measurements 
Filter grown cells were adapted to room temperature to allow for more standardized 
transepithelial electrical resistance (TER) measurements using the Millicell-ERS epithelial 
voltohmmeter (Millipore Co., Bedford, USA). The TER was measured prior to and during the 
experiments to monitor cell layer confluence and the integrity of the tight junctions. The TER 
of the cell layers was calculated according to the following equation: TER = (RtotarRbiank) X A 
(Q.cm2), Rtotal is the resistance measured, R M ^ is resistance of control filters without cells 
(approximately 140 Q.cm2), A = surface area of filter (1 cm2). 
Exposure to palmitoyl carnitine 
Caco-2 cells with a TER > 600 Q.cm2 and IEC-18 cells with a TER > 40 Q.cm2 (both 
determined at room temperature) were transferred to new wells with 1.8 ml basal medium 
(HEPES buffered DMEM with non-essential amino acids, 6 mM L-glutamine, gentamycin, 
and 0.1% BSA). The apical medium was changed for 0.5 ml basal medium supplemented with 
0-1 mM freshly dissolved palmitoyl-L carnitine hydrochloride (Aldrich, Milwaukee, USA). 
After 30 minutes preincubation at room temperature, the apical test medium was removed and 
used for LDH leakage measurements. Subsequently, the inserts with cells were used for 
assessment of transepithelial transport or immunocytochemistry. 
Exposure to Triton X-100 and EGTA 
The protocol for Triton X-100 exposure (0 - 0.05% v/v) was exactly the same as that 
for PCC incubation. The studies with EGTA ( 0 - 5 mM) were performed by preincubation 
with EGTA for 45 min at room temperature. During the preincubations EGTA was applied 
apically and basolaterally. After the preincubation the TER was measured and apical medium 
was collected for LDH measurements. Transport of mannitol and PEG-4000 was performed 
with EGTA basolateral. 
Transepithelial transport 
Transport experiments were carried out at 37°C in Transwell inserts with 0.5 ml basal 
medium with tracers apically and 1.8 ml basal medium basolaterally. A reduction of the 
unstirred water layer and homogeneous mixing of the probes was achieved by rotating the 
two-compartment transport system at 30 rpm on a rotating platform device in an incubator 
(Dulfer et al., 1996). Apparent Permeability coefficients (Papps) were determined on basis of 
appearance of the probe in the basolateral receiver compartment before 10% of the probe was 
transported (i.e. under sink conditions) according to the following equation (Artursson and 
Karlsson, 1991): P w - P/A*C0 (cm/s), P = permeability rate (mol/s), C0= Initial apical 
concentration of test substance (mol/ml), A = area of filter (cm2). The probes 14C-polyethylene 
glycol-4000 and 3H-mannitol (Amersham, Little Chalfont, UK) were mixed with unlabeled 
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compounds to yield final concentrations of 2.5 uM with specific activities of 2.5 GBq/mmol 
for 14C-polyethylene glycol-4000 and 1.5 GBq/mmol for 3H-mannitol. 3H and 14C labeled 
probes were analyzed using a Wallac 1409 Liquid Scintillation Counter after addition of 
Ultima Gold Scintillation liquid (Packard, Groningen, Netherlands). 
Immunocytochemistry 
For immunocytochemistry the cells were fixed in 1% formaldehyde in HBSS and 
permeabilized in 0.2% Triton X-100 in HBSS. F-actin was stained with phalloidin conjugated 
with TRITC or FITC (Sigma, St.Louis, USA). Polyclonal rabbit anti-ZO-1 and polyclonal 
anti-Occludin, anti-rabbit IgG-biotin and streptavidin-FITC (Zymed, San Francisco, USA) 
were used to visualize ZO-1 and occludin respectively, in both cell lines. 
Confocal scanning laser microscopy and image processing 
Confocal fluorescence microscopy was performed with the Bio-Rad MRC600, using 
the PlanApoChromat 40x objective with variable diaphragm (Zeiss, Oberkochen, Germany). 
All images were recorded at standardized acquisition conditions; per cell line and per 
experiment settings for gain and blacklevel were optimized and applied throughout that 
experiment. Images are single plains (a depth of 7 um covers >90% of the total intensity) 
recorded using the Kalman filter mode at n=5 with Bio-Rad software (COMOS version 7.0a). 
After transfer to an image processing workstation, the images were processed by a custom 
written program, based on the image processing toolbox SCIL-Image (version 1.3, Free 
University of Amsterdam, Netherlands). The program developed to select junction-related 
immunolabeled ZO-1, consists of three sequential steps. First, two methods are applied to 
differentiate between borderline and background using a threshold value of 1.4. Both resulting 
binary images are combined to a usually honeycomb-like skeleton. This intermediate skeleton 
represents most of the junction-related ZO-1 pattern with small discontinuities and some not 
junction-related appendixes. In the second part of the program, the skeleton can be improved, 
first by closing the small discontinuities of the borderlines using a maximum cost procedure 
(adding less than 0.5% to the total pixel count) and secondly, interactive and automatic 
removal of spurious line fragments. Finally, from the binary image of the optimized skeleton 
the total number of pixels is determined and the original grey value image was used to 
determine the average pixel intensity over the borderlines. 
Cytotoxicity and membrane damage assays 
LDH leakage into the apical medium resulting from PCC, Triton X-100 or EGTA 
exposure was determined with the Boehringer Mannheim kit for LDH at the BM/Hitachi 911. 
Total LDH content was determined after sonicating the inserts with cells in basal medium. In 
several experiments 5 pg/ml propidium iodide was added to the PCC exposure medium and 
uptake of this membrane impermeant fluorescent dye during PCC exposure was determined 
using images made with a standard fluorescence microscope from Zeiss equipped with a 
PlanApoChromat 40/1.0 (Zeiss, Oberkochen, Germany) objective and a COHU monochrome 
CCD camera. Quantification was performed with the Colourmorph program (Perceptive 
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Instruments, Halstead, UK.). Each image yielded 130-160 Caco-2 cells or 40-60 IEC-18 cells, 
5 images were recorded per filter (n=6 per exposure group). 
Neutral red uptake was determined directly after the transport experiments. For that 
purpose, cells were incubated with neutral red (50 ug/ml) in control medium for 30 minutes 
(37°C, 5%C02, 95% relative humidity). Subsequently, the cell layer was rinsed once with 
HBSS and the neutral red was extracted with 1% (v/v) acetetic acid in a 1:1 water-ethanol 
mixture. The A540ran was measured spectrophotometrically. 
Statistics 
Data on PCC (TER, LDH leakage, transport of mannitol and PEG-4000 and NR 
uptake) were obtained in 4 independent experiments with both cell types using 3 filters per 
exposure group. Data on EGTA and Triton X-100 reflect the means of 3 independent 
experiments. Data on immunolabeling of ZO-1 were obtained in 2 experiments using 2 filters 
per exposure group per experiment. Per filter 5 areas were recorded for junction-related ZO-1 
specific fluorescence quantification. Presented data are pooled data of all experiments. Data 
were analyzed using a two-tailed Students (paired) t-test. 
Results 
Effects of PCC on transepithelial electrical resistance 
In both cell lines the TER was decreased by PCC in a dose-dependent manner (Figure 
6.1). The reduction of the TER caused by 30 min PCC exposure was statistically significant at 
concentrations as low as 0.1 mM in IEC-18 and 0.4 mM in Caco-2. Most of the TER 
reduction was already accomplished within 5 min after exposure (data not shown). At the 
higher PCC concentrations the decrease in TER was more pronounced in Caco-2 then in IEC-
18. For instance, 1 mM PCC reduces the TER in Caco-2 to 29% (190 Q.cm2) and in IEC-18 to 
62% (40 Q.cm2). Note that the absolute TER of the 1 mM exposed Caco-2 monolayer was still 
higher than the TER of control IEC-18 cell layers (64.5 ± 12 Q.cm2). 
Effects of PCC on transepithelial transport rates 
Transport rates of mannitol and PEG-4000 were increased by PCC in a dose-
dependent manner in both cell lines (Figure 6.1). The apparent permeabilities of both 
compounds were significantly increased at PCC concentrations >0.2 mM in IEC-18 and at 
>0.4 mM in Caco-2 cells. Although the IEC-18 cells were affected at lower concentrations of 
PCC, the maximum relative increase in transport obtained with 1 mM PCC was larger in 
Caco-2 cells. The fluxes of mannitol (except for the higher PCC concentrations) and PEG-
4000 were constant throughout the 4 hours that transport was monitored, indicating that the 
effects on transport of 30 min PCC exposure did not change within 4 h after removal. 
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Figure 6.1: Effects of 30 min PCC exposure on apparant permeabilities of mannitol (•) and PEG-4000 (•) and 
TER (-) of Caco-2 (A) and IEC-18 (B) monolayers. TER was normalized with the TER prior to PCC exposure 
as 100%. Data are presented as mean±SD (n=4 experiments). 
* Significantly different from control, P<0.05 according to two-tailed Student's paired t-test. 
Effects of PCC on ZO-1 distribution 
Immunocytochemical localization of ZO-1 in untreated layers of Caco-2 and IEC-18 
cells showed a belt-like cell circumscribing pattern throughout the total area (Figure 6.2 A and 
3 A). In Caco-2 cells only local and subtle modifications of the ZO-1 pattern were seen at 
lower PCC concentrations. Up to a concentration of 0.4 mM PCC no interruption of the cell 
circumscribing pattern were detected. At 0.7 mM small holes, the size of only few cells, in the 
monolayer were found and the pattern of junction-related ZO-1 was locally disturbed (Figure 
6.2 B). Exposure to 1.0 mM PCC caused holes varying in size from a few up to many cells, 
but cells with a cell circumscribing ZO-1 pattern were still present (Figure 6.2 C). 
In control and PCC-treated cell layers, the effect of PCC on immunolocalization of ZO-1 was 
quantified according to the method described in the methods section, the data are presented in 
Figure 6.4 (see also Figure 6.2 D, E, F and Figure 6.3 D, E, F). In Caco-2, the selected pixel 
number was slightly reduced in a dose-dependent manner at PCC concentrations a 0.4 mM 
(Figure 6.4 A). The average pixel density of the selected cell borders did not change in Caco-
2, indicating that the junction-related ZO-1 density of the cell circumscribing pattern did not 
change. Immunolabeled monolayers of Caco-2 cells exposed to 0.4-1 mM PCC and PI at the 
same time showed that whenever the cell circumscribing ZO-1 pattern was disrupted, the 
nuclei were always stained with PI. 
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120 pm 
Figure 6.2: CSLM image showing immunolocalization of ZO-1 in control (A), 0.7 mM (B) and 1.0 mM (C) 
PCC treated Caco-2 monolayers. D, E and F are the binary images of A, B and C respectively after processing: 
the custom written program selected the honeycomb-like tight junctional pattern. 
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120 um 
Figure 6.3: CSLM image showing immunolocalization of ZO-1 in control (A), 0.4 mM (B) and 1.0 mM (C) 
PCC treated IEC-18 cell layers. D, E and F are the binary images of A, B and C respectively after processing, 
the custom written program selected the honeycomb-like tight junctional pattern. 
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In IEC-18 cells the ZO-1 pattern was locally disturbed in cell layers exposed to PCC 
concentrations as low as 0.1 mM. The localized interruptions in the belt-like structure became 
more pronounced with increasing PCC concentrations (Figure 6.3 B and C) and resulted in a 
significant decrease in selected pixel number (Figure 6.4 B) at PCC concentrations >0.4 mM. 
At these concentrations the average pixel densities (Figure 6.4 B) were also reduced, which 
indicates that the immunolocalization of the ZO-1 protein was less stringently organized in the 
cell periphery. Co-incubations with PCC and PI, followed by immunolabeling of ZO-1, 
showed that PI staining correlated with a disrupted ZO-1 pattern. 
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Figure 6.4: Effects of PCC exposure on immunolocalization of ZO-1 in Caco-2 (A) and IEC-18 (B) cells. A 
custom written program selected the junction-related ZO-1 pattern, shown are selected pixel number (•) and 
selected pixel density (•) . Data are presented as means±SD (n= 10). 
* Significantly different from control, P<0.05 according to Student's t-test. 
Effects of PCC on apical membrane integrity and cell viability 
Cytotoxic effects of PCC were determined by three different assays. LDH leakage and 
PI staining are based on detection of apical membrane damage and the neutral red assay is 
based on two processes: non-ionic passive diffusion through the apical membrane and 
intracellular accumulation in lysosomes (Babich and Bohrenfreund, 1990). Figure 6.5 shows 
that the release of the cytosolic enzyme lactate dehydrogenase into the apical medium 
increased in a dose-dependent manner after exposure to PCC. Leakage of this enzyme (MW 
140 kDa) is significantly increased at doses of >0.2 mM PCC in Caco-2 and > 0.1 mM in 
IEC-18 cells. Staining of cells with the DNA dye propidium iodide (MW 668 Da) occurred at 
higher PCC concentrations and was significantly increased at >0.4 mM PCC in both cell lines. 
Next to apical membrane damage, PCC caused a dose-dependent reduction of cell viability as 
assessed by the neutral red assay. Since we found increased apical membrane permeability 
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(LDH leakage and increased PI staining) after PCC exposure, we assume that lower A540 
readings in the NR assay indicate a reduced functionality of the lysosomes (NR retention) and 
not a reduced uptake of NR. 
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Figure 6.S: Effects of 30 min. PCC exposure on apical membrane integrity and cell viability of Caco-2 (A) and 
IEC-18 (B) cells. LDH leakage (n=4 experiments) is normalized with sonificated untreated cells as 100%. NR 
uptake (n=4 experiments) and PI staining (n=6 filters from 2 independent experiments) are presented with the 
control set to 100%. Data are presented as means±SD. 
* Significantly different from control, P<0.05 according to Student's paired t-test. 
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Comparison of effects of PCC, Triton X-100 and EGTA on Caco-2 cells 
In Figure 6.6 A the LDH leakage into the apical medium is presented as a function of 
the transport enhancing factor for PEG-4000. For PCC and Triton X-100 a similar relationship 
was found showing increased LDH leakage with increased transport enhancing factors. For 
EGTA the increase in transport enhancing factors was independent of LDH leakage. The 
relationship between the TER and the enhancing factor for PEG-4000 (Figure 6.6 B) is almost 
linear after exposure to Triton X-100, whereas after exposure to low concentrations of PCC or 
EGTA the limited decrease in TER is not accompanied by increased PEG-4000 permeability. 
Figure 6.6 C shows that when Caco-2 cells are exposed to PCC or Triton X-100, increased 
LDH leakage correlates with a decreased TER. Data on EGTA exposure show that it is 
possible to decrease the TER without causing membrane damage. 
Recovery of TER and cell viability after PCC exposure 
To investigate whether the effects of PCC on TER and cell viability were transient, 
both cell lines were allowed to recover for 22 h after 30 min exposure to 0, 0.4 and 1 mM 
PCC. In Caco-2 cells TER recovered completely within 6 h after exposure to 0.4 mM PCC 
(table 6.1) while recovery of TER after exposure to 1 mM PCC was only partial even after 22 
h. Cell viability as determined with the NR assay was still not restored 22 h after exposure to 
0.4 or 1 mM PCC (Table 6.1). 
The TER of IEC-18 cells recovered slow, but completely within 22 h after exposure to 
0.4 mM PCC, while no significant reconstitution of its barrier function after exposure to 1 
mM was observed within 22 h (Table 6.2). Exposure to 0.4 or 1 mM PCC resulted in 
significantly reduced NR uptake in IEC-18, indicating an incomplete recovery of cell viability 
within 22 h. 
Table 6. 1: Recovery of TER and cell viability of Caco-2 cells after 30 min palmitoyl carnitine hydrochloride 
(PCC) exposure. 
PCC 
mM 
0 
0.4 
1 
Normalized TER 
% 
30 min 
96.213.1 
53±9.2" 
42±6.8* 
6h 
90.610.8 
94.8+1.5 
76.2+2.3* 
22 h 
88.612.9 
88.8+4.6 
82.710.7' 
Neutral Red 
Uptake 
22 h (%) 
10011.5 
89.817.5 
84.5+1.5' 
Data are presented as mean + SD (n=3). TER was normalized by using the TER value prior to PCC exposure as 
100%. Timepoints are given with start of luminal exposure to PCC as t=0 min. 
* Significantly different from control, P<0.05 according to Student's t-test. 
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Table 6.2: Recovery of TER and cell viability of IEC-18 cells after 30 min palmitoyl carnitine hydrochloride 
(PCC) exposure. 
PCC 
raM 
0 
0.4 
1 
Normalized TER 
% 
30 min 
101±5.7 
48.6±9.6* 
26.3±4.f 
6h 
107±7.8 
81.3±4.9* 
46.4±15* 
22 h 
115.3+14 
102.3+15 
37.4±9.5* 
Neutral Red 
Uptake 
22 h (%) 
10012.7 
79.2±5.1* 
39.4±5.8* 
Data are presented as mean ± SD (n=3). TER was normalized by using the TER value prior to PCC exposure as 
100%. Timepoints are given with start of luminal exposure to PCC as t=0 min. 
* Significantly different from control, P<0.05 according to Student's t-test. 
Discussion 
The present study was intended to correlate absorption enhancing effects of PCC with 
effects on tight junction morphology and cytoxicity on the intestinal epithelium. For that 
purpose a small intestinal (IEC-18) and a colonic (Caco-2) cell line were apically exposed to 
PCC and TER and transport of mannitol and PEG-4000 were determined. Under similar 
conditions the immunolocalization of ZO-1, uptake of PI and NR, and release of LDH were 
assessed. It was found that PCC caused a decrease in TER and a concomitant increase in the 
permeability for mannitol and PEG-4000 in both cell lines. In IEC-18 cells, the PCC induced 
transport enhancement of the hydrophilic markers mannitol and PEG-4000 was slightly lower 
than in Caco-2. The finding that the absorption enhancement was smaller for small intestinal 
then for colonic cells is supported by studies of Sutton et al. (1993a) who used isolated 
ligaments of the rat and showed that ileal bioavailability of the drug cefoxitin was increased 
less than colonic bioavailability after co-administration with PCC. This indicates that the IEC-
18 cell line could not only be a useful model for small intestinal paracellular transport (Duizer 
et al. 1997) but also for the study of transport enhancement across the small intestinal 
epithelium. 
Both parameters, increased transport of mannitol and PEG-4000 and decreased TER, 
are generally considered to be indicators of increased paracellular permeability in experiments 
using cell lines. Nevertheless, it has been shown by Bernards and Kern (1996) that an 
increased transmeningeal flux of hydrophilic compounds caused by PCC exposure resulted 
from an increased transcellular flux. Furthermore, increased transport of PEG-4000 and 
decreased TER are seen as the result of affected membrane integrity, rather than a specific 
effect on paracellular permeability (Fagerholm et al., 1996). Thus, even though hydrophilic 
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Figure 6.6: Effects of various concentrations of PCC (+) , Triton-X-100 ( • ) or EGTA (A) on Caco-2 cells. 
Expressed are the LDH leakage (A) and Normalized TER (B) as a function of the enhancing factor for PEG-
4000, and the normalized TER as a function of LDH leakage (C). Data are presented as best fitted curves and 
mean ± SD (n=4 experiments for PCC, n= 3 experiments for Triton X-100 and EGTA). 
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macromolecular permeability and TER are, under physiological conditions, indicators of 
paracellular permeability, in case of increased membrane permeability these parameters can 
indicate increased transcellular permeability as well. 
In an attempt to visualize alterations in the paracellular pathway as a result of PCC 
exposure, immunolocalization of ZO-1 was studied. It was hypothesized that if the permeation 
enhancing effect of PCC was mainly due to increasing the paracellular permeability, changes 
would be visible in the distribution of the tight junctional proteins. Indeed, PCC caused small 
irregularities in the ZO-1 pattern of Caco-2 and discontinuities in the ZO-1 pattern of IEC-18 
cells. In order to quantify the changes in the ZO-1 pattern, we have developed a method with 
which we were able to determine pixel number and intensity as a measure for the 
immunolocalization of this tight junctional protein. The very local disruptions caused by 0.1-
0.2 mM PCC in IEC-18 cells, could not be quantified by this method. However, as soon as the 
effects on ZO-1 pattern became more apparent (0.4 and 1 mM PCC) the pixel density and 
pixel number were reduced. Quantification of immunolocalization of junction-related ZO-1 
seemed to correlate with transport of mannitol and PEG-4000 in IEC-18 cells after exposure 
to PCC. It appeared thus that the quantification of this tight junctional protein might be a 
valuable tool to assess changes in the tight junctional complex complementary to the 
determination of TER and apparent permeability of hydrophilic compounds. 
In Caco-2 no reduction in pixel density as a result of PCC exposure was detected; 
either the ZO-1 pattern was located in the cell periphery and cell circumscribing or whole cells 
were dislodged or lysed. This shows the heterogeneity of the Caco-2 cell line, clearly some 
cells are more sensitive to PCC than others. But it probably also indicates that PCC does not 
selectively cause alterations in the intracellular ZO-1 distribution in Caco-2 cells. Since all 
cells with detectable defects in ZO-1 or occludin immunolocalization also had increased 
propidium iodide uptake, while not all cells with increased propidium iodide uptake showed 
an altered ZO-1 or occludin pattern, we conclude that increased permeability of the apical 
membrane is an earlier effect of PCC exposure than disruption of tight junction structure. In 
general, interactions of PCC with biological membranes are widely studied and are held 
responsible for most of the effects, such as blocking of inward rectifier K+ channels in 
myocytes (Sato ex al., 1993), inhibition of insulin receptor tyrosine phosphorylation 
(McCallum and Epand, 1995) and protein Kinase C (Nakadate and Blumberg, 1987) but also 
for enhancement of drug absorption as shown clearly in this study and in the study of 
LeCluyse ef aZ. (1991). 
To assess the severity of the membrane damaging effects and cytotoxicity of PCC, 
three tests were performed. A clear indicator for apical membrane damage is leakage of 
cytosolic enzymes into the apical medium. This type of assay has been shown to be very 
sensitive in studies on the effects of surfactants on intestinal epithelial cells (Anderberg et al. 
1992 and this study). In the present study we show that in both intestinal cell lines, leakage of 
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the 140 kDa enzyme LDH through the apical membrane started at lower PCC concentrations 
then transport enhancement of mannitol and PEG-4000 across the cell layer. Similar findings 
as with the LDH leakage assay were obtained with the PI uptake assay, although the latter was 
slightly less sensitive. In pilot studies we were unable to detect an increase in PI stained nuclei 
in Caco-2 cells after exposure to PCC concentrations up to 0.4 mM, similar as reported by 
Hochman et al. (1994). However, we detected an increased cytosolic PI staining prior to 
nucleus staining and therefore choose to determine the total PI fluorescence intensity in the 
final studies instead of performing a nuclei count. Using this method the PI uptake was shown 
to be increased at 0.4 mM PCC in Caco-2 and IEC-18 cells. In addition to LeCluyse et al. 
(1991) who found that perturbation of the lipid order of biological membranes correlated well 
with the absorption enhancing action of PCC, we report a good correlation between the 
absorption enhancing action of PCC and the membrane damage assays LDH leakage and PI 
uptake. 
The neutral red assay showed that in both intestinal cell lines cytotoxicity of PCC is 
concomitant with increased transepithelial permeability of mannitol and PEG-4000. In Caco-
2, cell damage as measured by LDH leakage and NR uptake was of the same order of 
magnitude, while in IEC-18 cells the reduction in NR uptake is much larger than would be 
anticipated from the LDH leakage. One possible explanation is that PCC has additional (toxic) 
effects on IEC-18 cells which occur during or after the immediate lysis of the membrane. For 
example, PCC has been proposed to deplete ATP (Hochman and Artursson, 1994) which 
might finally result in cell death and thus in lower NR uptake or retention in the cells. 
In an attempt to establish the balance between selective paracellular transport 
enhancement and transcellular transport enhancement we exposed Caco-2 monolayers to 
PCC, Triton X-100 and EGTA and compared the TER, the transport enhancing factors for 
PEG-4000 and the LDH leakage (Figure 6.6). We found that increased PEG-4000 transport 
correlated with LDH leakage into the apical medium in cells exposed to PCC or Triton X-100, 
whereas no correlation was found for EGTA treatment. This similarity between the effect of 
PCC and Triton X-100 suggests transcellular transport enhancement. On the other hand, at 
lower concentrations of PCC and EGTA the decrease in TER did not correlate with an 
increased transport of PEG-4000, which suggests a selectivity of PCC and EGTA for 
increased electrolyte permeability (indicated by the TER) prior to macromolecule 
permeability. This generally indicates involvement of the paracellular pathway. However, it 
also shows that the initial reduction in TER is not necessarily indicative for paracellular 
transport enhancement of macomolecules. The parallelism in the correlation between LDH 
leakage and the TER after exposure to PCC and Triton X-100, show that the lytic effect of 
PCC contributes to the decrease in TER to almost the same extent as the lytic effect of Triton 
X-100. 
In both cell lines the reversibility of the PCC effect on permeability and cell viability 
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was tested in additional experiments. In both cells the TER reduction caused by 0.4 mM PCC 
was transient (Hochman et al., 1994; Raeissi and Borchardt, 1993; and this study). However, 
at this PCC concentration the cells were unable to recover viability to the full extent, as shown 
by decreased readings in the NR uptake assay. After exposure to 1 mM PCC, neither TER, nor 
cell viability could be recovered in IEC-18 or Caco-2. 
The present study shows clear signs of cell damage at all effective (i.e. mannitol or 
PEG-4000 transport enhancing) concentrations of PCC. Although we show the cytotoxicity of 
PCC on intestinal epithelial cells, one should be careful with direct extrapolation of our results 
to the in vivo situation. It has been shown previously that the Caco-2 cells were much more 
sensitive and responsive to PCC than intestinal mucosa mounted in Ussing chambers (Sutton 
et al., 1992; Hochman et al., 1994) and intestinal tissues of rats and beagle dogs in vivo (Fix et 
al., 1986). And even though PCC damages cells in the mucosa, the intestinal tract may be 
assumed to be able to deal with loss of cells to a certain extent due to the high rate of cell 
turn-over. Thus further studies will be needed to elucidate the balance between absorption 
enhancement and cytotoxicity in the intestinal mucosa in vivo. 
In conclusion, PCC is effective as absorption enhancer for hydrophilic 
macromolecules, however, lytic effects on the apical cell membrane and reduced cell viability 
were concomitant with transport enhancement at all concentrations. Although the peripheral 
tight junctional network and the paracellular pathway are altered by PCC, our results indicate 
that this is not an initial effect but rather the result of interaction of PCC with the cell 
membrane, suggesting that enhancement of the transcellular route or cell lysis contributes 
considerably to the increased permeability. 
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Abstract 
In the present study we characterized the functional and structural disruption of the 
paracellular barrier of intestinal epithelium in vitro in relation to cytotoxicity after apical Cd2+ 
exposure. For that purpose filter-grown Caco-2 and IEC-18 cells were apically exposed to 5 to 
100 uM CdCl2 for 4 or 14 hr. It was found that the effects of Cd2+ on the epithelial barrier 
were concentration- and time-dependent. The first detected effects of Cd2+ in Caco-2 cells 
after 4 hr exposure were a decrease in transepithelial electrical resistance, increased 
permeabilities of mannitol and PEG-4000 and changes in intercellular localization of ZO-1, 
occludin and e-cadherin. The effects were far more pronounced after prolonged exposure. The 
disruption of the paracellular barrier by 5-30 uM Cd2+ was detected without a significant loss 
of viability of the Caco-2 cells. In the IEC-18 cells, Cd2+ concentrations affecting the barrier 
(50 and 100 pM) also affected cell viability. In both cell lines the effects on the cell layers 
continued to develop after removal of extracellular Cd2+. This correlated with the cellular 
retention of Cd2+, which was high for the 12 hr following 4 hr accumulation. This study 
showed that the decreased epithelial barrier function of intestinal epithelial cells is 
accompanied by tight junction disruption. It is concluded that Cd2+ causes increased 
paracellular permeability by disruption of junctional function and structure. The initial 
junctional effects of Cd2+ suggest that Cd2+ increases its own bioavailability by causing 
disruption of the intestinal paracellular barrier. 
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Introduction 
The intestinal epithelium is the main port of entrance for nutrients and at the same time 
the main barrier for absorption of other orally administered compounds such as food 
additives, drugs and toxicants. The epithelial cell itself with its membranes forms the barrier 
in the transcellular route, while the junctional complexes between the cells seal the 
paracellular route and regulate its permeability. The junctional complex consists of 
desmosomes, adherens junctions and tight junctions. The apical tight junction contributes 
mostly to the barrier/occluding function of this complex. Several studies into barrier 
functionality have shown reduced paracellular barrier function in various epithelia as a result 
of exposure to cadmium (Cd2+). For instance, Janecki et al. (1992) found a reduced 
development of transepithelial electrical resistance (TER) in Sertoli cell monolayers when 
grown in the presence of cadmium. Also, the collapse of domes and reduction in TER was 
reported in several renal epithelial cell lines (Prozialeck and Niewenhuis, 1991; Niewenhuis et 
al, 1997). Structural studies with renal epithelial cells revealed disrupted actin filaments, an 
increased lateral intracellular space and a decreased density of adherens junction-associated 
plaques (Mills and Ferm, 1989; Prozialeck and Niewenhuis, 1991; Hazen-Martin et al, 1989). 
However, none of these studies showed a clear disruption of the structure of the tight 
junctions which could account for the significant reduction in the barrier function. 
Damage of the intestinal epithelium was reported to occur after exposure to high 
concentrations of Cd2+ in mice (Valberg et al., 1977). Moreover, epithelial accumulation and 
absorption into the serosal compartment are increased at higher concentrations in vivo (Goon 
and Klaasen, 1989; Groten et al, 1994) and in Caco-2 cells (Rossi et al, 1996; Pigman et al, 
1997). In a study of the toxicity of heavy metals, Rossi et al. (1996) described a reduction in 
TER and increase in transepithelial mannitol passage in the Caco-2 monolayers after exposure 
to Cd2+. It is, however, not yet established whether the selective effects of Cd2+ on the 
paracellular barrier function,-as found in several epithelia, can account for the increased 
absorption of Cd2+ in the intestinal epithelium. 
In this paper, we would like to establish the relation between a reduced tissue 
functionality (decreased TER and increased Cd2+ and mannitol and PEG-4000 transport), the 
structural disruption of the junctional complex (immunolocalization of ZO-1, occludin and e-
cadherin) and the cytotoxicity (LDH leakage and neutral red (NR) uptake) in intestinal 
epithelial cells after Cd2+ exposure. We use filter-grown intestinal epithelial cells as a model 
to determine the sequence of events in the modification of the junctional barrier function of 
the intestinal epithelium in vitro as a result of Cd2+ exposure. The human colon carcinoma cell 
line Caco-2 was used for its enterocytic differentiation (Hildalgo et al., 1989) and widespread 
use as a transport model in pharmacology and toxicology (reviewed by Artursson et al, 1996). 
In addition to the villus-like Caco-2 cells, we used the rat small intestinal crypt cell line IEC-
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18 because it was used earlier to study Cd2+ toxicity and accumulation (Groten et al, 1992). 
Furthermore, the relation found between the molecular size of several hydrophilic molecules 
and the Papps, allowed for a more accurate prediction of transepithelial transport rates on the 
basis of molecular size in IEC-18 than in Caco-2 cells (Duizer et al., 1997). 
Materials and methods 
Cell culture 
The Caco-2 cell line originating from a human colorectal carcinoma, and IEC-18 cells 
originating from rat ileum epithelium were obtained from the American Type Culture Collec-
tion. Cells were maintained as described previously (Duizer et al., 1997). For experiments 
both cell types were seeded on Transwell polycarbonate cell culture inserts with a mean pore 
size of 0.4 um (Costar, Badhoevedorp, Netherlands) at 2-3 *105 cells/cm2 and cultivated for 
17-24 days. Caco-2 cells were used at passages 30-40, IEC-18 cells at passages 20-30. 
TER measurements 
Filter grown cells were adapted to room temperature to allow for more standardized 
transepithelial electrical resistance (TER) measurements using the Millicell-ERS epithelial 
voltohmmeter (Millipore Co., Bedford, USA). The TER was measured prior to and during the 
experiments to monitor cell layer confluency and the integrity of the tight junctions. The TER 
of the cell layers was calculated according to the following equation: TER = (Rlola|-Rb]ank) x A 
(Q.cm2), Rtota, is the resistance measured, Rbtank is resistance of control filters without cells 
(approximately 130 Q.cm2), A = surface area of filter (1 cm2). 
Exposure to CdCl2. 
Two exposure scenarios were used to study the mechanism of action of Cd2+. In both 
cases the basolateral medium was DMEM (Gibco, Paisley, Scotland) supplemented with non-
essential amino acids, 6 mM L-glutamine, gentamycin and 0.1% BSA (basal medium). The 
apical medium was protein free basal medium with freshly dissolved CdCl2 in concentrations 
ranging from 0-100 pM (test medium). In the first scenario, in which acute effects are studied, 
the inserts with cells were transferred to new wells with 1.8 ml basal medium in the 
basolateral compartment and cells were apically exposed to 0.5 ml test medium for 4 hr or 14 
hr (37°C, 5%C02, 95% relative humidity). After the exposure time the TER was determined 
and the apical test medium was removed and used for LDH leakage measurements. Subse-
quently, the inserts with cells were used for assessment of transepithelial transport and neutral 
red (NR) uptake or immunocytochemistry. In the second exposure scenario the cells were 
apically exposed for 4 hr after which time the apical and basolateral medium were carefully 
removed and fresh basal medium was added to both sides. Cells were incubated overnight 
(12-14 h, 37°C, 5%C02, 95% relative humidity) and subsequently the same measurements 
were performed as for the 4 or 14 hr incubations. This was done to study acute and delayed 
effects of a 4 hr Cd2+ exposure period. 
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Transepithelial transport ofmannitol and PEG-4000 
Transport experiments were carried out as described previously (Duizer et al., 1997). 
Apparent Permeability coefficients (Papps) of mannitol and PEG-4000 were determined on 
the basis of appearance of the probe in the basolateral receiver compartment before 10% of 
the probe was transported (Artursson and Karlsson, 1991). 
Transepithelial transport and cellular accumulation of'^Cd2* 
The effect of Cd2+ exposure on transepithelial transport of 109Cd2+ (DuPont, Boston, 
USA, kindly provided by F. Schulz, University of Utrecht, Netherlands) was followed for 24 
h. The cellular sequestration of 109Cd2+ was determined after 4 hr exposure to 5 and 30 uM 
Cd2+. After the exposure time cells were washed with basal medium and PBS with 0.022% 
(w/v) EDTA to remove all extracellular Cd2+ (Prozialeck and Lamar, 1993). Subsequently, 
cells were incubated in basal medium and release of 109Cd2+ was measured for 12 hr (37°C, 
5%C02, 95% relative humidity). Prior to the experiments the 109Cd2+ was mixed with 
unlabeled Cd2+ to yield specific activities of 5-30 mCi/mol for experiments with Caco-2 cells, 
and 1 mCi/mol for IEC-18 cells. All 109Cd2+ samples were counted for 3 min in a 1272 
Clinigamma counter from Wallac. 
Immunocytochemistry 
For immunocytochemistry the filters with cells were fixed in 1% formaldehyde in HBSS 
(5 min, RT) and permeabilized in 0.2% Triton X-100 in HBSS (20 min, RT). Polyclonal 
rabbit anti-ZO-1 and polyclonal rabbit anti-Occludin, anti-rabbit IgG-biotin and streptavidin-
FITC or-TRITC (Zymed, San Francisco, USA) were used to visualize ZO-1 and occludin 
respectively. E-cadherin was labeled in Caco-2 cells with monoclonal anti-uvomorulin 
(Sigma, St.Louis, USA), biotin conjugated goat-anti-rat IgG and streptavidin-FITC (Zymed, 
San Francisco, USA). 
Confocal scanning laser microscopy and image processing 
Confocal fluorescence microscopy was performed with the Bio-Rad MRC600, using the 
PlanApoChromat 40x objective with variable diaphragm (Zeiss, Oberkochen, Germany). 
Images were recorded with Bio-Rad software and transferred to an image processing 
workstation. The images were processed by a custom written program, using the image 
processing toolbox SCIL-Image (Free University of Amsterdam, Netherlands) as a basis. The 
program developed to select junction-related immunolabeled ZO-1, consists of three 
sequential steps (Duizer et al, 1998). In brief, a threshold value (1.4 for Caco-2 cells and 1.6 
for IEC-18 cells) was applied to differentiate between junction-related ZO-1 pattern and 
background. This step usually results in a honeycomb-like skeleton with small discontinuities, 
representing most of the junction-related ZO-1 pattern. In the second step of the program, the 
skeleton can be improved by closing the small discontinuities of the borderlines and removal 
of spurious line fragments. Finally, from the binary image of the optimized skeleton 
representing only junction-related ZO-1, the total number of pixels is determined (as a 
measure of the junctional length) and the original grey value image was used to determine the 
average pixel intensity over the junctional pattern (as a measure of the junctional density). 
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Cytotoxicity and membrane damage assays 
LDH leakage into the apical medium resulting from Cd exposure at the apical cell side 
was determined with the Boehringer Mannheim kit for LDH at the BM/Hitachi 911. Total 
LDH content was determined after sonicating the inserts with cells in basal medium. 
Neutraluptake was determined directly after the transport experiments. For that purpose, cells 
were incubated with NR (50 pg/ml) in basal medium for 30 minutes (37°C, 5%C02, 95% 
relative humidity). Subsequently, the cell layer was rinsed once with HBSS and the NR was 
extracted with 1% (v/v) acetic acid in a 1:1 water-ethanol mixture. The A540nm was measured 
spectrophotometrically. 
Statistics 
Data on TER, LDH leakage, transport of mannitol and PEG-4000 and NR uptake were 
obtained in 2 independent experiments with both cell types using 3 filters per exposure group 
in each experiment. For the figures and statistical analysis data were calculated for n=6. Data 
on immunocytochemistry were obtained in 2 experiments using 2 filters per exposure group 
for each experiment, 5 areas per filter were recorded to quantify ZO-1 specific fluorescence. 
Presented data are mean ± SD of two pooled independent experiments, unless mentioned 
otherwise. Data were analyzed using two-tailed students t-test. 
RESULTS 
Effects ofCd2+ on Transepithelial Electrical Resistance and Paracellular Transport in Caco-2 
cells 
Apical exposure to 0-100 uM Cd2+ caused a small but dose-dependent decrease in TER 
and slightly increased Papps for mannitol and PEG-4000 directly after a 4 hr preincubation 
(Figure 7.1 A). The decrease in TER and increased Papps for mannitol and PEG-4000 caused 
by a 4 hr preincubation with Cd2+, and subsequently maintained in basal medium, were more 
severe when measured 14 hr later (Figure 7.IB). This indicates that the effects induced by a 4 
hr incubation period are irreversible and initial effects of Cd2+ are decisive, even in the 
absence of a continued Cd2+ exposure. The 14 hr full-time exposure resulted in decreases in 
TER and increased transport rates of mannitol and PEG-4000 at Cd2+ concentrations of 10 
uM and higher. 
Effects ofCd2+ on Transepithelial Electrical Resistance and Paracellular Transport in IEC-18 
cells 
In IEC-18 cell layers apical exposure to 50-100 uM Cd2+ resulted in significantly 
increased permeability rates for mannitol and PEG-4000, when compared to 0 pM Cd2+, in all 
three exposure scenarios (Figure 7.2 A, B and C). The decrease in TER after exposure to 50-
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100 uM Cd2+ was statistically significant in the 14 h full-time exposure only. The 14 h full-
time preincubation with 0, 5 and 10 uM Cd2+ resulted in increased Papps for mannitol and 
PEG-4000, whereas these concentrations had no effect after 4 h preincubation. 
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exposure on apparent permeabilities of 
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Figure 7.2: Effects of apical CdCl2 exposure on apparent permeabilities of mannitol (a) and PEG-4000 (•) and 
TER (-A-) of IEC-18 cells. Cells were exposed for 4 hr and used immediately (A) or after 14 hr recovery (B), or 
cells were exposed for 14 hr (C). TER was normalized with the TER prior to CdCl2 exposure set to 100%. Data 
are presented as mean±SD (n=6). 
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Effect ofCd2* on Transport ofmCa^* 
Figure 3 shows the transepithelial transport of Cd2+ across Caco-2 and IEC-18 cells. The 
5 uM Cd2+ was considered as control, no unlabeled Cd2+ was added and this concentration 
was found to be ineffective towards TER and permeability of mannitol and PEG-4000 in both 
cell lines (Figure 7.1 and 7.2). Compared to 5 uM Cd2+, transepithelial transport of Cd2+ is 
increased at 15 and 30 uM Cd2+ in Caco-2 monolayers. In these cells the first signs of the 
effect of Cd2+ on its transport occurred between 6 and 9 hours after onset of exposure. The 
steady-state flux of Cd2+ across Caco-2 cells (determined between 12-18 h) was 5.1 ±0.7 
pmol/h when the Cd2+ concentration was 5 uM. The flux was increased to 43±9 pmol/h and 
327±89 pmol/h, after addition of 15 and 30 uM Cd2+, respectively. 
Transport of Cd2+ across IEC-18 cell layers was higher than across Caco-2 monolayers 
but was also dependent on the concentration. The lag-phase of approximately 6 hr as found for 
transport across Caco-2 cells was not found for Cd2+ transport across IEC-18 cells. Cd2+ fluxes 
were 89±13 pmol/h and 1003±146 pmol/h (determined between 0-9 h), after addition of 5 and 
30 uM Cd2+, respectively. 
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Figure 7.3: Cumulative apical to basolateral l09Cd2* transport profiles across Caco-2 (A) and IEC-18 cell layers 
(B). 109Cd2* was added apically at t=0 hr at a concentration of 5 uM (-+-), 15 uM (-•-) or 30 uM (-A-) and 
appearance in the basolateral compartment was measured. Data are presented as mean±SD (n=3). 
Effects ofCcP* on the Cellular Distribution ofZO-1 in Caco-2 cells 
Immunocytochemical localization of ZO-1 in untreated layers of Caco-2 cells showed a 
continuous belt-like cell circumscribing pattern at all sites of cell-to-cell contact (Figure 
7.4A). After 4 hr exposure to 30 uM Cd2+ the first signs of fragmentation of the ZO-1 pattern 
became visible (data not shown). Locally, densely stained spots of immunofluorescent ZO-1 
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Control ZO-1 
100 ]iM Cd 
Occludin 
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Figure 7.4: Immunofluorescent staining for junctional proteins in Cd2+ exposed Caco-2 cells. Cells were labeled 
for ZO-1 (A and B), Occludin (C and D) or E-cadherin (E and F) after apical exposure to 0 (A, C, E) or 100 pM 
(B, D, F) Cd2+ for 4 h. 
103 
Chapter 7 Cadmium disrupts the intestinal paracellular barrier 
appeared in the cell periphery, but the belt-like pattern was in general still continuous and cell 
surrounding. After 4 hr exposure to 100 uM Cd2+, clusters of Caco-2 cells showed a clearly 
damaged ZO-1 pattern (Figure 7.4B). This fragmentation was more severe than after 30 uM 
exposure, and the cell surrounding pattern showed interruptions. Exposure to 15 uM Cd2+ or 
higher concentrations for 14 hr led to severe disruptions of the ZO-1 pattern (Figure 7.5A). In 
substantial parts of the monolayer the belt-like structure was no longer recognizable, but the 
ZO-1 protein could still be detected as intensely stained spots throughout the affected cells. 
The ZO-1 pattern of the Caco-2 monolayers exposed to 15 uM Cd2+ for 4 hr but maintained in 
culture for 14 hr in basal medium, showed a few localized spots of severe disturbances of the 
cell surrounding pattern in an overall normal appearing monolayer. The cells surrounding the 
affected spots appear to extend into the area to close the holes in the monolayer (Figure 7.5B). 
The quantitative analysis of ZO-1 localization in Caco-2 cells (Table 7.1) showed that 
immediately after 4 hr exposure to 100 pM Cd2+ the junctional length was decreased. This 
effect became more apparent after 14 hr exposure, even at lower concentrations of Cd2+. After 
a 4 hr exposure to 15 or 30 uM Cd2+ followed by a recovery period of 14 h, the net junctional 
length was not affected. 
The junctional density was reduced by 4 hr exposure to 100 uM Cd2+ but remained 
unchanged after 14 hr exposure to 15 or 30 uM. The 4 hr exposure followed by 14 hr in 
culture resulted in a slight decrease in net junctional density at 15 uM Cd2+ but not at 30 uM. 
Effects ofCd1* on the Cellular Distribution of ZO-1 in IEC-18 cells 
The high background of non-junctional ZO-1 in control cell layers of IEC-18 (Figure 
7.6A) makes it difficult to characterize early changes in the junctional pattern. The Cd2+ 
dependent disruption of the ZO-1 pattern in IEC-18 cells appeared to evolve in a less 
organized manner than Caco-2 cells. The 14 hr exposure to 50 pM Cd2+ led to rounded cells 
with a vaguely stained nucleus and a complete lack of cell-surrounding junctional staining 
(Figure 7.6B). After 14 hr exposure to 10 uM Cd2+, the junctional ZO-1 pattern has become 
invisible in several patches throughout the cell layer and a decreased junctional length as 
determined by the quantified immunolocalization of ZO-1 (Table 7.1) was observed. 
Effects ofCd2* on the Cellular Distribution ofOccludin and E-cadherin in Caco-2 cells 
Since the undifferentiated IEC-18 cells did not express detectable levels of occludin and 
E-cadherin, the effects of Cd2+ on the cellular distribution of these two proteins was studied 
only in Caco-2 cells. Immunocytochemical localization of occludin in untreated Caco-2 
monolayers showed a continuous belt-like cell-circumscribing pattern at all sites of cell-to-cell 
contact (Figure 7.4B). Occludin appeared in punctuates near the sites of cell-cell contacts after 
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4 hr exposure to 100 uM Cd2+ (Figure 7.4D) and as punctuates throughout the cell after 14 hr 
exposure to 15 uM Cd2+ (not shown). The intercellular localization of occludin was 
indiscernible from that of ZO-1, in control and Cd2+ exposed monolayers after all exposure 
scenarios. All disturbances of the patterns of the junctional proteins tested (ZO-1, occludin 
and e-cadherin) started locally, i.e. in patches in an overall normally appearing monolayer. 
Only after exposure to 100 uM Cd2+ for 4 hr or >20 uM Cd 2+for 14 hr effects are more 
general throughout the monolayers. 
A . • ' %• 
120 um 
Figure 7.5: Immunofluorescent staining for ZO-1 in Cd2+ exposed Caco-2 cells. Cells exposed to 15 uM Cd for 
14 h(A) or for 4 hr followed by 14 hr recovery (B). 
120 um 
Figure 7.6: Immunofluorescent staining for ZO-1 in Cd2+ exposed IEC-18 cells. Control (A) or cells exposed to 
50uMCd2 <forl4hr(B). 
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In contrast to the punctuated pattern of ZO-1 and occludin, the junctional organization of 
e-cadherin as found in control cell layers at sides of cell-to-cell contacts (Figure 7.4E) faded 
after 4 hr exposure to 100 uM Cd2+, leading to vaguely recognizable cell nuclei without 
peripheral staining (Figure 7.4F). Immunofluorescent double labeling of Caco-2 cells for ZO-
1 and e-cadherin revealed that in these cases a punctuate ZO-1 pattern co-occurred with a 
vague or undetectable e-cadherin labeling. Thus the localization of e-cadherin was changed 
but in a different way than that of ZO-1 and occludin. 
Table 7.1: Quantitative analysis of immunolocalization of ZO-1 in Caco-2 and IEC-18 cells. 
Cells 
Caco-2 
IEC-18 
Treatment 
Exposure time, concentration 
Control 
4h, 30 uM 
4h, lOOuM 
4h ,15uM, 14 hc 
4h, 30 uM, 14 h 
14h, 15 uM 
14 h, 30 uM 
Control 
14h, lOuM 
14h,50pM 
junctional length" 
100 ±6.04 
98.2 ± 5.3 
89.8 ± 9.4* 
108.1 ±6.6 
97.3 ± 9.8 
71.5 + 23.9* 
42.3 ±21.3* 
100 ±6.0 
80.3 ±16.7* 
<10 
junctional density* 
% 
100 ±11.8 
92.9 ±8.5 
77.3± 14.8* 
85.1 ±14' 
102.5 ±14 
113.6 ±17.7 
103.7± 17.7 
100± 11.5 
111.3 ±14.6 
ndd 
" Junctional length is based on the number of pixels belonging to the junctional pattern as selected by a custom 
written program after immunolabeling the ZO-1 protein 
* Junctional density is based on the pixel intensity of the pixels forming the junctional pattern. 
c
 Time after exposure to cadmium, cells were maintained in culture prior to fixation. 
d
 not determined because of the limited junctional length 
* Statisticaly significant with p<0.05. 
Cell Viability after Cd1* Exposure 
Figure 7 A-C show that Cd2+ exposure did not cause LDH leakage in Caco-2 cells, thus 
in this cell line none of the exposure scenarios resulted in membrane damage. Cell viability, as 
determined by the NR assay ^rformed after the transport experiments (i.e. 4 hr after end of 
exposure), was slightly, but significantly, reduced after 4 hr exposure to 50 and 100 uM Cd2+. 
Cells exposed to Cd2+ for 4 hr and maintained in culture for another 14 hr showed similar 
viabilities as the 14 h full time exposure. 
The IEC-18 cells exposed to 10 -100 uM Cd2+ for 4 hr did not show a significant 
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increase in the LDH leakage but the NR uptake was reduced in a dose-dependent manner 
directly after the transport experiment. Cells exposed to 50-100 uM Cd2+ for 4 hr and 
maintained in culture for 14 hr did show a clear increase in LDH leakage and reduction in NR 
uptake. A similar tendency was observed after 14 hr Cd2+ exposure. 
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Figure 7.7: Effects of apical CdCl2 exposure on LDH leakage (bars) and NR uptake (lines) of Caco-2 (A, B, C) 
and IEC-18 (D, E, F) cells. Cells were exposed for 4 hr and used immediately (A, D) or after 14 hr recovery (B, 
E), or cells were exposed for 14 hr (C, F). Data are presented as mean±SD (n=6). *, p<0.05 in two-tailed 
Students t-test. 
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Fate of'09Ccf+ after 4 hr exposure 
Since we found that even after removal of extracellular Cd2+, the effects on the cell 
layers continued to develop, the cellular retention of 109Cd2+ was followed for 12 h. After 4 hr 
incubation with Cd2+ a dose-dependent cellular accumulation of 10Cd 2+was found in Caco-2 
cells (Figure 7.8). In IEC-18 cells the cellular Cd2+ accumulation was increased 1.6-fold when 
the Cd2+ concentration was increased 6-fold (from 5 to 30 uM). During the 12 hr recovery 
period in culture medium, 65-85% of the Cd2+ was retained in the cells. More than 70% of the 
released fraction was found in the apical medium in both cell lines at all concentrations (data 
not shown). 
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Figure 7.8: Cellular accumulation of l09Cd2+ in cells exposed apically to 5 and 30 uM Cd2* for 4 hr ( • ) and 
subsequent retention during maintenance in basal medium for 12 hr ( • ). Data are presented as mean±SD 
(n=3). 
DISCUSSION 
In the present study we characterized the effects of apical Cd2+ exposure on the barrier 
function of intestinal epithelium. For that purpose a small intestinal crypt cell line (IEC-18) 
and a colonic (Caco-2) cell line with enetrocytic-like differentiation, were apically exposed to 
CdCl2 and the permeability of electrolytes (TER), Cd2+ and medium-sized and large 
hydrophilic molecules (mannitol and PEG-4000) were determined. Under similar conditions 
the immunolocalization of junctional proteins (ZO-1, occludin and e-cadherin), the release of 
LDH and uptake of NR were assessed. 
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It was found that the effects of Cd2+ on the epithelial barrier function were 
concentration- and time-dependent. Although the first effects of Cd2+ on Caco-2 cells ( i.e. 
decrease in TER, increased permeabilities of mannitol and PEG-4000 and qualitative and 
quantitative changes in intercellular ZO-1, occludin and e-cadherin localization) were already 
apparent after a 4 hi incubation, the effects were far more pronounced after prolonged 
exposure. These changes were detected without a significant loss of cell viability of the Caco-
2 cells. Whereas Cd2+ appeared to interfere particularly with the epithelial barrier function of 
Caco-2 cells, this specific effect was not found in the IEC-18 cells. In this cell line of poorly 
differentiated small intestinal epithelial cells, Cd2+ concentrations affecting the barrier 
function and ZO-1 expression also caused a reduced cell viability and membrane damage. 
Although IEC-18 cells do express ZO-1 in a junctional pattern, we were unable to detect a 
peripheral expression of occludin and e-cadherin. The low expression of junctional proteins 
and the relatively high permeability for hydrophilic macromolecules in IEC-18 cells indicate 
that the junctional complexes are less tightly organized, which might explain the lack of early 
specific effects of Cd2+ on the paracellular barrier function in IEC-18 cells. Furthermore, the 
relative early beginning of cytotoxic effects in IEC-18 cells, compared to Caco-2 cells, may be 
enhanced by the two-sided exposure due to the high permeability of Cd2+. The higher 
sensitivity due to basolateral or two-sided exposure was already found for epithelial kidney 
cells (Prozialeck and Niewenhuis, 1991; Hazen-Martin et al, 1993; Prozialeck and Lamar, 
1997) and for Caco-2 cells (Rossi et al, 1996). 
In this study we found relatively high transepithelial passage of mannitol, PEG-4000 
and Cd2+ across IEC-18 cells, compared to Caco-2 cells. Since cellular accumulation and 
retention were comparably low in both cell lines after exposure to 5 uM Cd2+, we suggest that 
the extra Cd2+ transport across IEC-18 cells compared to Caco-2 cells, occurs by the 
paracellular pathway. It was found earlier that the paracellular permeability of hydrophilic 
macromolecules across IEC-18 cells correlated with the intestinal permeability in vivo (Duizer 
et al., 1997). The transepithelial permeability of Cd2+, however, seemed to be more closely 
resembled by the permeability across Caco-2 cells. This suggest that other mechanisms limit 
the absorption of Cd2+. For example, Cd2+ can be bound by the well-organized brush border, 
present on small intestinal villus and Caco-2 cells, or to a variety of macromolecules in the 
luminal contents of the gastrointestinal tract. In both cases the Cd2+ availability in the more 
permeable crypts will be decreased and therefore absorption will be low. This also explains 
the overestimation of Cd2+ absorption on basis of Cd2+ permeability in the ileal crypt cell line 
IEC-18. 
In order to be able to relate the decrease in barrier function to changes in tight junction 
patterns, we have developed a method which enabled us to quantify junctional length (pixel 
number) and density (pixel intensity) on the basis of the immunolocalization of the tight 
junctional protein ZO-1. The quantification of the tight junctional protein ZO-1 was used 
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previously in a study into the mechanism of the absorption enhancing effect of 
palmitoylcarnitine (Duizer et al., 1998). It was found that the sequence of events after 
palmitoylcarnitine exposure was first membrane damage (increased LDH leakage), followed 
by reduced barrier function and decreased junctional ZO-1 expression. This led to the 
conclusion that transcellular transport enhancement or cell lysis contribute significantly to the 
increase in intestinal permeability. In the present study we found that in Caco-2 cells the 
barrier function was decreased concomitantly with decreased junctional ZO-1 expression but 
without LDH leakage after Cd2+ treatment. Thus, the increased permeability, observed at 
relatively low Cd2+ concentrations, is most likely attributable to increased paracellular 
permeability. 
In our view several adverse effects can lead to reduced junctional length or reduced 
junctional density in confocal images. Obviously, effects as cell lysis, junctional protein 
breakdown or changes in the epitope would result in decreased pixel density and/or number. 
But even more subtle effects as a reduced connection to the cytoskeleton may result in 
decreased pixel density and/or number due to the permeabilization step with Triton-XlOO in 
the labeling procedure. One reason for the reduction in pixel density of the fluorescent signal 
of tight junctional proteins after exposure to Cd2+ was already proposed by Hazen-Martin et 
al. (1993). They found that the sealing tight junctional strands of human proximal tubule cells 
were overall intact after Cd2+ exposure, however, the distance between the strands was 
increased, i.e. the junctional strands were distributed over a larger area of the lateral 
membrane. Such an increase in junctional width would lead to a decrease in intensity in a 
confocal image as observed in the present study. 
The early effects of low concentrations of Cd2+ were detected as altered junctional 
patterns in localized patches of cells. At higher concentrations these effects became more 
general throughout the monolayer, whereas after prolonged incubation to the lower 
concentrations the effects remain more localized. Detection of the localized early effects can 
be considered as one of the major advantages of the integration of immunolabeling and 
fluorescence microscopy compared with electron microscopy or light microscopy using cross 
sections. Within a reasonable amount of time and effort the total area of monolayer of cells 
can be screened for irregularities. This may be the reason why we were able to detect 
morphological changes in the tight junctions whereas Rossi et al. (1996), and Niewenhuis et 
al. (1997) did not detect changes in zonula occludens by using electron microscopy. 
Prozialeck and Niewenhuis (1991) did detect a decrease in membrane associated e-cadherin in 
LLC-PK, cells by using immunolabeling and fluorescence microscopy. In Caco-2 cells the 
immunofluorescent pattern of e-cadherin is somewhat vague or disorganized in patches 
(clones) of cells in the control monolayers. It was, therefore, difficult to determine early 
effects on basis of changes in the e-cadherin pattern in the Caco-2 cells. However, all 
exposures which caused a decrease of junctional ZO-1 also led to a decrease in membrane 
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associated e-cadherin. 
Despite the differences between the responses of IEC-18 and Caco-2 cells to Cd2+ 
exposure with respect to paracellular permeability and cytotoxicity, in both cell lines the 
effects following the "4 hr Cd2+ exposure + 14 hr culture" scenario, resemble the effects of a 
14 hr incubation more than the effects directly after 4 hr incubation. This shows that the 
effects of Cd2+ develop rather slowly and that the cells are unable to immediately start 
recovery after removal of extracellular Cd2+. The lack of recovery can be explained by the 
high cellular Cd2+ retention after termination of exposure. The fact that cellular Cd2+ retention 
in Caco-2 cells leads to selective effects on the barrier function might indicate that junction-
related molecules are involved in Cd2+ retention. The inability of the known Cd2+-binding 
compound gluthatione to reduce these effects in other epithelial cell lines (Prozialeck and 
Lamar, 1995) suggests that these junction-related molecules have a high affinity for Cd2+. The 
binding of Cd2+ with a polypeptide analog of a Ca-binding side of e-cadherin was studied by 
Prozialeck et al. (1996), but the binding of Cd2+ seemed to have a low affinity (Kd ~ 20 uM). 
Furthermore, best known Cd2+ binding polypeptides have a high affinity due to their cysteine 
groups, making it reasonable to assume a cysteine-rich peptide to be an early target of Cd2+ 
toxicity. Although ZO-1 and occludin are as a whole poor in cysteine residues, ZO-1 and 
occludin are possible targets since ZO-1 has a cysteine cluster at the c-terminus region (Itoh et 
al., 1993) and occludin has, among others, 2 cysteine-groups in one of the extracellular loops 
(Mitic and Anderson, 1998). The involvement of junctional proteins in Cd2+ binding may 
serve as protective mechanism in vivo. Conformational changes in these proteins as a result 
Cd2+-binding could reduce cell adhesion and thereby facilitate exfoliation of Cd2+ containing 
cells into the lumen. More studies will be necessary to elucidate the relation between the 
cellular Cd2+ retention and the selective early junctional effects. 
In this study we have shown that Cd2+ exposure to the apical side of intestinal epithelial 
cells in vitro compromises the epithelial barrier function. The decreased barrier functionality 
is characterized by a decrease in TER, an increased permeability for mannitol, PEG-4000 and 
Cd2+, a disorganization of the honeycomb-like pattern of the tight junctional proteins ZO-1 
and occludin, a loss of adherens junctional e-cadherin, and the lack of membrane damage. 
These changes in cell layer integrity and permeability are being considered as an initial effect 
and appeared to be a general phenomenon of acute Cd2+ dosing, as it was found for the 
vascular endothelium, Sertoli cell monolayers, several epithelial kidney cell lines and 
intestinal epithelial cells. To the best of our knowledge we are the first to show that the 
decreased epithelial barrier function is accompanied by tight junction disruption. We conclude 
that Cd2+ causes increased paracellular permeability and that adverse effects on the junctional 
complexes are early effects of Cd2+ on intestinal epithelium in vitro. 
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113 
Chapter 8 Summary and concluding remarks 
Chapter 8 
Summary and concluding remarks 
The studies described in Section II of this thesis were aimed at determining the "pros 
and cons" of filter-grown small intestinal IEC-18 cells, relative to the colonic Caco-2 cells, as 
model for small intestinal permeability. In Section III both cell types were used to study the 
effects of barrier perturbants on the intestinal epithelium and a set of parameters was 
composed allowing the assessment of the most likely mechanism of permeation enhancement. 
In this chapter, the Section II and III are summarized, some overall conclusions are drawn and 
the implications of these conclusions are presented. 
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§ 8.1 Transepithelial permeability of the filter-grown Caco-2 and IEC-18 cells. 
In Section II we characterized growth, morphology, differentiation, absorption and 
barrier functions of the cell lines Caco-2 and IEC-18. In the studies described in Chapter 3 
we found that Caco-2 cells formed a monolayer of polarized epithelial cells with brush 
borders with sucrase-isomaltase and intestinal alkaline phosphatase activity, an obvious 
peripheral F-actin belt and a cell circumscribing pattern of the tight junctional protein ZO-1. 
The IEC-18 cells grew into several layers of cells, did not express sucrase isomaltase activity 
and alkaline phosphatase activity was present as the fetal isoform. In these cells the F-actin 
was not organized into a peripheral actin belt, but the tight junctional protein ZO-1 was 
organized into virtually cell circumscribing strands. In addition to the morphological 
differences, both cell lines differed significantly in the TER they developed: the Caco-2 cells 
obtained a TER of 350±14 Q*cm2 while the TER of IEC-18 cells was 55+4 Q*cm2. This 
marked difference was also reflected by the permeability rates of the paracellular permeation 
of all hydrophilic compounds (mannitol, fluorescein, FD4, PEG-4000, FD20, FD70 and 
FD500), which were low in the Caco-2 monolayers, but higher and clearly size specific in 
IEC-18 cell layers. The permeability rates of the transcellular permeation of lipophilic 
compounds (salicylic acid, acetyl salicylic acid, propranolol and testosterone) were, on the 
other hand, high and comparable in both cell lines. 
In Chapter 4 we examined the activity of several intestinal transporters in the two cell 
lines. In order to determine H+-coupled di/tnpeptide carrier activity we have examined the pH-
dependent bidirectional transport of glycylsarcosine (GlySar). Transport was enhanced by a 
proton-gradient, it was faster than the permeation of mannitol which is approximately the 
same size, and transport in the absorptive direction (from apical to basolateral) was higher 
than transport in the secretive direction in Caco-2, but not in IEC-18 cells. We concluded that 
the FT-coupled di/tripeptide carrier was present in Caco-2 cells but not in IEC-18 cells. The 
activity of glucose carriers was studied by the bidirectional transport of O-methyl-D-glucose, 
this activity again, was found in Caco-2 but not in IEC-18 cells. Next to these two absorptive 
activities, we also studied the activity of two secretive systems (P-glycoprotein and 
MRP/cMOAT). The preferential transport in the secretive direction of vincristine and 
rhodamine 123, and the fact that this could be inhibited by verapamil, revealed P-glycoprotein 
(P-gp) activity in Caco-2 cells. These experiments gave no indication for the expression of P-
gp in IEC-18 cells. However, both, IEC-18 and Caco-2, cells showed probenecid-sensitive 
transport of the organic anions calcein and DNPSG, across the apical and basolateral 
membranes, indicating the activity of MRP/cMOAT in both cell lines at both cell sides. The 
presence of an H+-coupled di/tripeptide carrier, glucose carriers and P-glycoprotein in Caco-2 
cells confirms the enterocytic differentiation of these cells. Likewise, the lack of these 
activities in the IEC-18 cells is in agreement with their, crypt-like, and thus low state of 
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differentiation. The expression of MRP/cMOAT mediated efflux activity in the human small 
intestine is still unknown. Perhaps the expression in the crypt (IEC-18) and villus-like (Caco-
2) intestinal epithelial cells, as shown in Chapter 4, is indicative for the expression of 
MRP/cMOAT along the intestinal crypt-villus axis in vitro. However, more studies will be 
needed to assess the relation between intestinal epithelial cell differentiation and the exact 
intestinal expression of this efflux system. 
In conclusion, experiments with the filter-grown Caco-2 cells yielded discriminative 
permeation rates for the transcellular permeation of lipophilic, and actively transported 
(nutritional) hydrophilic compounds on the one hand, and paracellular permeation of 
hydrophilic (non-nutritional or) macromolecular compounds on the other hand (Figure 8.1). 
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Figure 8.1: Human absorption data for several drugs and model compounds as a function of the apparent 
permeability coefficients obtained in the Caco-2 or the IEC-18 system. 
A: Transcellularly permeating compounds; high Papps and high absortion due to lipophylicity or active transport. 
B: Paracellularly permeating compounds; low or moderate absorption and variable Papps. 
In general, this is in good agreement with human absorption data and Caco-2 monolayers are 
considered an appropriate model to study the intestinal permeation rates for many different 
classes of compounds (Artursson and Karlsson 1991; Artursson et ah, 1996; and chapter 3 and 
4 of this thesis). In practice, it is suggested to divide human oral absorption levels in 3 groups 
(Yee, 1997), for example as follows: 
a) less than 5 or 10% absorption correlates with Papps < 0.1 *10'6 cm/s, 
b) 5-70% absorption for 0.1*106 cm/s < Papp < 1 *106 cm/s, and 
c) more than 70% absorption for Papp > 1 *10"6 cm/s. 
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However, an important drawback of the Caco-2 system is the improper ratio between the 
different transepithelial permeation routes. As shown in Chapter 3 and 4, the paracellular 
permeability is relatively low in comparison with the passive transcellular permeability for 
lipophilic molecules. Additionally, the expression of the active absorptive systems (glucose, 
di/tripeptide transporters) is low compared to the small intestinal epithelium in vivo (Hidalgo 
and Li, 1996; Chong et al., 1996), while the expression of the MDR1 gene product P-gp is 
relatively high, probably due to the fact that the cell line is colonic carcinoma derived (Gan 
and Thacker, 1997; Yee, 1997). This implies that for different pathways (i.e. classes of 
compounds) different cut-off values need to be assessed in the Caco-2 model. Furthermore, 
due to the heterogeneity of the Caco-2 cell line there will be considerable inter-laboratory 
variations in permeability rates and the suitable cut-off values (Gres et ah, 1998). 
Whereas, the Caco-2 cells present a good model for a general screen on intestinal 
permeation for a wide variety of compounds, the IEC-18 cells did allow for a better 
discrimination between the hydrophilic compounds on the basis of their molecular weight 
(Figure 8.2). Consequently, experiments with the filter-grown IEC-18 cells yielded 
discriminative permeation rates for the paracellular permeation of hydrophilic compounds 
with differing bioavailabilities (Figure 8.3). Thus, data presented in this thesis suggest that the 
filter-grown IEC-18 cells could be valuable as model for paracellular permeability in the small 
intestine, but more data will be necessary to verify this hypothesis. 
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Figure 8.2: Apparant permeability coefficients of hydrophilic model compounds as a function of their molecular 
weight. Permeation was determined in the apical to basal direction across Caco-2 or IEC-18 cells, or across 
empty filters. The IEC-18 system forms a size-dependend barrier. 
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Figure 8.3: Human absorption data of hydrophilic model compounds as a function of their apparent 
permeability coefficients. The IEC-18 system allows for a more accurate prediction of human absorption rates 
than the Caco-2 system does. 
The combined results concerning IEC-18 cells as presented in chapter 3 and 4 indicate 
that these cell are very primitive with respect to their differentiation status. Especially the fact 
that they did not form a monolayer but instead grew into several cell layers, indicates that the 
cells do have a high proliferative potential which is a characteristic of the stem cells, 
positioned low in the intestinal crypts. The availability of the lower parts of the intestinal 
crypts for luminal contents is low, and it might thus be argued that more detailed studies to 
transport processes with these undifferentiated crypt cells, are of little physiological 
importance. Therefore, several experiments were performed to try to differentiate these cells 
in order to establish a cell model with villus-epithelium characteristics. In Chapter 5 we 
describe the differentiation of the ileal crypt cell line IEC-18 by exposure to dexamethasone, 
and correlated cell proliferation and differentiation to paracellular barrier development. 
Addition of dexamethasone to the standard culture medium resulted in the formation of a 
monolayer of morphologically epithelial-like cells. In these cells the F-actin was organized in 
a peripheral actin-belt, and the localization of the tight junctional protein ZO-1 was more 
strand-like than in non-dexamethasone exposed cell layers. The morphological maturation of 
the IEC-18 cells co-occurred with an increase in paracellular barrier function for electrolytes 
(increase in TER) and hydrophilic macromolecules. Inhibition of cell proliferation, formation 
of a peri-junctional F-actin belt and increased tight junctional sealing as induced by 
dexamethasone in IEC-18 cells, are all natural events reported to occur in the enterocytes in 
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the small intestine along the crypt-villus axis. It might thus be concluded that the IEC-18 cells 
can be induced to form a small intestinal villus-like phenotype when cultured in the presence 
of dexamethasone. These cells might therefore present an in vitro model to study the relation 
between intestinal epithelial cell differentiation and paracellular barrier development along the 
crypt-villus axis. We were, however, unable to detect sucrase isomaltase or intestinal alkaline 
phosphatase activity. The activity of fetal ALP, however, was reduced, which might be an 
early sign of the cells transition to a more differentiated status. Therefore, additional studies 
are required to determine the exact differentiation status of the dexamethasone treated IEC-18 
cells and to assess the value of the more villus epithelial-like monolayers as in vitro model for 
the small intestinal epithelium. It should also be mentioned that the differentiation process 
evoked in the IEC-18 cells by dexamethasone, might be representative for the intestinal 
closure known to occur during the suckling-weaning transition in rodents. During that stage 
the permeability of the small intestinal epithelium for macromolecules is greatly reduced. This 
reduction in permeability is the result of a diminished transcytotic capacity of the epithelial 
cells, and of a tightening of the paracellular pathway, probably by a maturation of the 
junctional complexes. An in vitro model for the study of the changes in permeability during 
the intestinal closure would be of considerable interest since a vast amount of data is available 
on brush border enzyme activity development, but only limited information is available on the 
development of the barrier functions (Henning et al., 1994). 
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§ 8.2 Modulation of the intestinal epithelial barrier: 
The relation between increased permeability and toxicity in cell culture systems. 
In Section III we have studied the effects of several compounds on the epithelial 
barrier function of filter-grown intestinal epithelial cells, with emphasis on the structure and 
function of the paracellular barrier. These experiments are also used to explore combined 
determinations of epithelial permeability (TER and hydrophilic macromolecular permeation), 
membrane damage and cell viability (LDH leakage and PI or NR uptake) and tight junction 
structure (immunolocalization of tight junctional proteins) to determine the mechanism of 
permeation enhancement (i.e. to discriminate between paracellular and transcellular). 
Thereto, we determined the sequence of events during and after the exposure of filter-grown 
cells to PCC, Triton X-100, EGTA (Chapter 6), and cadmium (Chapter 7), by applying the 
following general protocol: 
1/ Measurement of the TER prior to exposure 
2/ Start of (apical) exposure 
3/ End of exposure: Measurement of TER and LDH leakage 
4/ Start of 4 h transport experiment or fixation for immunolocalization of junctional 
proteins (for PCC and cadmium only) 
5/ End of transport experiment: Measurement of neutral red uptake or medium 
refreshment for the determination of recovery of cell viability (i.e. assessment 
of the reversibility of the cytotoxic effects). 
The disruption of the epithelial barrier, measured as enhancement factor for PEG-4000 
permeation, will be evaluated with the other parameters in order to determine the mechanism 
of barrier disruption. The TER was found to be a sensitive indicator for the detection of 
decreased cell layer integrity. In all cases that the permeation of the hydrophilic molecules was 
increased the TER was decreased (Figure 8.4). However, significant decreases in TER could 
be measured without concomitant increase in tracer permeation at high TER values, and 
significant increases in PEG-4000 permeation were detected without decrease in TER at low 
TER values. Thus, the TER, as such, is not a good quantitative predictor for macromolecular 
permeability. 
The immunolocalization of the tight junctional protein ZO-1 was used to indicate 
structural changes in the tight junctional barrier. It was hypothesized that if the permeation 
enhancing effect was mainly due to increasing the paracellular permeability, changes would be 
visible in the distribution of the tight junctional proteins. An advantage of 
immunofluorescence microscopy is that it allows the screening of the whole monolayer within 
an acceptable amount of time, making this method more convenient for the screening of 
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localized (clonal) effects compared to electron- or light microscopy using cross-sections. An 
important restriction is that the changes in the tight junction structure might be so subtle that 
they can not be visualized by this method. Furthermore, the high background of non-
junctional ZO-1 in control cell layers of IEC-18 makes it difficult to characterize early 
changes in the junctional pattern. Nonetheless, we were able to detect changes in ZO-1 
localization after cadmium, and after PCC treatment in both cell lines. It was also found that 
all detectable changes in the ZO-1 pattern started as localized disruptions which became more 
omnipresent at higher concentrations of cadmium or PCC. 
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Figure 8.4: The TER as a function of the increased permeation of PEG-4000 across Caco-2 monolayers after 
exposure to PCC, Triton X-100, Cd or EGTA (Chapter 6 and 7). 
In order to quantify the changes in the ZO-1 pattern, we have developed a method with 
which we were able to determine pixel number and intensity as a measure for the 
immunolocalization of this tight junctional protein. It was found that very local disruptions 
could not be quantified by this method. However, as soon as the effects on ZO-1 pattern 
became more generalized, changes in the pixel density and pixel number could be quantified. 
It appeared that in Caco-2 cells, PCC (Chapter 6) caused a dose-dependent decrease in 
junctional pixel number (junctional length) without having an effect on junctional pixel 
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density, while cadmium (Chapter 7) caused a dose-dependent decrease in both, pixel number 
and density after 4 h exposure. These findings could indicate that different mechanisms are 
involved in the barrier disruption by PCC or cadmium. Since both, pixel number and density, 
are affected by cadmium, it is likely that the effects of cadmium are more selective on the 
tight junctions. Since a functional reduction of barrier integrity (i.e. increased macromolecular 
permeation) could be detected prior to morphometric changes in the junctional network, it 
must be concluded that the quantification of ZO-1 immunolocalization was not a very 
sensitive method for detecting localized disruptions of the junctional pattern. Nevertheless, 
with the morphometric analysis using the custom written image processing program, 
generalized changes in pixel density could be determined while this is very hard to do with 
CLSM images only. 
To assess membrane damage, the LDH leakage into the apical compartment, i.e. at the 
side of exposure, was determined. LDH leakage was found to be a sensitive indicator for 
membrane damage. Since LDH leakage is such a direct measure of increased (apical) 
membrane permeability (or cell lysis), and the surface area of the cell membranes is at least 
1000 times larger that the paracellular surface area, we assume a correlation between LDH 
leakage and transcellular permeation enhancement. In Chapter 6 we describe that after PCC 
exposure, increased LDH leakage preceded the permeation enhancement in both cell lines. 
Cadmium exposure (Chapter 7), on the other hand, induced no LDH leakage in Caco-2 cells 
at all, thus there was no relation between membrane damage and permeation enhancement 
found (Figure 8.5). In IEC-18 cells cadmium induced a dose-dependent increase in LDH 
leakage, however, after short term exposure the increase in transepithelial permeability was 
more pronounced, and occurred prior to, the small increases in LDH leakage. The PI uptake 
assay as measure for membrane damage proved very useful to detect cell lysis when used in 
combination with ZO-1 immunolocalization. The combination of those two stains showed that 
the decrease in junctional pixel number after PCC exposure was mainly due to the lysis of 
whole cells and not to a specific effect on the junctions. 
In order to assess cell viability after the transport experiment, a quantitative neutral red 
uptake assay was performed. In Caco-2 cells it was found that after exposure to PCC 
(Chapter 6) or cadmium (Chapter 7) the NR uptake correlated well with the LDH leakage, 
although after exposure to high levels of cadmium the NR uptake was slightly reduced even 
when no LDH leakage was found. This might indicate that one of the cytotoxic effects of 
cadmium involves the functionality of the lysosomes (i.e. sequestration of NR). In IEC-18 
cells, effects on NR uptake were in general more severe than effects on LDH leakage. Based 
on the fact that NR uptake was determined after 4 h recovery (4 h transport), whereas the LDH 
leakage was determined directly at the end of exposure, it can be concluded that no recovery 
of cell viability during the 4 h transport took place. When the cells were allowed to recover 
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from PCC exposure for 22 h, some recovery of TER and cell viability was found, indicating 
that the cell layers were able to partly restore the barrier integrity. 
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Figure 8.5: The LDH leakage (membrane damage) as a function of the increased permeation of PEG-4000 
across Caco-2 monolayers after exposure to PCC, Triton X-100, Cd or EGTA (Chapter 6 en 7). 
In summary, it was found that the sequence of events after palmitoyl carnitine 
exposure (Chapter 6) was first membrane damage (increased LDH leakage), followed by 
reduced barrier function (increased hydrophilic macromolecular permeability and decreased 
TER) and decreased junctional ZO-1 expression. After cadmium exposure (Chapter 7) the 
barrier function was decreased concomitantly with decreased junctional ZO-1 expression but 
without LDH leakage. Chapter 6 and 7 illustrate that a combination of several parameters was 
needed to elucidate the mechanism of permeation enhancement (i.e. increased permeation of 
tracers as mannitol and PEG-4000) and to assess epithelial (cell) damage. For example, the 
TER was a sensitive indicator for the detection of decreased cell layer integrity but not a good 
indicator to determine the mode of action of the enhancers. Figure 8.4 and 8.5 show that a 
decreased TER was indeed found when the permeability was increased without concomitant 
membrane damage (EGTA and Cd), but also when the permeability was enhanced with 
concomitant membrane damage (Triton X-100 and PCC). Thus, hydrophilic macromolecular 
permeability and TER are, under physiological conditions, indicators of paracellular 
permeability, however, in case of increased membrane permeability, these parameters can 
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indicate increased transcelluiar permeability as well. Furthermore, when the integrity of the 
tight junctional network, as assessed by the ZO-1 immunolocalization, was affected, 
macromolecular permeation was increased. However, macromolecular permeation could be 
increased without detection of effects on ZO-1 distribution. Thus, an disturbed junctional ZO-
1 localization is an indicator for enhanced macromolecule permeabilty, but it is not a 
prerequisite. 
In conclusion, the occurrence of increased hydrophilic macromolecular permeability 
concomitant with LDH leakage but without alterations in junctional ZO-1 expression as early 
effect, strongly suggests the enhancement of the transcelluiar pathway. On the other hand, 
increased hydrophilic macromolecular permeability and a decreased TER, concomitant with 
alterations in junctional ZO-1 expression but without LDH leakage strongly suggests the 
enhancement of the paracellular pathway. 
With respect to studies on the modulation of intestinal epithelial barrier function, the 
Caco-2 proves to be a more convenient model than the IEC-18 cells. The most important 
reason is the high basal barrier function for hydrophilic molecules of the Caco-2 cells relative 
to the low barrier function of IEC-18 cells. In IEC-18 cells it proved difficult to measure TER 
accurately and the window for decreases in TER or increases in permeability rates were much 
more narrow than in Caco-2 cells. The IEC-18 cells were also found to be somewhat more 
sensitive to cell damage than Caco-2 cells, and both cell lines are probably more sensitive than 
the intestinal epithelium in vivo. The higher sensitivity may be due to the lack of a mucus 
layer in cultures of these two cell lines. Attempts to tackle this problem by the co-culture of 
enterocyte-like and mucus secreting Goblet-like cells, met with limited success (Wikman-
Larhed and Artursson, 1995). Additionally, it must be noted that Caco-2 cells are adenoma 
carcinoma derived and some of the cell signaling pathways, involved in for example tight 
junction regulation, may not be operative in these cells. Other cell lines such as HT-29 or T84 
or perhaps, differentiated IEC-18 cells, will prove to be more appropriate for studies to 
physiological barrier integrity regulation. 
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§ 8.3 Conclusions and Perspectives 
From the work described in this thesis the following conclusions are drawn: 
In vitro permeation rates obtained with filter-grown IEC-18 cells allowed for a better 
discrimination between hydrophilic compounds, which differed in their molecular 
size, than the rates obtained in the Caco-2 system did. Consequently, filter-grown IEC-
18 cells can be valuable as model to assess small intestinal paracellular permeability. 
IEC-18 cells can be induced to acquire a more villus-like phenotype when cultured in 
the presence of dexamethasone. After the transition from flat, stapling cells, to 
cuboidal cells forming a monolayer, the cells had achieved a higher organization of 
junction-related proteins (F-actin and ZO-1). Moreover, the monolayer of cells 
presented an increase in paracellular barrier function for electrolytes (increase in TER) 
and hydrophilic macromolecules. The IEC-18 cells might thus present an in vitro 
model to study the relation between intestinal epithelial cell differentiation and 
paracellular barrier development along he crypt-villus axis. 
- The intestinal Caco-2 and IEC-18 cells in the two compartment system present a 
valuable model to screen for effects of ingested compounds on intestinal epithelial 
barrier integrity. Due to their high basal barrier function, the Caco-2 cells present a 
more convenient model to assess enhancement of epithelial permeability than the IEC-
18 cells. 
- Increased hydrophilic macromolecular permeability concomitant with LDH leakage 
but without alterations in junctional ZO-1 expression (as early effect), is indicative for 
transcellular permeation enhancement. Increased hydrophilic macromolecular 
permeability and a decreased TER, concomitant with alterations in junctional ZO-1 
expression but without LDH leakage, is indicative for paracellular permeation 
enhancement. 
With the evaluation of filter-grown IEC-18 cells as a model to study transepithelial 
permeability of hydrophilic macromolecules, we show that "paracellular permeation prognosis 
beyond Caco-2" is possible. The IEC-18 cells, cultured under standard conditions or in the 
presence of dexamethasone, might offer the possibility to close one of the gaps left open by 
the Caco-2 system. The Caco-2 cells present a good first screen to distinguish between 
paracellular or transcellular permeation and to determine permeation rates for the transcellular 
permeating compounds. Permeation experiments with IEC-18 cells should allow for the 
assessment of in vitro permeation rates which can be used to predict oral bioavailability, of 
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hydrophilic compounds which depend on paracellular permeation. These two intestinal cell 
lines together, offer the possibility to obtain permeation rates enabling bioavailability 
modeling for virtually all classes of compounds. Without doubt it would be much more 
convenient if permeability rates for all compounds could be assessed with one cell culture 
model. Perhaps the IEC-18 cells cultured in the presence of dexamethasone present the basis 
for that model. 
Furthermore, the filter-grown intestinal epithelial cell lines can be used to determine 
adverse effects of, for example, drug absorption enhancers, food contaminants or 
nutraceuticals on the intestinal epithelium. Since this system offers the possibility to assess 
several parameters, such as TER, LDH leakage, and macromolecular permeation or junctional 
protein localization within one experiment, it allows for the determination of the most likely 
mechanism of barrier disruption. Additionally, the fact that it is now possible to elucidate the 
ratio between the efficacy and the toxicity may advance the search for a save drug permeation 
enhancer. Since the co-administration of absorption enhancers has met with little success, due 
to the surfactant-like lytic properties, most recently much attention has been paid to other, 
maybe more selective strategies, such as receptor-mediated transcytosis for macromolecules 
(Swaan, 1998) and the development of peptidomimetric drugs which can be substrates for the 
di/tripeptide transporters (Eddy et ah, 1995). Nevertheless, the search for drug absorption 
enhancers with a specific effect on the paracellular permeation is still continuing, and some 
promisfull compounds (e.g. zonula occludens toxin and chitosans) are still under 
investigation. The in vitro systems and research strategies presented in this thesis might help 
to elucidate the modes of action of these, and other compounds, in the future. 
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Samenvatting 
Doorlaatbaarheid en beinvloeding van het darmepitheel in vitro 
Inleiding 
Niet alle stoffen die we via de mond binnen krijgen, worden in gelijke mate 
opgenomen. De hoeveelheid van een stof die wordt opgenomen wordt voor een belangrijk 
deel bepaald door de snelheid waarmee die stoffen de darmwand kunnen passeren en deze 
darmwand bestaat uit verschillende lagen weefsel, waarvan het epitheel de belangrijkste is. 
Het epitheel is slechts een cellaag dik en vormt de bekleding van de darm en dus de eigenlijke 
afscheiding tussen de inhoud van de darm (het darm lumen), en de systemische bloedsomloop 
(het inwendige lichaam). Het epitheel beschikt over allerlei transport-systemen die zorgen 
voor de actieve opname van voedingstoffen, zouten en water, maar het epitheel verhindert ook 
de opname van giftige stoffen en voorkomt het binnendringen van virussen en bacterien. Het 
is dus duidelijk dat inzicht in de eigenschappen die de permeabiliteit van het darm epitheel 
bepalen, belangrijk is om in te kunnen schatten wat de actuele opname (de bio-
beschikbaarheid) van een voedingsmiddel, een medicijn, een voedingsupplement of juist een 
giftige stof, zal kunnen zijn. In de darm en het lichaam van vrijwilligers en proefdieren spelen 
echter zoveel complexe processen door elkaar, dat het moeilijk is om op die manier, dus in 
vivo, aan voldoende nauwkeurige gegevens te komen. Daarbij worden tegenwoordig zoveel 
medicijnen en andere chemische producten ontwikkeld dat het ondoenlijk en on-ethisch is 
deze allemaal in vivo te testen op hun bio-beschikbaarheid. 
Om deze redenen is een eenvoudig, goedkoop, nauwkeurig en reproduceerbaar model 
nodig die het mogelijk maakt om in vitro de permeabiliteit van het darm epitheel voor die stof 
te bepalen. In de experimenten beschreven in dit proefschrift wordt een in vitro systeem 
gebruikt waarbij darm epitheel cellen worden gekweekt op een filter dat in een kweekbakje 
hangt. Zodra de cellen tegen elkaar aangroeien, een confluente cellaag vormen, hechten ze aan 
elkaar en vormen ze een barriere waardoor ze het systeem verdelen in twee compartimenten. 
Als, zoals hier het geval is, gebruik wordt gemaakt van darm epitheel cellen wordt het 
bovenste compartiment, de apicale of luminale zijde genoemd en de het onderste 
compartment de basolaterale of serosale zijde. Dit twee-compartimenten systeem maakt het 
mogelijk om de passage van allerlei stoffen door de epitheliale cellaag te bepalen. Deze trans-
epitheliale passage kan plaatsvinden langs twee verschillende wegen, dwars door de eel heen, 
de transcellulaire route, of tussen de cellen door, de paracellulaire route. 
In hoeverre de in het twee-compartimenten in vitro systeem vastgestelde 
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transepitheliale passage van een bepaalde stof een goede maat is voor de permeabiliteit van 
die stof in de menselijke darm in vivo, wordt dan ook in belangrijke mate bepaald door het eel 
type dat gebmikt wordt. Een inmiddels bekende en veel gebruikte eel is de Caco-2, deze 
epitheliale eel is oorspronkelijk afkomstig van een humane dikke darmkanker, maar in een 
kweekbakje en in het twee-compartimenten systeem groeien de cellen uit tot een cellaag die 
veel lijkt op het dunne darm epitheel. Aangezien het epitheel van de dunne darm 
verantwoordelijk is voor het belangrijkste deel van de opname van voedingsstoffen, lijkt het 
Caco-2 systeem een goed model voor de bestudering van de intestinale absorptie. Voor heel 
veel stoffen is de snelheid van passage door de Caco-2 cellaag bepaald en voor veel van deze 
stoffen is de passage snelheid een goede maat voor de bio-beschikbaarheid van die stof. 
Echter, de passage van de grotere wateroplosbare stoffen (hydrofiele macromoleculen zoals 
eiwitten en sommige medicijnen) is relatief te langzaam in het Caco-2 systeem vergeleken 
met in vivo waarden. Deze hydrofiele stoffen worden niet actief opgenomen en kunnen ook 
niet passief door de eel heen, dus voor opname zijn deze stoffen afhankelijk van de 
paracellulaire route. Dit is een route die niet door de cel(membraan) heen gaat maar langs de 
cellen, dus tussen de cellen door. De barriere in de paracellulaire route, die vooral bepaald 
word door de tight junctions, is te groot in de Caco-2 eel laag en daardoor is de paracellulaire 
permeabiliteit te laag. Dit komt doordat de structuur van deze tight junctions in de Caco-2 
cellen meer lijkt op de structuur van de tight junctions in dikke darm cellen dan op die van de 
tight junctions van dunne darm cellen. Aangezien de bio-beschikbaarheid van de hydrofiele 
macromoleculen vooral bepaald wordt door de permeabiliteit van de dunne darm is voor deze 
stoffen de Caco-2 niet de meest geschikte eel. Daarom was een van de doelen van het hier 
beschreven onderzoek het opzetten en evalueren van een in vitro model voor de 
transepitheliale permeabiliteit van de dunne darm. Hierbij werd extra aandacht besteed aan de 
permeabiliteit van de hydrofiele macromoleculen. In het hier beschreven onderzoek is gebruik 
gemaakt van een epitheliale cellijn uit de dunne darm van een rat, de IEC-18 cellijn. In de 
hoofdstukken 3 en 4 zijn verschillende, aan de permeabiliteit gerelateerde karakteristieken 
van Caco-2 en IEC-18 cellen in het twee-compartimenten systeem met elkaar vergeleken. In 
hoofdstuk 3 ligt daarbij de nadruk op de ontwikkeling en groei van de cellen en de passieve 
diffusie van verschillende modelstoffen over de gekweekte epitheellagen. Tevens wordt met 
behulp van immunocytochemische technieken de intracellulaire lokalisatie van het structurele 
tight junction eiwit ZO-1 bestudeerd. In hoofdstuk 4 worden enkele actieve transport 
systemen voor bestudeerd waarvan er twee van belang zijn voor de opname van 
voedingsstoffen (absorptie functie van de darm) en twee juist van belang voor de uitscheiding 
of beperking van de opname van mogelijk schadelijke stoffen (barriere functie van de darm). 
Naast het verschil in permeabiliteit tussen de dikke en de dunne darm zijn er ook 
binnen de dunne darm langs de crypt-villus as weer locale verschillen in de epitheliale 
permeabiliteit. In de crypten worden de cellen gevormd door celdeling, de cellen verplaatsen 
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zich richting de villus en aan de top van de villus laten de cellen los en worden afgevoerd met 
de bolus (de darm inhoud). Tijdens de verplaatsing van de crypte naar de villus rijpen de 
cellen, ze krijgen steeds meer eigenschappen die van belang zijn om de uiteindelijke taak van 
de volwassen (gedifferentieerde) darmcellen, de opname van voedingsstoffen en het 
tegenhouden van schadelijke stoffen, uit te kunnen voeren. Door het rijpen (differentieren) 
van de cellen langs de crypt-villus as, is ook de permeabiliteit van het epitheel in de crypten 
anders dan de permeabiliteit van het epitheel aan de villi (zie ook figuur 2.2). het is echter nog 
niet duidelijk hoe de relatie tussen de differentiatie van de darmcellen en de paracellulaire 
permeabiliteit van het epitheel is. Daarom zijn we vervolgens in hoofdstuk 5 nagegaan in 
hoeverre de IEC-18 cellen kunnen worden aangezet zich te differentieren tot volgroeide dunne 
darm cellen en hoe tijdens dat proces de permeabiliteit van de cellaag veranderd. 
Zoals in de vorige alinea's is beschreven zijn er verschillen in de permeabiliteit van 
het darmepitheel tussen de verschillende regio's van de darm en langs de crypt-villus as in de 
dunne darm. De permeabiliteit kan echter ook bei'nvloed worden door stoffen die we via de 
mond kunnen binnenkrijgen zoals sommige voedsel-componenten, gifstoffen of (additieven 
van) medicijnen. De meeste stoffen waarvan bekend is hoe ze de permeabiliteit van de darm 
verhogen blijken dat te doen vanwege de oppervlakte-spanning verlagende eigenschappen van 
die stoffen. Doordat ze geheel of gedeeltelijk de celmembranen oplossen, zorgen ze voor een 
verlaging van de transcellulaire barriere en dus voor een verhoging van de passieve 
transcellulaire diffusie van hydrofiele macromoleculen. Er zijn echter ook stoffen die juist de 
paracellulaire barriere, de tight junctions, verstoren en dus zorgen voor een verhoogde 
permeabiliteit van de paracellulaire route. Het is recentelijk ontdekt dat de tight junctions 
fysiologisch gereguleerd worden en dat het dus wellicht mogelijk is om de permeabiliteit van 
de darm te verhogen zonder de cellen zelf ernstig te beschadigen of op te lossen. Deze manier 
van de permeabiliteit verhogen wordt gezien als goede methode om de opname van 
medicijnen die normaal slecht worden opgenomen, te verhogen. Het blijkt echter tot op heden 
moeilijk om onderscheid te maken tussen de stoffen die de transcellulaire permeabiliteit 
verhogen en stoffen die de paracellulaire permeabiliteit verhogen. 
Om meer inzicht te krijgen in mogelijke effecten van oraal ingenomen stoffen op het 
darmepitheel, wordt in de hoofdstukken 6 en 7 nagegaan of het mogelijk is met behulp van 
het twee-compartimenten systeem met Caco-2 of IEC-18 cellen effecten van bijvoorbeeld 
transepitheliale passage-versnellers (permeatie verhogers) of voedselcontaminanten op het 
darmepitheel in vitro te bestuderen. Uit de gegevens van hoofdstuk 6 en 7 willen we tevens 
bepalen welke parameters gemeten moeten worden om een uitspraak te kunnen doen of de 
verhoogde permeabiliteit vooral te danken is aan een verhoogde transcellulaire permeabiliteit 
of aan een verhoogde paracellulaire permeabiliteit. 
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Samenvatting van de hoofdstukken 
Transepitheliale permeabiliteit van Caco-2 en IEC-18 
Hoofdstuk 3 
Vergelijking van de permeabiliteits-karakteristieken van Caco-2 (humane colon) en 
IEC-18 (rat dunne darm) cellen. 
In de literatuur worden verschillende in vitro modellen beschreven om het transport 
over, en de doorlaatbaarheid van, het darmepitheel te bepalen. In een van die in vitro 
systemen, het twee-compartimenten celkweek-systeem, wordt veelvuldig gebruik gemaakt van 
cellen afkomstig van een colon carcinoom (Caco-2). Deze cellen lijken in veel opzichten op 
de absorptie-cellen (enterocyten) van de dunne darm, maar ze hebben ook verschillende 
eigenschappen die bij de dikke darm horen. Een belangrijk verschil tussen de dunne en de 
dikke darm is bijvoorbeeld de zeer geringe passieve diffusie van wateroplosbare stoffen door 
de paracellulaire route in de dikke darm en de daarvan afgeleide celkweek-systemen zoals de 
Caco-2 cellen in vergelijking met de paracellulaire diffusie in de dunne darm. Om in deze 
paracellulaire permeabiliteit meer inzicht te krijgen hebben we dikke (Caco-2) en dunne darm 
(IEC-18) cellen gekweekt in het twee-compartimenten systeem en de permeabiliteit van 
verschillende, water- en vetoplosbare, stoffen bestudeerd. 
Tijdens langdurige kweek (2 tot 3 weken) op filters, groeien de Caco-2 cellen uit tot 
een monolaag van volwassen enterocyt-achtige cellen: de cellen zijn gepolariseerd en hebben 
een borstelzoom waarin de enzymen sucrase-isomaltase en het darm-specifieke alkalische 
fosfatase zijn aangetoond. Daarnaast is met immunofluorescentie aangetoond dat het F-actine 
(een eiwit van het cytoskelet dat betrokken is bij cel-cel contacten) is georganiseerd in een 
perifeer gelokaliseerde ring. Bovendien komt het tight junction eiwit ZO-1 op een cel-
omgevende manier tot expressie en is het gelokaliseerd op plaatsen waar cellen onderling 
contact hebben. De IEC-18 cellen daarentegen, vormen tijdens langdurige kweek, meerdere 
cellagen op elkaar, hebben geen borstelzoom of sucrase-isomaltase activiteit maar ze vertonen 
wel, zij het niet darm-specifieke, alkalische fosfatase activiteit. Het F-actine in IEC-18 cellen 
vormt geen perifere ring maar het meeste ZO-1 is, net als in Caco-2, wel zichtbaar als een cel-
omgevende ring. Naast deze structurele verschillen is er ook een duidelijk verschil in de 
transepitheliale elektrische weerstand (TER), de Caco-2 monolaag ontwikkeld een TER van 
ongeveer 350 Q.cm2 terwijl de TER van IEC-18 cellen slechts ongeveer 55 Q.cm2 is. Dat wil 
zeggen dat de permeabiliteit voor de elektrolyten van de IEC-18 cellaag overeenkomt met de 
permeabiliteit van de dunne darm, terwijl de permeabiliteit van de Caco-2 cellaag meer op de 
permeabiliteit van de dikke darm lijkt. De permeabiliteit van beide cellen voor hydrofiele 
macromoleculen (met molecuul-gewichten van 180 tot 500.000 Da) verschilt ook aanzienlijk. 
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De permeabiliteit is voor alle hydrofiele macromoleculen laag in het Caco-2 systeem, maar 
duidelijk hoger en afhankelijk van de grootte van het molecuul, in het IEC-18 systeem. De 
permeabiliteit van vetoplosbare stoffen is daarentegen hoog en vergelijkbaar in beide 
systemen. Het blijkt dat Caco-2 cellen, met betrekking tot opname snelheid, een goed 
onderscheid maken tussen vet en wateroplosbare stoffen, maar slecht discrimineren tussen de 
paracellulair passerende wateroplosbare stoffen onderling. De IEC-18 cellen discrimineren 
minder goed tussen water en vetoplosbare stoffen maar maken wel goed onderscheid tussen 
de wateroplosbare stoffen die verschillen in molecuul-grootte. Naar aanleiding van deze 
resultaten concluderen wij dat voor het modelleren van de opname van de vetoplosbare 
stoffen het Caco-2 systeem, geschikt is, maar dat voor het modelleren van de opname van 
wateroplosbare stoffen, die alleen via de paracellulaire route kunnen worden opgenomen, 
beter het IEC-18 systeem gebruikt kan worden. 
Hoofdstuk 4 
Vergelijking van transport activiteiten in Caco-2 (humane colon) en IEC-18 (rat dunne 
darm) cellen. 
In hoofdstuk 3 is beschreven hoe de doorlaatbaarheid is van de Caco-2 en IEC-18 
cellen voor stoffen die door passieve diffusie het darm epitheel passeren. Met de proeven 
beschreven in dit hoofdstuk wordt bestudeerd in hoeverre beide cellen beschikken over de 
enzymsystemen die in de darm zorgen voor de goede opname van voedingsstoffen, of er juist 
voor zorgen dat mogelijk schadelijke stoffen niet worden opgenomen. Als voorbeelden van de 
voedingsstoffen hebben we gekeken naar het transport van het dipeptide (verbinding van 2 
aminozuren) Glycyl-Sarcosine (GlySar) en de suiker O-methyl-D-Glucose (Meth-Gluc). We 
hebben gevonden dat het enzym systeem dat zorgt voor het transport van GlySar, de proton-
afhankelijke di/tripeptide carrier, wel aanwezig is in Caco-2 cellen maar niet in de IEC-18 
cellen. Hetzelfde geldt voor de glucose carrier; er is wel actief transport van Meth-Gluc in het 
Caco-2 systeem maar niet in het IEC-18 systeem. 
Als voorbeelden van de transportsystemen die betrokken zijn bij uitscheiding, of 
beperking van de opname vanuit de darm, van mogelijk schadelijke stoffen hebben we de 
activiteiten van de transport-eiwitten P-glycoproteine en MRP2/cMOAT bestudeerd. 
Vincristine en rhodamine 123 zijn gebruikt als modelsubstraten waarvan bekend is dat de 
opname in de darm actief wordt beperkt door het P-glycoproteine. Dit eiwit is ontdekt doordat 
het in sommige tumorweefsels in hoge mate voorkwam en er voor zorgde dat cytostatica 
(tumorgroei-remmende middelen) niet werkte doordat ze actief de tumorcel werden 
uitgepompt. P-glycoproteine is ook aangetoond in de darm waar het de opname van mogelijk 
schadelijke stoffen kan verminderen. We vonden dit eiwit wel in Caco-2 cellen maar niet in 
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IEC-18 cellen. De activiteit van het andere eiwit met een mogelijk beschermende functie, het 
MRP2/cMOAT, is bestudeerd aan de hand van de efflux (het transport de eel uit) van de 
modelsubstraten calce'ine en DNP-SG. Beide substraten werden in het apicale en in het 
basolaterale compartiment teruggevonden bij zowel Caco-2 als IEC-18 cellen. Tevens was de 
efflux van calceine en DNP-SG te remmen met probenecid, een remmer van MRP2/cMOAT. 
We concluderen dan ook dat dit MRP2/cMOAT aanwezig is in de apicale en de basolaterale 
membraan in beide typen darmcellen. 
Hoofdstuk 5 
Dexamethason remt cel-proliferatie en verhoogd de paracellulaire barriere functie van 
de ratte-ileum cellijn IEC-18. 
Nadat uit de resultaten van hoofdstuk 3 en 4 bleek dat de IEC-18 cellen slechts een 
lage differentiatie graad bereikten, is geprobeerd deze cellen aan te zetten tot differentiatie 
waardoor ze meer eigenschappen gaan vertonen die horen bij een darm-villus eel in plaats van 
bij een darm-crypte eel. Door toevoeging van 1 uM dexamethason aan het kweekmedium van 
de IEC-18 cellen groeiden de cellen in een mooie mono-laag over het filter terwijl de cellen 
over elkaar heen groeiden en stapelen, als er geen dexamethason is toegevoegd. Bovendien 
veranderde door dexamethason toevoeging de vorm van de cellen van vrij platte, naar kubus-
achtige cellen en de activiteit van het foetale alkalische fosfatase werd onderdrukt. Tevens 
werd het in de eel aanwezige fibrillaire actine georganiseerd in een perifere actine ring en het 
tight junction eiwit ZO-1 werd zichtbaar als een echte cel-omgevende-ring in plaats van als 
een gefragmenteerde ketting zoals in de onbehandelde cellen. Naast al deze morfologische 
veranderingen, verminderde de permeabiliteit van de cellaag voor zowel de elektrolyten 
(lagere TER), als voor de grotere wateroplosbare moleculen. Tevens werd aangetoond dat de 
toegenomen barriere functie van de cellaag weer verlaagd kon worden, tot het niveau van de 
onbehandelde cellen, als de cellaag behandeld werd met TPA of EGTA. Omdat deze stoffen 
specifiek de permeabiliteit van de paracellulaire route verhogen door een effect op de tight 
junctions werd verondersteld dat toevoeging van dexamethason leidde tot een verhoogde 
functionaliteit van de tight junctions. Omdat ook in de darm waarschijnlijk de permeabiliteit 
van de paracellulaire route bij de villus lager is dan in de crypt, wordt gesuggereerd dat het 
kweken van deze IEC-18 cellen in aanwezigheid van dexamethason kan leiden tot een model 
waarmee de permeabiliteit van de paracellulaire route langs de crypt-villus as in de darm kan 
worden bestudeerd. 
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Effecten op de intestinale epitheliale barriere in vitro 
In de experimenten die beschreven zijn in de hoofdstukken 6 en 7 zijn de op de filters 
gekweekte cellen blootgesteld aan een zogenaamde "drug absorption enhancer" (opname 
verhoger, hoofdstuk 6) en aan het zware metaal cadmium (Hoofdstuk 7), waarvan bekend is 
dat het effecten heeft op het junctional complex en de permeabiliteit van niercellagen in vitro. 
Een "drug absorption enhancer" is een stof die aan bijvoorbeeld medicijnen kan worden 
toegevoegd om er voor te zorgen dat de opname van het medicijn in de darm tijdelijk wordt 
verhoogd. Voor beide stoffen hebben we bestudeerd wat de effecten zijn op de gekweekte 
cellen die model staan voor het epitheel van de darm. Er werd daarbij vooral gelet op welke 
manier en in welke mate de barriere wordt aangetast. Hierbij werd gebruik gemaakt van 
functionele parameters (de TER en de permeabiliteit voor hydrofiele macromolculen), van 
morfologische parameters (kwalitatieve en kwantitatieve immunohistochemische localizatie 
van tight junction eiwitten en F-actine) en van cytotoxiciteits-testen (LDH lekkage, opname 
van neutral rood of propidium jodide). 
Hoofdstuk 6 
Verhoogde absorptie, structured verandering in de tight junctions en cytotoxiciteit 
veroorzaakt door palmitoyl carnitine in Caco-2 en IEC-18 cellen. 
Van palmitoyl carnitine (PCC) is bekend dat het de opname van wateroplosbare 
stoffen in de darm kan verhogen, dus dat het de barriere functie verlaagt. Het is echter niet 
bekend wat het werkingsmechanisme is waarmee de barriere functie word verminderd. Om 
meer inzicht te krijgen in dat werkingsmechanisme hebben we de cellen, Caco-2 en IEC-18, 
vanaf de darm-lumen kant blootgesteld aan PCC en bepaald wat de effecten zijn op de 
doorlaatbaarheid voor grote wateroplosbare moleculen, wat er vervolgens gebeurd met de 
viabiliteit ("gezondheid" of "levensvatbaarheid") van de cellen en wat er gebeurd met de 
expressie of de lokalizatie van het ZO-1 eiwit. 
We hebben gevonden dat door blootstelling aan PCC de transepitheliale elektrische 
weerstand van de cellagen werd verlaagd en dat de doorlaatbaarheid voor grotere 
wateroplosbare moleculen werd verhoogd. Daarnaast Week dat PCC de cel-membranen 
beschadigde. Bij hoge concentraties (> 0.4 mM) was ook de verdeling van het ZO-1 eiwit in 
de cellen veranderd waardoor plaatselijk de tight junctions geen duidelijke cel-omcirkelende 
structuren meer waren. Voor een goede analyse van de lokalisatie van het ZO-1 eiwit hebben 
we een methode ontwikkeld waarmee we in staat waren om te bepalen hoeveel van het ZO-1 
eiwit gerelateerd was aan het tight junction netwerk. Hiervoor werd gebruik gemaakt van met 
de confocale laser scanning microscoop gemaakte opnamen en een speciaal ontwikkeld 
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beeldverwerkings-programma. Hieruit bleek dat bij de hogere concentraties PCC de lengte 
van het tight junction gerelateerd ZO-1 netwerk inderdaad was verminderd. 
We concluderen dat PCC inderdaad de doorlaatbaarheid van de darm eel lijnen voor 
wateroplosbare moleculen verhoogt. De verhoging is echter meer gecorreleerd aan de mate 
waarin de celmembranen zijn beschadigd dan aan veranderingen in de tight junctions. We 
veronderstellen dan ook dat de verhoogde doorlaatbaarheid wordt veroorzaakt door een 
verhoging van de transcellulaire doorlaatbaarheid en niet in de eerste plaats door een 
verhoging van de paracellulaire doorlaatbaarheid. 
Hoofdstuk 7 
Effecten van cadmium chloride op de paracellulaire barriere van intestinale epitheliale 
eel lijnen. 
In de experimenten voor dit hoofdstuk hebben we in grote lijnen hetzelfde gedaan voor 
cadmium als in het vorige hoofdstuk is beschreven voor PCC. Van het zware metaal cadmium 
was bekend dat het in hoge concentraties het darm-epitheel van muizen beschadigde en dat het 
in niercellen in vitro de paracellulaire permeabiliteit verhoogde. Het was echter nog niet 
bekend of cadmium ook de structuur van de tight junction aantastte en of de effecten op de 
permeabiliteit vroege of late effecten waren. De cellen zijn blootgesteld aan cadmium en er is 
bepaald wat de effecten zijn op de TER, op de doorlaatbaarheid voor grote wateroplosbare 
moleculen, wat er gebeurd met de viabiliteit van de cellen en wat er gebeurd met het ZO-1 
eiwit. 
We hebben gevonden dat door blootstelling aan 5-10 uM cadmium de 
doorlaatbaarheid van de IEC-18 en Caco-2 cellagen voor zowel kleine geladen moleculen 
(bepaald met de TER) als voor grote wateroplosbare moleculen, werd verhoogd. Deze 
verhoging van de doorlaatbaarheid ging gepaard met zichtbare verandering in de verdeling 
van het ZO-1 eiwit maar niet met schade aan de eel membranen. De effecten van cadmium 
kwamen langzaam op gang (pas na ongeveer 4 uur) en ontwikkelde zich verder in de tijd ook 
als het extra-cellulaire cadmium werd verwijderd na 4 uur. Het bleek ook dat de cellen erg 
veel cadmium opnamen en dit niet meer uitscheidde. 
We concludeerden dat cadmium de doorlaatbaarheid van de cellagen verhoogde door 
vooral de paracellulaire route te vergemakkelijken en niet de transcellulaire route. Het is ook 
waarschijnlijk dat cadmium op deze manier zijn eigen passage door de darmwand kan 
verhogen bij niet direct cytotoxische concentraties. Dat de echte opname van cadmium 
desalniettemin toch laag is komt waarschijnlijk voor een belangrijk deel doordat de cellen veel 
cadmium kunnen opnemen en vasthouden. 
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Conclusies en perspectieven 
Uit dit onderzoek is gebleken dat het goed mogelijk is om het darmepitheel na te 
bootsen met gekweekte darm eel lijnen in het twee-compartimenten systeem. Het gebruik van 
Caco-2 cellen in dit systeem leidt tot een model dat geschikt is als eerste screening voor de 
bepaling van de opname route (dus of de transepitheliale passage transcellulair of paracellulair 
plaatsvind). Daarnaast voldoet het Caco-2 syteem goed voor de kwantitatieve bepaling van de 
te verwachte opname van de transcellulair passerende stoffen. Voor bepaling van de opname 
van de grotere wateroplosbare moleculen lijkt het IEC-18 systeem echter een beter model 
omdat met dit systeem een beter onderscheid kan worden maakt tussen de paracellulaire 
passage snelheden van moleculen die verschillen in molecuul-grootte. Door gebruik te maken 
van beide eel lijnen is het mogelijk om voor vrijwel alle klassen van stoffen de te verwachte 
opname te modelleren. Het zou zonder twijfel handiger zijn als dit met een cel-systeem zou 
kunnen, dit is tot nu toe nog niet goed mogelijk, wellicht bieden de met dexamethason 
behandelde IEC-18 cellen, de basis voor een dergelijk compleet model. 
Daarnaast heeft het in dit proefschrift beschreven onderzoek aangetoond dat het twee-
compartimenten systeem met Caco-2 en IEC-18 cellen ook gebruikt kan worden om de 
effecten van stoffen te bestuderen die de integriteit van het darmepitheel beinvloeden 
(bijvoorbeeld toevoegingen aan de voeding of aan medicijnen). Een belangrijk voordeel van 
deze in vitro systemen is dat verschillende metingen aan dezelfde darmcellaag bepaald 
kunnen worden, waardoor het mogelijk is om het meest waarschijnlijke mechanisme achter de 
verhoogde doorlaatbaarheid te bepalen. Daardoor is het nu bijvoorbeeld beter mogelijk om bij 
een verhoogde permeabiliteit te bepalen wat de verhouding is tussen de effectiviteit (voor 
hoeveel extra opname zorgt het product) en de toxiciteit (hoeveel schade aan het darm-
epitheel veroorzaakt het product). Wellicht dat de in dit proefschrift beschreven systemen en 
strategieen kunnen bijdragen aan de zoektocht naar veilige toedienings-vormen van nieuw 
ontwikkelde medicijnen of voeding-supplementen, met een suboptimale (lage) opname in de 
darm. 
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Voor onder andere je labwerk, de leuke tijden en je gezelligheid; Thea bedankt voor de 
bergen (jammer van de dalen). 
Volgens mij is er nog steeds (bijna) niets leuker dan over de kop gaan met een paar goeie 
vrienden: Arno, Jan en heren van TIVM, bedankt, ik zou die uurtjes gymmen voor geen goud 
hebben willen missen! 
Als laatste, maar zeker niet als minste, wil ik mijn familie bedanken, voor het 
onvoorwaardelijke vertrouwen in mijn kunnen, voor het altijd opdraven bij alweer de zoveelste 
verhuizing en voor alle andere vormen van steun die je tijdens zo'n promotie maar net nodig kunt 
hebben. Nel, Jan, Eric en Teuni: ontzettend bedankt! 
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